
<html lang="en"     class="pb-page"  data-request-id="a13794fe-71c6-45bc-9367-6f8b13e8ee0e"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2011.54.issue-3;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/jm101236h"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery of a 3-Pyridylacetic Acid Derivative (TAK-100) as a Potent, Selective and Orally Active Dipeptidyl Peptidase IV (DPP-4) Inhibitor" /></meta><meta name="dc.Creator" content="Yasufumi  Miyamoto" /></meta><meta name="dc.Creator" content="Yoshihiro  Banno" /></meta><meta name="dc.Creator" content="Tohru  Yamashita" /></meta><meta name="dc.Creator" content="Tatsuhiko  Fujimoto" /></meta><meta name="dc.Creator" content="Satoru  Oi" /></meta><meta name="dc.Creator" content="Yusuke  Moritoh" /></meta><meta name="dc.Creator" content="Tomoko  Asakawa" /></meta><meta name="dc.Creator" content="Osamu  Kataoka" /></meta><meta name="dc.Creator" content="Hiroaki  Yashiro" /></meta><meta name="dc.Creator" content="Koji  Takeuchi" /></meta><meta name="dc.Creator" content="Nobuhiro  Suzuki" /></meta><meta name="dc.Creator" content="Koji  Ikedo" /></meta><meta name="dc.Creator" content="Takuo  Kosaka" /></meta><meta name="dc.Creator" content="Shigetoshi  Tsubotani" /></meta><meta name="dc.Creator" content="Akiyoshi  Tani" /></meta><meta name="dc.Creator" content="Masako  Sasaki" /></meta><meta name="dc.Creator" content="Miyuki  Funami" /></meta><meta name="dc.Creator" content="Michiko  Amano" /></meta><meta name="dc.Creator" content="Yoshio  Yamamoto" /></meta><meta name="dc.Creator" content="Kathleen  Aertgeerts" /></meta><meta name="dc.Creator" content="Jason  Yano" /></meta><meta name="dc.Creator" content="Hironobu  Maezaki" /></meta><meta name="dc.Description" content="Inhibition of dipeptidyl peptidase IV (DPP-4) is an exciting new approach for the treatment of diabetes. To date there has been no DPP-4 chemotype possessing a carboxy group that has progressed int..." /></meta><meta name="Description" content="Inhibition of dipeptidyl peptidase IV (DPP-4) is an exciting new approach for the treatment of diabetes. To date there has been no DPP-4 chemotype possessing a carboxy group that has progressed int..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="January 10, 2011" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm101236h" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2011 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm101236h" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm101236h" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm101236h" /></link>
        
    
    

<title>Discovery of a 3-Pyridylacetic Acid Derivative (TAK-100) as a Potent, Selective and Orally Active Dipeptidyl Peptidase IV (DPP-4) Inhibitor | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm101236h" /></meta><meta property="og:title" content="Discovery of a 3-Pyridylacetic Acid Derivative (TAK-100) as a Potent, Selective and Orally Active Dipeptidyl Peptidase IV (DPP-4) Inhibitor" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-3/jm101236h/production/images/large/jm-2010-01236h_0015.jpeg" /></meta><meta property="og:description" content="Inhibition of dipeptidyl peptidase IV (DPP-4) is an exciting new approach for the treatment of diabetes. To date there has been no DPP-4 chemotype possessing a carboxy group that has progressed into clinical trials. Originating from the discovery of the structurally novel quinoline derivative 1, we designed novel pyridine derivatives containing a carboxy group. In our design, the carboxy group interacted with the targeted amino acid residues around the catalytic region and thereby increased the inhibitory activity. After further optimization, we identified a hydrate of [5-(aminomethyl)-6-(2,2-dimethylpropyl)-2-ethyl-4-(4-methylphenyl)pyridin-3-yl]acetic acid (30c) as a potent and selective DPP-4 inhibitor. The desired interactions with the critical active-site residues, such as a salt-bridge interaction with Arg125, were confirmed by X-ray cocrystal structure analysis. In addition, compound 30c showed a desired preclinical safety profile, and it was encoded as TAK-100." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm101236h"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm101236h">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm101236h&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm101236h&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm101236h&amp;href=/doi/10.1021/jm101236h" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2011</span><span class="cit-fg-volume">, 54</span><span class="cit-fg-issue">, 3</span><span class="cit-fg-pageRange">, 831-850</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/54/3" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm1012193" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm101273e" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of a 3-Pyridylacetic Acid Derivative (TAK-100) as a Potent, Selective and Orally Active Dipeptidyl Peptidase IV (DPP-4) Inhibitor<a class="ref internalNav" href="#ac1" aria-label=""></a></span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yasufumi++Miyamoto">Yasufumi Miyamoto</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yoshihiro++Banno">Yoshihiro Banno</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tohru++Yamashita">Tohru Yamashita</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tatsuhiko++Fujimoto">Tatsuhiko Fujimoto</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Satoru++Oi">Satoru Oi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yusuke++Moritoh">Yusuke Moritoh</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tomoko++Asakawa">Tomoko Asakawa</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Osamu++Kataoka">Osamu Kataoka</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hiroaki++Yashiro">Hiroaki Yashiro</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Koji++Takeuchi">Koji Takeuchi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nobuhiro++Suzuki">Nobuhiro Suzuki</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Koji++Ikedo">Koji Ikedo</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Takuo++Kosaka">Takuo Kosaka</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Shigetoshi++Tsubotani">Shigetoshi Tsubotani</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Akiyoshi++Tani">Akiyoshi Tani</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Masako++Sasaki">Masako Sasaki</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Miyuki++Funami">Miyuki Funami</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michiko++Amano">Michiko Amano</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yoshio++Yamamoto">Yoshio Yamamoto</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kathleen++Aertgeerts">Kathleen Aertgeerts</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jason++Yano">Jason Yano</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hironobu++Maezaki">Hironobu Maezaki</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">‡</span> <span class="aff-text">Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 17-85, Jusohonmachi 2-Chome, Yodogawa-ku, Osaka 532-8686, Japan</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">§</span> <span class="aff-text">Takeda San Diego, Inc., 10410, Science Center Drive, San Diego, California 92121, United States</span></div><div class="corresp-info"><strong>*</strong>Corresponding author. Tel: +81-6-6300-6263. Fax: +81-6-6300-6306. E-mail: <a href="/cdn-cgi/l/email-protection#450824203f242e2c1a0d2c372a2b2a27300531242e2021246b262a6b2f35"><span class="__cf_email__" data-cfemail="eca18d89968d8785b3a4859e8382838e99ac988d8789888dc28f83c2869c">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm101236h&amp;href=/doi/10.1021%2Fjm101236h" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2011</span></span><span class="cit-volume">, 54</span><span class="cit-issue">, 3</span><span class="cit-pageRange">, 831–850</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">January 10, 2011</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>23 September 2010</li><li><span class="item_label"><b>Published</b> online</span>10 January 2011</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 10 February 2011</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm101236h" title="DOI URL">https://doi.org/10.1021/jm101236h</a></div><div class="article_header-article-copyright"><strong>Copyright © 2011 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D831%26pageCount%3D20%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DYasufumi%2BMiyamoto%252C%2BYoshihiro%2BBanno%252C%2BTohru%2BYamashita%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D54%26issueNum%3D3%26contentID%3Djm101236h%26title%3DDiscovery%2Bof%2Ba%2B3-Pyridylacetic%2BAcid%2BDerivative%2B%2528TAK-100%2529%2Bas%2Ba%2BPotent%252C%2BSelective%2Band%2BOrally%2BActive%2BDipeptidyl%2BPeptidase%2BIV%2B%2528DPP-4%2529%2BInhibitor%26numPages%3D20%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D850%26publicationDate%3DFebruary%2B2011">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm101236h"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3999</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">45</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm101236h" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of a 3-Pyridylacetic Acid Derivative (TAK-100) as a Potent, Selective and Orally Active Dipeptidyl Peptidase IV (DPP-4) Inhibitor&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Yasufumi&quot;,&quot;last_name&quot;:&quot;Miyamoto&quot;},{&quot;first_name&quot;:&quot;Yoshihiro&quot;,&quot;last_name&quot;:&quot;Banno&quot;},{&quot;first_name&quot;:&quot;Tohru&quot;,&quot;last_name&quot;:&quot;Yamashita&quot;},{&quot;first_name&quot;:&quot;Tatsuhiko&quot;,&quot;last_name&quot;:&quot;Fujimoto&quot;},{&quot;first_name&quot;:&quot;Satoru&quot;,&quot;last_name&quot;:&quot;Oi&quot;},{&quot;first_name&quot;:&quot;Yusuke&quot;,&quot;last_name&quot;:&quot;Moritoh&quot;},{&quot;first_name&quot;:&quot;Tomoko&quot;,&quot;last_name&quot;:&quot;Asakawa&quot;},{&quot;first_name&quot;:&quot;Osamu&quot;,&quot;last_name&quot;:&quot;Kataoka&quot;},{&quot;first_name&quot;:&quot;Hiroaki&quot;,&quot;last_name&quot;:&quot;Yashiro&quot;},{&quot;first_name&quot;:&quot;Koji&quot;,&quot;last_name&quot;:&quot;Takeuchi&quot;},{&quot;first_name&quot;:&quot;Nobuhiro&quot;,&quot;last_name&quot;:&quot;Suzuki&quot;},{&quot;first_name&quot;:&quot;Koji&quot;,&quot;last_name&quot;:&quot;Ikedo&quot;},{&quot;first_name&quot;:&quot;Takuo&quot;,&quot;last_name&quot;:&quot;Kosaka&quot;},{&quot;first_name&quot;:&quot;Shigetoshi&quot;,&quot;last_name&quot;:&quot;Tsubotani&quot;},{&quot;first_name&quot;:&quot;Akiyoshi&quot;,&quot;last_name&quot;:&quot;Tani&quot;},{&quot;first_name&quot;:&quot;Masako&quot;,&quot;last_name&quot;:&quot;Sasaki&quot;},{&quot;first_name&quot;:&quot;Miyuki&quot;,&quot;last_name&quot;:&quot;Funami&quot;},{&quot;first_name&quot;:&quot;Michiko&quot;,&quot;last_name&quot;:&quot;Amano&quot;},{&quot;first_name&quot;:&quot;Yoshio&quot;,&quot;last_name&quot;:&quot;Yamamoto&quot;},{&quot;first_name&quot;:&quot;Kathleen&quot;,&quot;last_name&quot;:&quot;Aertgeerts&quot;},{&quot;first_name&quot;:&quot;Jason&quot;,&quot;last_name&quot;:&quot;Yano&quot;},{&quot;first_name&quot;:&quot;Hironobu&quot;,&quot;last_name&quot;:&quot;Maezaki&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2011&quot;,&quot;month&quot;:&quot;01&quot;,&quot;day&quot;:&quot;10&quot;,&quot;issue&quot;:&quot;3&quot;,&quot;volume&quot;:&quot;54&quot;,&quot;pages&quot;:&quot;831-850&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm101236h&quot;},&quot;abstract&quot;:&quot;Inhibition of dipeptidyl peptidase IV (DPP-4) is an exciting new approach for the treatment of diabetes. To date there has been no DPP-4 chemotype possessing a carboxy group that has progressed into clinical trials. Originating from the discovery of the structurally novel quinoline derivative 1, we designed novel pyridine derivatives containing a carboxy group. In our design, the carboxy group interacted with the targeted amino acid residues around the catalytic region and thereby increased the inhibitory activity. After further optimization, we identified a hydrate of [5-(aminomethyl)-6-(2,2-dimethylpropyl)-2-ethyl-4-(4-methylphenyl)pyridin-3-yl]acetic acid (30c) as a potent and selective DPP-4 inhibitor. The desired interactions with the critical active-site residues, such as a salt-bridge interaction with Arg125, were confirmed by X-ray cocrystal structure analysis. In addition, compound 30c showed a desired preclinical safety profile, and it was encoded as TAK-100.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm101236h&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm101236h" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm101236h&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm101236h" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm101236h&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm101236h" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm101236h&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm101236h&amp;href=/doi/10.1021/jm101236h" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm101236h" /></input><a href="/doi/pdf/10.1021/jm101236h" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm101236h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm101236h%26sid%3Dliteratum%253Aachs%26pmid%3D21218817%26genre%3Darticle%26aulast%3DMiyamoto%26date%3D2011%26atitle%3DDiscovery%2Bof%2Ba%2B3-Pyridylacetic%2BAcid%2BDerivative%2B%2528TAK-100%2529%2Bas%2Ba%2BPotent%252C%2BSelective%2Band%2BOrally%2BActive%2BDipeptidyl%2BPeptidase%2BIV%2B%2528DPP-4%2529%2BInhibitor%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D54%26issue%3D3%26spage%3D831%26epage%3D850%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=290703" title="Pyridines">Pyridines</a>,</li><li><a href="/action/doSearch?ConceptID=290795" title="Quinolines">Quinolines</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/54/3" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-3/jmcmar.2011.54.issue-3/production/jmcmar.2011.54.issue-3.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-3/jm101236h/production/images/medium/jm-2010-01236h_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-3/jm101236h/production/images/large/jm-2010-01236h_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101236h&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Inhibition of dipeptidyl peptidase IV (DPP-4) is an exciting new approach for the treatment of diabetes. To date there has been no DPP-4 chemotype possessing a carboxy group that has progressed into clinical trials. Originating from the discovery of the structurally novel quinoline derivative <b>1</b>, we designed novel pyridine derivatives containing a carboxy group. In our design, the carboxy group interacted with the targeted amino acid residues around the catalytic region and thereby increased the inhibitory activity. After further optimization, we identified a hydrate of [5-(aminomethyl)-6-(2,2-dimethylpropyl)-2-ethyl-4-(4-methylphenyl)pyridin-3-yl]acetic acid (<b>30c</b>) as a potent and selective DPP-4 inhibitor. The desired interactions with the critical active-site residues, such as a salt-bridge interaction with Arg125, were confirmed by X-ray cocrystal structure analysis. In addition, compound <b>30c</b> showed a desired preclinical safety profile, and it was encoded as TAK-100.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div class="extra-info-sec articleNote withdrawn"><h4><span>†</span> </h4><p class="last">PDB ID codes: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3O9V">3O9V</a> (compound <b>27c</b>) and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3O95">3O95</a> (compound <b>30c</b>).</p></div><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14128" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14128" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Inhibition of dipeptidyl peptidase IV (DPP-4<a class="ref internalNav" href="#fn1" aria-label="a">a</a><div class="NLM_fn" id="fn1">a<p class="last">Abbreviations: DPP-4, dipeptidyl peptidase IV; SBDD, structure-based drug design; SAR, structure−activity relationship.</p></div>) is an exciting new approach for the treatment of diabetes. DPP-4 is a serine protease that is ubiquitously distributed as both a membrane-bound protein and a soluble protein in plasma.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> It mediates the activities of regulatory peptides by cleaving dipeptides from the N-terminus of glucagon-like peptide-1 [7-36] amide (GLP-1[7-36]-NH<sub>2</sub>) and glucose-dependent insulinotropic polypeptide [1-42] (GIP[1-42]) to yield inactive GLP-1[9-36]-NH<sub>2</sub> peptide and GIP[3-42], respectively.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Consequently, inhibition of DPP-4 is rapidly emerging as a novel therapeutic approach for the treatment of type 2 diabetes. Extensive research efforts from both academia and industry have yielded potent DPP-4 inhibitors.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Indeed, these inhibitors have shown antidiabetic activities in both animals and humans, and clinical proof of concept has already been established with DPP-4 inhibitors. Among these, (2<i>R</i>)-4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-<i>a</i>]pyrazin-7(8<i>H</i>)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine (MK-0431, sitagliptin),<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4, 5)</a> which is the first approved DPP-4 inhibitor, has been prescribed in the US since 2006. 1-[[(3-Hydroxy-1-adamantyl)amino]acetyl]-2-cyano-(<i>S</i>)-pyrrolidine (LAF-237, vildagliptin) was approved in Europe in 2008,<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> and (1<i>S</i>,3<i>S</i>,5<i>S</i>)-2-[(<i>2S</i>)-2-amino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile (BMS-477118, saxagliptin)<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> has been approved and on the market in the US and Europe for several years. 2-({6-[(3<i>R</i>)-3-Aminopiperidin-1-yl]-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2<i>H</i>)-yl}methyl)benzonitrile (SYR-322, alogliptin) was approved in Japan in 2010.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a></div><div class="NLM_p">We previously discovered a structurally novel quinoline derivative <b>1</b><a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> that showed potent DPP-4 inhibitor activity (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-3/jm101236h/production/images/medium/jm-2010-01236h_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-3/jm101236h/production/images/large/jm-2010-01236h_0016.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structure of compound <b>1</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-3/jm101236h/production/images/large/jm-2010-01236h_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101236h&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">A docking study of the DPP-4 protein and compound <b>1</b> was conducted, and the result is shown in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>. This study showed that the primary amino group at the 3-position of the quinoline ring can interact with the Glu-motif (Glu205-Glu206) of the enzyme. The pendant phenyl group can effectively occupy the S1 pocket, and the isobutyl group can have a hydrophobic interaction with Phe357. In addition, the 2 carbonyl groups on the piperazine-2,6-dione substituent can form hydrogen bonds with Lys554 and Tyr631. This hydrogen bond formation with Lys554 indicates that the piperazine-2,6-dione can be replaced by a more appropriate substituent bearing a carboxy group. The resulting salt-bridge interaction between the carboxy group and Lys554 could then serve to increase the DPP-4 inhibitory activity. Although a number of DPP-4 inhibitors have been designed and their X-ray cocrystal structures obtained,<a onclick="showRef(event, 'ref3 ref4 ref5 ref6 ref7 ref8 ref10'); return false;" href="javascript:void(0);" class="ref ref3 ref4 ref5 ref6 ref7 ref8 ref10">(3-8, 10)</a> there are currently no reports of DPP-4 inhibitors targeting and achieving an interaction with the Lys554 of the enzyme. As described in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>, some quinoline derivatives <b>17a</b>−<b>d</b> possessing a carboxy group and with an appropriate spacer were designed and synthesized, and subsequent evaluations of these derivatives showed that they had potent DPP-4 inhibitory activities. Thus, the compounds <b>17a</b>−<b>d</b> afforded us the novel and important information that the incorporation of a carboxy group is an effective and useful way to increase the inhibition of DPP-4.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-3/jm101236h/production/images/medium/jm-2010-01236h_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-3/jm101236h/production/images/large/jm-2010-01236h_0017.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Docking study of DPP-4 protein and compound <b>1</b> (blue carbon). The amino acids (orange carbons, white text) and binding sites (red text) are indicated. The important pharmacophore is indicated by the square of red dotted lines. The hydrogen bonds are shown as yellow dotted lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-3/jm101236h/production/images/large/jm-2010-01236h_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101236h&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-3/jm101236h/production/images/medium/jm-2010-01236h_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-3/jm101236h/production/images/large/jm-2010-01236h_0018.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Design of novel quinoline derivatives possessing a carboxy group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-3/jm101236h/production/images/large/jm-2010-01236h_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101236h&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compounds <b>17a</b>−<b>d</b> are characterized by the presence of a carboxy group as a substituent. However, only a few studies have reported DPP-4 inhibitors bearing a carboxy group,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> and none of the reported molecules progressed to human clinical trials. Therefore, the discovery of DPP-4 inhibitors with a carboxy group would provide an interesting new finding in this field. As described above, the docking study of compound <b>1</b> provided us the information regarding a pharmacophore that contained a salt-bridge interaction with the Glu-motif, a hydrophobic interaction with the S1 pocket, and a hydrophobic interaction with Phe357; this pharmacophore is marked in red dotted lines in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>. The structure of this pharmacophore was consistent with what we had obtained from our X-ray cocrystal studies of small molecules with the DPP-4 enzyme and from the results of our docking studies. Therefore, we utilized this pharmacophore in the subsequent design of our pyridine derivatives. When the pyridine derivatives were designed, we employed our new finding that a carboxy group could increase the inhibitory activity by interacting with amino acid residues, especially Lys554. Although the docking study of compound <b>1</b> showed that Lys554 is a suitable target for increasing the inhibitory activity of the drug, Lys554 was widely separated from the pyridine ring. Therefore, we focused on other amino acid residues that could more easily interact with the carboxy group, for example, Arg125, His740, Ser630 and Tyr547 (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). These amino acid residues were located so close to the quinoline ring that the quinoline derivatives could not effectively utilize these interactions. In contrast, the newly designed pyridine derivatives would be able to interact with these residues effectively.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-3/jm101236h/production/images/medium/jm-2010-01236h_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-3/jm101236h/production/images/large/jm-2010-01236h_0019.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Design for reducing the conjugation of the molecule.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-3/jm101236h/production/images/large/jm-2010-01236h_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101236h&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Herein, we describe our approach that yielded a novel and highly potent DPP-4 inhibitor, a hydrate of [5-(aminomethyl)-6-(2,2-dimethylpropyl)-2-ethyl-4-(4-methylphenyl)pyridin-3-yl]acetic acid (TAK-100). This approach involved 3 major steps: (1) introduction of a carboxy group to interact with Lys554 by structure-based drug design (SBDD) analysis; (2) design of novel pyridine derivatives by preserving the fundamental pharmacophore of quinolines; and (3) optimization of the pyridine-based DPP-4 inhibitors.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80872" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80872" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The quinoline ring was constructed by the condensation of an <i>o</i>-amino benzophenone and a β-ketonitrile as described in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. The <i>o</i>-amino benzophenone <b>5</b> was prepared from commercially available anthranilic acid <b>2</b> in 3 steps: The prepared compound <b>5</b> was condensed with the β-ketonitrile <b>11A</b>, which was prepared from the compound <b>10A</b>,<a onclick="showRef(event, 'ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref11 ref12">(11, 12)</a> to yield the quinoline derivative <b>6</b>. The bromo group of <b>6</b> was then converted to a hydroxy group by performing palladium-catalyzed etheration followed by acidolysis of the resulting <i>tert</i>-butyl ether to yield <b>7</b>. The cyano group of <b>7</b> was hydrogenated using a Raney-nickel (Ni)/H<sub>2</sub> system, and the resulting amino group was protected with a <i>tert</i>-butoxycarbonyl (Boc) group to afford <b>8</b>. The obtained compound <b>8</b> was converted to the desired intermediate trifluoromethane sulfonate <b>9</b> with good yields.</div><figure id="sch1" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-3/jm101236h/production/images/medium/jm-2010-01236h_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-3/jm101236h/production/images/large/jm-2010-01236h_0020.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compounds <b>6</b> and <b>9</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-3/jm101236h/production/images/large/jm-2010-01236h_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101236h&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) triphosgene, THF, reflux, 2 h; (b) <i>N</i>,<i>O</i>-dimethyl hydroxylamine hydrochloride, Et<sub>3</sub>N, EtOH, reflux, 2 h; (c) 4-Me-C<sub>6</sub>H<sub>4</sub>−MgBr, THF, Et<sub>2</sub>O, 0 °C, 30 min; (d) <b>11A</b>, MsOH, toluene, reflux, Dean−Stark, 17 h; (e) (1) <i>tert</i>-BuOH, <i>tert</i>-BuONa, racemic BINAP, Pd(OAc)<sub>2</sub>, toluene, 70 °C, 15 h; (2) TFA, THF, rt, 4 h; (f) (1) H<sub>2</sub>, Raney-Ni, 25% NH<sub>3</sub>, MeOH, 70 °C, 8 h; (2) (Boc)<sub>2</sub>O, THF, rt, 3 h; (g) NaH, <i>N</i>-phenyl bis(trifluoromethanesulfonimide), DMF, rt, 30 min; (h) NaH, MeCN, THF, reflux, 15 h.</p></p></figure><div class="NLM_p">The quinoline derivatives possessing a carboxy group <b>17a</b>−<b>d</b> were synthesized as described in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>. Ethyl acrylate and acrolein were introduced to the compounds <b>6</b> and <b>9</b> by Heck reaction with palladium catalyst to obtain <b>12</b> and <b>13</b>, respectively. The aldehyde <b>13</b> was reduced to the corresponding alcohol. After simultaneous hydrogenation of the cyano group and olefinic double bond using the Raney-Ni/H<sub>2</sub> system, the amino group was protected with a Boc group, and the hydroxy group was converted to a cyano group to obtain <b>14</b>. Horner−Wadsworth−Emmons reaction of <b>13</b> yielded compound <b>15</b>. 5-Cyano-1-pentyne was introduced to compound <b>9</b> by Sonogashira coupling with a copper catalyst to obtain the nitrile <b>16</b>. The quinolin-6-ylpropenylate <b>12</b> was successively hydrogenated, hydrolyzed, and deprotected to obtain the quinolin-6-ylpropanoic acid <b>17a</b>. Alkali hydrolysis of the nitriles <b>14</b> and <b>16</b> followed by Boc-deprotection yielded the quinolin-6-ylbutanoic acid <b>17b</b> and the quinolin-6-ylhexanoic acid <b>17d</b>, respectively. Hydrogenation of <b>15</b> by using Raney-nickel (Ni)/H<sub>2</sub> in the DMA system yielded the corresponding quinolin-6-ylpentanoate, and subsequent hydrogenation of the cyano group by using Raney-Ni/H<sub>2</sub> in the EtOH system, Boc-protection, hydrolysis of ester, and Boc-deprotection yielded the quinolin-6-ylpentanoic acid <b>17c</b>.</div><figure id="sch2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-3/jm101236h/production/images/medium/jm-2010-01236h_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-3/jm101236h/production/images/large/jm-2010-01236h_0001.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compounds <b>17a</b>−<b>d</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-3/jm101236h/production/images/large/jm-2010-01236h_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101236h&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, ethyl acrylate, Et<sub>3</sub>N, DMF, 70 °C, 6 h; (b) acrolein, Pd(OAc)<sub>2</sub>, BnEt<sub>3</sub>NCl, DMF, 70 °C, 20 h; (c) NaBH<sub>4</sub>, THF, MeOH, 0 °C, 10 min; (d) H<sub>2</sub>, Raney-Ni, 25% NH<sub>3</sub>, MeOH, 70 °C, 3 h; (e) (Boc)<sub>2</sub>O, THF, rt, 1−3 h; (f) MsCl, Et<sub>3</sub>N, DMF, 0 °C, 30 min; (g) KCN, DMSO, 60 °C, 1.5 h; (h) NaH, (EtO)<sub>2</sub>P(O)CH<sub>2</sub>COOEt, THF, rt, 10 min; (i) 5-cyano-1-pentyne, PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, Et<sub>3</sub>N, CuI, THF, 80 °C, 10 min; (j) H<sub>2</sub>, Pd/C, EtOH, THF, rt, 2−3.5 h; (k) 1 or 2 M NaOH, THF, rt, 40 min−4 h; (l) 4 M HCl in AcOEt or dioxane, rt, 20 min−4 h; (m) 2 M NaOH, EtOH, reflux, 6−13 h; (n) (1) H<sub>2</sub>, Raney-Ni, 25% NH<sub>3</sub>, DMA, rt, 4 h; (2) H<sub>2</sub>, Raney-Ni, 25% NH<sub>3</sub>, MeOH, rt, 3 h.</p></p></figure><div class="NLM_p">The nicotinic acid derivatives <b>27a</b>−<b>i</b> were synthesized as described in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>. The pyridine ring was constructed using modified Hantzsch’s pyridine synthesis.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Commercially available esters <b>10A</b>−<b>D</b> were converted to β-ketonitriles <b>11A</b>−<b>D</b>.<a onclick="showRef(event, 'ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref11 ref12">(11, 12)</a> From <b>11A</b>−<b>D</b>, the benzylidene derivatives <b>18A</b>−<b>D</b> were prepared using Knoevenagel condensation with <i>p</i>-tolualdehyde. Condensation of Meldrum’s acid <b>20</b> with acid chlorides yielded the corresponding acyl-Meldrum’s acids <b>21A</b>−<b>E</b>. The obtained <b>21A</b>−<b>E</b> were reacted with <i>tert</i>-butanol and subsequently with ammonia to obtain aminoacrylates <b>22C</b>−<b>G</b>. The aminoacrylate <b>22B</b> was prepared from β-ketoester <b>19A</b>. The aminoacrylates <b>22A</b>−<b>G</b> were condensed with the benzylidene derivatives <b>18A</b>−<b>D</b> in acetic acid (AcOH) to obtain dihydropyridines <b>23a</b>−<b>j</b>. The dihydropyridines <b>23a</b>−<b>j</b> were oxidized with cerium ammonium nitrate (CAN) to obtain pyridine derivatives <b>24a</b>−<b>j</b>. A cyano group of <b>24a</b>−<b>j</b> was reduced to an aminomethyl group by hydrogenation with Raney-Ni/H<sub>2</sub> to obtain <b>25a</b>−<b>j</b>. After Boc-protection of <b>25a</b>−<b>c</b>, the obtained <b>26a</b>−<b>c</b> were hydrolyzed with sodium hydroxide and then deprotected with hydrochloride to obtain compounds <b>27a</b>−<b>c</b>. Acidolysis of <i>tert</i>-butyl esters <b>25d</b>−<b>i</b> yielded the desired compounds <b>27d</b>−<b>i</b>.</div><figure id="sch3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-3/jm101236h/production/images/medium/jm-2010-01236h_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-3/jm101236h/production/images/large/jm-2010-01236h_0002.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Compounds <b>27a</b>−<b>i</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-3/jm101236h/production/images/large/jm-2010-01236h_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101236h&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NaH, MeCN, THF, reflux, 8−15 h; (b) <i>p</i>-tolualdehyde, piperidine, AcOH, toluene, reflux, Dean−Stark, 5−8 h; (c) 25% NH<sub>3</sub>, MeOH, rt, 15 h; (d) R<sup>2</sup>COCl, CH<sub>2</sub>Cl<sub>2</sub>, rt; (e) (1) <i>tert</i>-BuOH, toluene, reflux, 6 h; (2) 25% NH<sub>3</sub>, MeOH, rt, 12 h; (f) AcOH, 80 °C, 1 h; (g) CAN, H<sub>2</sub>O, acetone, rt, 30 min; (h) H<sub>2</sub>, Raney-Ni, 25% NH<sub>3</sub>, MeOH, 40 °C, 6 h; (i) (Boc)<sub>2</sub>O, THF, rt, 1 h; (j) TFA, rt, 4 h; (k) (1) 1 M NaOH, THF, MeOH, rt, 15−72 h; (2) 4 M HCl in AcOEt or dioxane, 2 h.</p></p></figure><div class="NLM_p">3-Pyridylacetic acids <b>30a</b>−<b>c</b>, 3-pyridylpropenoic acid <b>32</b>, and 3-pyridylpropanoic acid <b>33</b> were synthesized as described in Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>. A methoxycarbonyl group of compounds <b>25c</b>, <b>25d</b>, and <b>25j</b><a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> was converted to a hydroxymethyl group with diisobutylaluminum hydride (DIBAL-H), and then an amino group of the obtained compounds was protected with the Boc group to obtain <b>28a</b>−<b>c</b> in good yield. In contrast, the DIBAL-H reduction after the <i>N</i>-Boc-protection provided only low yields of the product (data not shown), which was because of the instability of the <i>N</i>-Boc group under DIBAL-H reduction. After mesylation of the hydroxy group of <b>28a</b>−<b>c</b>, a cyano group was introduced by treating trimethylsilyl cyanide (TMSCN) and tetrabutylammonium fluoride (TBAF) in good yield. Finally, the cyano group of <b>29a</b>−<b>c</b> was hydrolyzed to a carboxy group under acidic conditions, and the subsequent <i>N</i>-deprotection yielded the desired 3-pyridylacetic acids <b>30a</b>−<b>c</b>. The obtained <b>28a</b> was oxidized to the corresponding aldehyde and subsequently converted to an α,β-unsaturated ester <b>31</b> by the Horner−Wadsworth−Emmons reaction. Alkali hydrolysis and deprotection yielded 3-pyridylpropenoic acid <b>32</b>. The alkali hydrolysis and deprotection for compound <b>32</b> after hydrogenation of <b>31</b> yielded 3-pyridylpropanoic acid <b>33</b>.</div><figure id="sch4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-3/jm101236h/production/images/medium/jm-2010-01236h_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-3/jm101236h/production/images/large/jm-2010-01236h_0003.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Compounds <b>30a</b>−<b>c</b>, <b>32</b> and <b>33</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-3/jm101236h/production/images/large/jm-2010-01236h_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101236h&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (1) DIBAL-H, toluene, −78 °C, 0.5−2 h; (2) (Boc)<sub>2</sub>O, THF, rt, 1 h; (b) (1) MsCl, Et<sub>3</sub>N, THF, 0 °C, 30 min; (2) TMSCN, TBAF, THF, rt, 1 h; (c) (1) 6 M HCl, reflux, 20−24 h; (2) (Boc)<sub>2</sub>O, AcOEt, 8 M NaOH, rt, 1−17 h; (3) 4 M HCl in dioxane, rt, 2−3 h; (d) (1) 6 M HCl, reflux, 24 h; (2) (Boc)<sub>2</sub>O, AcOEt, 8 M NaOH, rt, 1 h; (3) 6 M HCl, rt, 3 h; (4) 1 M NaOH, 5 °C, 1 h; (e) (1) MnO<sub>2</sub>, THF, rt, 19 h; (2) (EtO)<sub>2</sub>P(O)CH<sub>2</sub>CO<sub>2</sub>Et, NaH, THF, rt, 45 min; (f) 1 M NaOH, THF, 60 °C, 12 h; (g) 4 M HCl, dioxane, rt, 15 min; (h) H<sub>2</sub> (0.5 MPa), Pd/C, EtOH, 1 h.</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i7">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25822" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25822" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The synthesized compounds were evaluated for their in vitro inhibitory activity against human DPP-4, and this activity was described in terms of IC<sub>50</sub> values. We tested the enzyme selectivity against DPP-2, DPP-8, and DPP-9, since the inhibition of DPP-2<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> has been shown to result in the apoptosis of quiescent T-cells<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> and safety studies using a DPP-8/9 selective inhibitor suggest that the inhibition of both DPP-8 and DPP-9 is associated with profound toxicity in rats and dogs.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a></div><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> The Structure−Activity Relationships (SARs) of Quinoline Derivatives</h3><div class="NLM_p">First, we investigated the effect of the introduction of a carboxy group at the 6-position of the quinoline ring, and the SAR summary of this investigation is shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>. Compounds <b>17a</b>−<b>d</b> showed potent DPP-4 inhibitory activities, and these results verified our hypothesis that the introduction of a carboxy group increased the DPP-4 inhibitory activity. Compound <b>17a</b>, which possessed 2 carbon atoms between the quinoline ring and the carboxy group, showed weaker activity. On the other hand compound <b>17d</b>, which possessed 5 carbon atoms between the quinoline ring and the carboxy group, showed the most potent activity. The docking study of compound <b>17d</b> with DPP-4 protein was performed to explain the activity, and the result is shown in Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>. Compound <b>17d</b> has similar binding mode to those shown by compound <b>1</b>. For instance, the primary amino group at the 3-position of the quinoline ring can interact with the Glu-motif of the enzyme, and the pendant phenyl group can effectively occupy the S1 pocket. Furthermore, in our design, the carboxy group forms a hydrogen bond with Lys554. If the length of the linkage is two carbon atoms, the carboxy group can interact with Lys554 only in an extended form. However, if the length is five carbon atoms, multiple conformations are obtained, and the carboxy groups can interact with Lys554 by partially curling their alkyl chains. The potent inhibitory activity is well explained by two effects. One is the increase in hydrophobic interaction between the alkyl chain and DPP-4 protein, and the other is the flexible conformation of the alkyl chain that contributes to shift the carboxy group to an appropriate position near Lys554. Therefore, analysis of compounds <b>17a</b>−<b>d</b> yielded the novel and important finding that a carboxy group is an effective and useful option to increase the inhibition of DPP-4. On the basis of these results, we designed novel pyridine derivatives that contained both a carboxy group and the core pharmacophore. In the design, as shown above, Lys554 was widely separated from the pyridine ring. Therefore, for interaction with the carboxy group, we focused on other amino acid residues located near the pyridine ring, e.g., Arg125, His740, Ser630, and Tyr547.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. SAR Summary for the Quinoline Derivatives</div><p class="last"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-3/jm101236h/production/images/medium/jm-2010-01236h_0004.gif" alt="" id="fx1" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="(" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center" char="."><i>n</i></th><th class="colsep0 rowsep0" align="center" char="(">DPP-4 IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17a</b></td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char="(">23 (20−25)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17b</b></td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char="(">8.7 (7.8−9.6)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17c</b></td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char="(">9.6 (8.3−11)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17d</b></td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="char" char="(">6.6 (5.9−7.4)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="(">1.1 (1.1−1.2)</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">Inhibitory activity against human DPP-4. IC<sub>50</sub> values are shown as means with 95% confidence intervals (<i>n</i> = 3). IC<sub>50</sub> values and 95% confidence intervals were calculated from the concentration−response curves generated by GraphPad Prism and are shown in parentheses.</p></div></div></div><figure id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-3/jm101236h/production/images/medium/jm-2010-01236h_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-3/jm101236h/production/images/large/jm-2010-01236h_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. A docking study of DPP-4 protein and compound <b>17d</b> (blue carbons). The amino acids (orange carbons, white text) are indicated. The hydrogen bonds are shown as yellow dotted lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-3/jm101236h/production/images/large/jm-2010-01236h_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101236h&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> The SARs of Pyridine Derivatives</h3><div class="NLM_p">The contribution to the activity of a carbon spacer between the pyridine ring and a carboxy group is shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>. Notably, the initially designed compounds shown in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a> possessed potent DPP-4 inhibitory activities that validated our rational design. The 3-pyridylacetic acid <b>30a</b> showed potent DPP-4 inhibitory activity. The DPP-4 inhibitory activities of compounds <b>32</b> and <b>33</b>, which had a longer chain, were lower. These results indicate that the carboxy group of compounds <b>27c</b> and <b>30a</b> could interact with some of the amino acid residues near the 3-position of the pyridine ring, e.g., Arg125, Ser630, and Tyr547, as we had envisioned while designing these molecules. Longer ethylene linkage chains were found to be less appropriate for the interaction with the target residues. The X-ray structure of compound <b>27c</b> in a complex with human DPP-4, as shown in Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>, also establishes our design rationale. This structure showed that the important pharmacophore was preserved, and the primary amino group at the 5-position of the pyridine ring interacts with the Glu-motif and Tyr662. The pendant phenyl group and the isobutyl group can show interactions similar to those observed with compound <b>1</b>. Meanwhile, the methyl group at the 2-position of the pyridine ring has no important contribution to the inhibitory activity. The carboxy group at the 3-position of the pyridine ring interacts with Tyr547, which is one of our targeted amino acid residues near the pyridine ring. Compound <b>27c</b> could show potent activity by interacting with Tyr547, which was a feature that the quinoline derivatives lacked. The 3-pyridylacetic acid derivative <b>30a</b> also might interact with the targeted amino acid residues effectively. Additionally, the 3-pyridylacetic acid derivative <b>30a</b> showed remarkable selectivity for the related proteases.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. SAR Summary for the 3-Position of the Pyridine Derivatives<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div><p class="last"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-3/jm101236h/production/images/medium/jm-2010-01236h_0006.gif" alt="" id="fx2" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table single-image" border="0"><colgroup><col align="center" /></col></colgroup><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-3/jm101236h/production/images/medium/jm-2010-01236h_0007.gif" alt="" id="fx3" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Superscript <i>a</i> in column heading refers to Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>. Superscript <i>b</i>−<i>d</i> in column heading indicate inhibitory activity against rat DPP-2, human DPP-8, and human DPP-9. IC<sub>50</sub> values are shown as means with 95% confidence intervals (<i>n</i> = 3). IC<sub>50</sub> values and 95% confidence intervals were calculated from the concentration−response curves generated by GraphPad Prism and are shown in parentheses. Superscript <i>e</i>: NT, not tested.</p></div></div></div><figure id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-3/jm101236h/production/images/medium/jm-2010-01236h_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-3/jm101236h/production/images/large/jm-2010-01236h_0008.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. X-ray structure of compound <b>27c</b> (blue carbons) in a complex with human DPP-4. The amino acids (orange carbons, white text) are indicated. The hydrogen bonds are shown as yellow dotted lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-3/jm101236h/production/images/large/jm-2010-01236h_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101236h&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Because the nicotinic acid and 3-pyridylacetic acid derivatives showed almost the same activity, we selected the nicotinic acids as our lead compounds based on the fact that they were more suitable for structural conversions from a synthetic point of view. In our previous study, the <i>p</i>-tolyl group was found to be one of the most effective substituents at the 4-position of the pyridine ring. Actually, in the X-ray structure of compound <b>27c</b> in a complex with human DPP-4 (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>), the pendant phenyl group extends into the S1 pocket and shows a hydrophobic interaction. Specifically, the methyl group of the <i>p</i>-tolyl group fits well in the small hydrophobic hole at the bottom of the S1 pocket. Therefore, we investigated the SARs of the nicotinic acid derivatives at the 2- and 6-positions of the pyridine ring.</div><div class="NLM_p">The in vitro activities of compounds <b>27a</b>, <b>27b</b>, and <b>27d</b>, which bore varieties of alkyl groups at the 6-position of the pyridine ring, were evaluated and are shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>. As described above, because the 6-substituent can show a hydrophobic interaction with Phe357, the effect of hydrophobic substituent was mainly examined at the 6-position. The DPP-4 inhibitory activity of the sterically bulky analogue <b>27d</b> was same as that of <b>27c</b>. The DPP-4 inhibitory activities of compounds <b>27a</b> and <b>27b</b>, which possessed a linear alkyl chain, were 3 times lower than that of <b>27c</b>. These results indicate that the bulky alkyl chain shows more potent DPP-4 inhibitory activity. These results were explained by an interaction of the bulky hydrophobic group with the side chain of Phe357. Meanwhile, the substituents at the 6-position of the pyridine ring did not influence the selectivity for the related proteases. The neopentyl group was selected as the best substituent at the 6-position of the pyridine ring, and, next, we focused on the substituents at the 2-position of the pyridine ring.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. SAR Summary for the 6-Position of the Pyridine Derivatives</div><p class="last"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-3/jm101236h/production/images/medium/jm-2010-01236h_0009.gif" alt="" id="fx4" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="(" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" colspan="4" align="center" char="(">IC<sub>50</sub> (nM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center" char="(">DPP-4<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">DPP-2<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">DPP-8<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">DPP-9<a class="ref internalNav" href="#t3fn4" aria-label="d">d</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27a</b></td><td class="colsep0 rowsep0" align="left">Pr</td><td class="colsep0 rowsep0" align="char" char="(">57 (51−63)</td><td class="colsep0 rowsep0" align="left">NT<a class="ref internalNav" href="#t3fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">NT</td><td class="colsep0 rowsep0" align="left">NT</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27b</b></td><td class="colsep0 rowsep0" align="left">Bu</td><td class="colsep0 rowsep0" align="char" char="(">58 (49−69)</td><td class="colsep0 rowsep0" align="left">11000 (9300−13000)</td><td class="colsep0 rowsep0" align="left">NT</td><td class="colsep0 rowsep0" align="left">NT</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27d</b></td><td class="colsep0 rowsep0" align="left">neopentyl</td><td class="colsep0 rowsep0" align="char" char="(">18 (17−19)</td><td class="colsep0 rowsep0" align="left">10000 (8700−12000)</td><td class="colsep0 rowsep0" align="left">12000 (8200−17000)</td><td class="colsep0 rowsep0" align="left">12000 (9800−16000)</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">Refers to Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>.</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">Refers to Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>.</p></div><div class="footnote" id="t3fn3"><sup>c</sup><p class="last">Refers to Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>.</p></div><div class="footnote" id="t3fn4"><sup>d</sup><p class="last">Refers to Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>.</p></div><div class="footnote" id="t3fn5"><sup>e</sup><p class="last">NT: Not tested.</p></div></div></div><div class="NLM_p">The in vitro activities of compounds <b>27e</b>−<b>i</b> bearing varieties of alkyl groups at the 2-position of the pyridine ring were investigated, and the results are shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>. Selectivity for the related proteases DPP-2, DPP-8, and DPP-9 are also described in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>. Except in the case of compound <b>27g</b>, as the substituent at the 2-position of the pyridine became bulkier (Me < Et < Pr < <i>i</i>-Bu < Bn), the DPP-4 inhibitory activities increased. The DPP-4 inhibitory activity of compound <b>27g</b>, which possessed an isopropyl group, was lower than that of <b>27d</b>. This indicates that a branched-alkyl chain directly attached to the pyridine ring decreases the DPP-4 inhibitory activity and that an appropriate methylene linker between the pyridine ring and the bulky group could be necessary for potent inhibitory activity. Although compound <b>27i</b> having a benzyl group showed the most potent DPP-4 inhibitory activity, it showed poor selectivity for DPP-2. Concerning the substituent at the 2-position of pyridine ring, the presence of a bulkier substituent increased DPP-4 inhibitory activity and concurrently decreased the selectivity for DPP-2. In view of both activity and selectivity, we selected a methyl group and an ethyl group as the substituents at the 2-position of the pyridine ring, and we investigated the activities of the corresponding 3-pyridylacetic acids.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. SAR Summary for the 2-Position of the Pyridine Derivatives</div><p class="last"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-3/jm101236h/production/images/medium/jm-2010-01236h_0010.gif" alt="" id="fx5" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="(" /></col><col align="char" char="(" /></col><col align="char" char="(" /></col><col align="char" char="(" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" colspan="4" align="center" char="(">IC<sub>50</sub> (nM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center" char="(">DPP-4<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char="(">DPP-2<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char="(">DPP-8<a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char="(">DPP-9<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27e</b></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="char" char="(">5.7 (5.1−6.4)</td><td class="colsep0 rowsep0" align="char" char="(">4000 (3400−4500)</td><td class="colsep0 rowsep0" align="char" char="(">820 (560−1200)</td><td class="colsep0 rowsep0" align="char" char="(">2400 (1700−3300)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27f</b></td><td class="colsep0 rowsep0" align="left">Pr</td><td class="colsep0 rowsep0" align="char" char="(">4.4 (4.0−4.8)</td><td class="colsep0 rowsep0" align="char" char="(">2000 (1700−2300)</td><td class="colsep0 rowsep0" align="char" char="(">630 (470−840)</td><td class="colsep0 rowsep0" align="char" char="(">1600 (1300−2000)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27g</b></td><td class="colsep0 rowsep0" align="left"><i>i</i>-Pr</td><td class="colsep0 rowsep0" align="char" char="(">19.0 (17−21)</td><td class="colsep0 rowsep0" align="char" char="(">1600 (1500−1800)</td><td class="colsep0 rowsep0" align="char" char="(">2300 (1700−3000)</td><td class="colsep0 rowsep0" align="char" char="(">11000 (5400−21000)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27h</b></td><td class="colsep0 rowsep0" align="left"><i>i</i>-Bu</td><td class="colsep0 rowsep0" align="char" char="(">4.6 (4.2−5.0)</td><td class="colsep0 rowsep0" align="char" char="(">1500 (1200−1700)</td><td class="colsep0 rowsep0" align="char" char="(">420 (340−520)</td><td class="colsep0 rowsep0" align="char" char="(">3000 (2300−3800)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27i</b></td><td class="colsep0 rowsep0" align="left">Bn</td><td class="colsep0 rowsep0" align="char" char="(">2.5 (2.3−2.7)</td><td class="colsep0 rowsep0" align="char" char="(">250 (210−310)</td><td class="colsep0 rowsep0" align="char" char="(">2000 (1600−2600)</td><td class="colsep0 rowsep0" align="char" char="(">5800 (3900−8600)</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">Refers to Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>.</p></div><div class="footnote" id="t4fn2"><sup>b</sup><p class="last">Refers to Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>.</p></div><div class="footnote" id="t4fn3"><sup>c</sup><p class="last">Refers to Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>.</p></div><div class="footnote" id="t4fn4"><sup>d</sup><p class="last">Refers to Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>.</p></div></div></div><div class="NLM_p">The in vitro activities and selectivity of the selected corresponding 3-pyridylacetic acids are shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>. Between the two compounds, the DPP-4 inhibitory activity of 3-pyridylacetic acid <b>30b</b> was lower than that of <b>30c</b>. Remarkably, the 3-pyridylacetic acid <b>30c</b> showed significant selectivity for the related proteases. Meanwhile, compound <b>30b</b> offered no advantage over <b>30c</b> in terms of activity and selectivity. Considering its potent DPP-4 inhibitory activity and good selectivity, compound <b>30c</b> was selected for further evaluations.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. DPP-4 Activity and Selectivity of Compounds <b>30b</b> and <b>30c</b></div><p class="last"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-3/jm101236h/production/images/medium/jm-2010-01236h_0011.gif" alt="" id="fx6" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="(" /></col><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" colspan="4" align="center" char="(">IC<sub>50</sub> (nM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center">salt</th><th class="colsep0 rowsep0" align="center">additive</th><th class="colsep0 rowsep0" align="center" char="(">DPP-4<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">DPP-2<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">DPP-8<a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">DPP-9<a class="ref internalNav" href="#t5fn4" aria-label="d">d</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30b</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">2 HCl</td><td class="colsep0 rowsep0" align="left">none</td><td class="colsep0 rowsep0" align="char" char="(">10 (9.6−11)</td><td class="colsep0 rowsep0" align="left">NT<a class="ref internalNav" href="#t5fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="char" char=".">>100000</td><td class="colsep0 rowsep0" align="left">>100000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30c</b> (TAK-100)</td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">none</td><td class="colsep0 rowsep0" align="left">H<sub>2</sub>O</td><td class="colsep0 rowsep0" align="char" char="(">5.3 (5.1−5.4)</td><td class="colsep0 rowsep0" align="left">>100000</td><td class="colsep0 rowsep0" align="char" char=".">>100000</td><td class="colsep0 rowsep0" align="left">60000 (48000−79000)</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">Refers to Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>.</p></div><div class="footnote" id="t5fn2"><sup>b</sup><p class="last">Refers to Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>.</p></div><div class="footnote" id="t5fn3"><sup>c</sup><p class="last">Refers to Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>.</p></div><div class="footnote" id="t5fn4"><sup>d</sup><p class="last">Refers to Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>.</p></div><div class="footnote" id="t5fn5"><sup>e</sup><p class="last">Refers to Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>.</p></div></div></div><div class="NLM_p">The X-ray structure of <b>30c</b> in a complex with human DPP-4 (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>) was obtained at a resolution of 2.85 Å with well-defined electron density for the compound. The primary amine group interacts with the Glu-motif, which is located on an α-helix that protrudes from the β-propeller domain into the active site and usually recognizes the charged N-terminal end of peptide substrates. The <i>p</i>-tolyl group occupies the well-defined and hydrophobic S1 pocket. The neopentyl group shows a hydrophobic interaction with Phe357. The carboxy group interacts with the catalytic residues Ser630 and His740. In addition, it forms a salt-bridge interaction with Arg125 to yield a tight binding with the enzyme. This X-ray structure established our design rationale that some amino acid residues such as Arg125, His740, and Tyr547 would be located near the pyridine ring and the interaction with these residues could increase DPP-4 inhibitory activity.</div><figure id="fig7" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-3/jm101236h/production/images/medium/jm-2010-01236h_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-3/jm101236h/production/images/large/jm-2010-01236h_0012.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. X-ray structure of compound <b>30c</b> (green carbons) in a complex with human DPP-4. The amino acids (orange carbons, white text) are indicated. The hydrogen bonds are shown as yellow dotted lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-3/jm101236h/production/images/large/jm-2010-01236h_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101236h&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The ADME properties of <b>30c</b> were evaluated and revealed to be excellent, as shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>. Compound <b>30c</b> exhibited good metabolic stabilities and also showed very high solubility. The bioavailabilities in both rats and dogs are high, and the <i>t</i><sub>1/2(oral)</sub> values are very large, which indicated potent and long-lasting effects in in vivo studies. Although compound <b>30c</b> was metabolized into the glucuronide of compound <b>30c</b> in rats and dogs, the compositional analysis of the plasma after single oral administration to rats and dogs revealed that compound <b>30c</b> was the main component and only a small amount of glucuronide was detected in the plasma. In an ex vivo study, compound <b>30c</b> quickly inhibited DPP-4 activity in plasma almost completely within 1 h after oral administration at the dose of 0.5 mg/kg in dogs (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>). Moreover, approximately 60% and 30% inhibition of DPP-4 activity was maintained for 12 and 24 h, respectively. Compound <b>30c</b> was assessed for its ability to improve glucose tolerance in female Wistar fatty rats. Administration of single oral doses reduced the blood glucose excursion in an oral glucose tolerance test (OGTT) in a dose-dependent manner from 0.1 mg/kg when administered 60 min before an oral glucose challenge (1 g/kg) as shown in Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>. These ex vivo and in vivo studies in dogs raised expectations of reliable efficacy and therapeutic duration in clinical studies.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. ADME Profiles of <b>30c</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" colspan="4" align="center">pharmacokinetic profile<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" colspan="2" align="center"><i>t</i><sub>1/2(oral)</sub> (h)</th><th class="colsep0 rowsep0" colspan="2" align="center">BA<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a> (%)</th><th class="colsep0 rowsep0" colspan="3" align="center">metabolic stability remaining ratio<a class="ref internalNav" href="#t6fn3" aria-label="c">c</a> (%)</th><th class="colsep0 rowsep0" colspan="2" align="center">solubility (μg/mL) (37 °C, 2 h)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">rat</th><th class="colsep0 rowsep0" align="center">dog</th><th class="colsep0 rowsep0" align="center">rat</th><th class="colsep0 rowsep0" align="center">dog</th><th class="colsep0 rowsep0" align="center">rat</th><th class="colsep0 rowsep0" align="center">dog</th><th class="colsep0 rowsep0" align="center">human</th><th class="colsep0 rowsep0" align="center">JP1<a class="ref internalNav" href="#t6fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center">JP2<a class="ref internalNav" href="#t6fn5" aria-label="e">e</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center">5.74 ± 2.6</td><td class="colsep0 rowsep0" align="center">4.97 ± 2.0</td><td class="colsep0 rowsep0" align="center">53.3 ± 12.8</td><td class="colsep0 rowsep0" align="center">88.0 ± 21.7</td><td class="colsep0 rowsep0" align="center">100.4</td><td class="colsep0 rowsep0" align="center">96.8</td><td class="colsep0 rowsep0" align="center">100.0</td><td class="colsep0 rowsep0" align="center">>1000</td><td class="colsep0 rowsep0" align="center">930</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>a</sup><p class="last">Rats and dogs were administered the drug intravenously at 0.1 mg/kg and orally at 1.0 mg/kg (rat: <i>n</i> = 3; dog: <i>n</i> = 4).</p></div><div class="footnote" id="t6fn2"><sup>b</sup><p class="last">BA: bioavailability.</p></div><div class="footnote" id="t6fn3"><sup>c</sup><p class="last">Metabolic stability in hepatic microsome (rat, dog, and human).</p></div><div class="footnote" id="t6fn4"><sup>d</sup><p class="last">First fluid for the disintegration test described in the Japanese Pharmacopoeia 15th edition (pH 1.2).</p></div><div class="footnote" id="t6fn5"><sup>e</sup><p class="last">Second fluid for the disintegration test described in the Japanese Pharmacopoeia 15th edition (pH 6.8).</p></div></div></div><figure id="fig8" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-3/jm101236h/production/images/medium/jm-2010-01236h_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-3/jm101236h/production/images/large/jm-2010-01236h_0013.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Ex vivo study of compound <b>30c</b> in dogs. Compound <b>30c</b> was dissolved in a 0.5% suspension of methylcellulose. Five dogs (age, 28−42 months) were orally administered the suspension at the dose of 0.5 mg/kg. Blood samples were collected from the cephalic vein before (0 h) and 0.5, 1, 2, 4, 6, 8, and 24 h after dosing. Plasma sample was prepared from each of the blood samples, and the residual DPP-4 activity was measured by a method similar to that described in the <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-3/jm101236h/production/images/large/jm-2010-01236h_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101236h&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig9" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-3/jm101236h/production/images/medium/jm-2010-01236h_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-3/jm101236h/production/images/large/jm-2010-01236h_0014.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Effects of <b>30c</b> on plasma glucose (A), plasma immunoreactive insulin (IRI) (B), baseline (0 min)-adjusted AUC<sub>0−60min</sub> of plasma glucose levels (C), and plasma IRI levels at 10 min after the oral glucose load (D) in glucose tolerance test of female Wistar fatty rats. These studies were conducted using monohydrate of compound <b>30c</b>. Doses are normalized to reflect the amount of free base administered. Values are the mean and SD (<i>n</i> = 6): (*) <i>p</i> ≤ 0.025 vs control by one-tailed Williams test; ($) <i>p</i> ≤ 0.025 vs control by one-tailed Shirley−Williams test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-3/jm101236h/production/images/large/jm-2010-01236h_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101236h&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02208" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02208" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">We optimized the lead compound 1 by using structure-based drug design (SBDD) to obtain a novel DPP-4 inhibitor for the treatment of the type 2 diabetes. We designed the introduction of a carboxy group that could increase the inhibitory activity by interacting with Lys554, which none of the previously reported DPP-4 inhibitors interacted with. Some quinoline derivatives possessing a carboxy group actually showed potent DPP-4 inhibitory activity, and the carboxy group was shown to interact with Lys554 in a docking study. Furthermore, the introduction of a carboxy group was indicated to yield DPP-4 inhibitors with a novel design. After assessing more than 50 DPP-4 X-ray cocrystal structures with small molecules originating from different chemical classes and by performing docking studies, we found an important pharmacophore for DPP-4 inhibitory activity. This pharmacophore includes a salt-bridge interaction with the Glu-motif, a hydrophobic interaction with the S1 pocket and a hydrophobic interaction with Phe357. On the basis of the information obtained by analysis of this pharmacophore, we preserved the fundamental substituents on the quinoline ring and removed the benzene ring of the quinoline. Furthermore, on the basis of the results of the docking study, we positioned the carboxy group at an appropriate site to interact with the target amino acid residues that were located near the pyridine ring, such as Arg125, His740, Ser630 and Tyr547. Actually, the designed pyridine derivatives showed potent DPP-4 inhibitory activities that were linked to the discovery of novel pyridine derivatives possessing a carboxy group as potent DPP-4 inhibitors. Finally, after further optimization, we identified a hydrate of [5-(aminomethyl)-6-(2,2-dimethylpropyl)-2-ethyl-4-(4-methylphenyl)pyridin-3-yl]acetic acid (<b>30c</b>) as a potent and selective DPP-4 inhibitor. The interaction between the carboxy group of <b>30c</b> and the target amino acid residues was confirmed by the X-ray cocrystal structure, and, especially, the carboxy group showed a salt-bridge interaction with Arg125. Finally, compound <b>30c</b> showed a desired preclinical safety profile.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38587" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38587" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Melting points were determined with a Yanagimoto melting point apparatus or a Büchi melting point apparatus B-545 and are uncorrected. <sup>1</sup>H NMR spectra were obtained at 200 or 300 MHz on a Varian Gemini-200 or a Varian Ultra-300 spectrometer. Chemical shifts are given in δ values (ppm) using tetramethylsilane as the internal standard. Peak multiplicities are expressed as follows. Abbreviations are used as follows: s, singlet; d, doublet; t, triplet; q, quartet; dd, doublet of doublets; brs, broad singlet; brd, broad doublet; m, multiplet. Elemental analyses and HRMS were carried out by Takeda Analytical Laboratories Ltd. Reactions were followed by TLC on silica gel 60 F 254 precoated TLC plates (E. Merck) or NH TLC plates (Fuji Silysia Chemical Ltd.). Chromatographic separations were carried out on silica gel 60 (0.063−0.200 or 0.040−0.063 mm, E. Merck) or basic silica gel (Chromatorex NH, 100−200 mesh, Fuji Silysia Chemical Ltd.) using the indicated eluents. Yields are unoptimized. Chemical intermediates were characterized by <sup>1</sup>H NMR. The purities of all compounds tested in biological systems were assessed as being >95% using analytical HPLC. The HPLC analyses were performed using a Shimadzu UFLC instrument. Elution was done with a gradient of 5−90% solvent B in solvent A (solvent A was 0.1% TFA in water, and solvent B was 0.1% TFA in acetonitrile) through an L-column 2 ODS (3.0 × 50 mm, 2 μm) column at 1.2 mL min<sup>−1</sup>. Area % purity was measured at 220 and 254 nm.</div><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> 6-Bromo-2<i>H</i>-3,1-benzoxazine-2,4(1<i>H</i>)-dione (<b>3</b>)</h3><div class="NLM_p last">A mixture of 2-amino-5-bromobenzoic acid <b>2</b> (25 g, 116 mmol) and triphosgene (34.4 g, 116 mmol) in THF (500 mL) was stirred at 70 °C for 2 h. The reaction mixture was cooled to room temperature and poured into water. The precipitate was collected by filtration and washed with MeOH to give <b>3</b> (27.1 g, 97%) as a white powder. <sup>1</sup>H NMR (200 MHz, CDCl<sub>3</sub>) δ: 7.19 (1H, d, <i>J</i> = 8.4 Hz), 7.96−8.02 (1H, m), 8.09 (1H, d, <i>J</i> = 2.6 Hz).</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> 2-Amino-5-bromo-<i>N</i>-methoxy-<i>N</i>-methylbenzamide (<b>4</b>)</h3><div class="NLM_p last">A mixture of triethylamine (22.3 mL, 160 mmol) and <i>N</i>,<i>O</i>-dimethyl hydroxylamine hydrochloride (15.6 g, 160 mmol) in EtOH (100 mL) was stirred at room temperature for 30 min. To the mixture was added <b>3</b> (27 g, 112 mmol), and the mixture was refluxed for 2 h. The reaction mixture was poured into water and extracted with AcOEt, and the mixture was washed with brine. The organic layer was separated, dried over anhydrous MgSO<sub>4</sub> and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (hexane/AcOEt = 50/50) to give <b>4</b> (21.4 g, 74%) as a yellow powder. <sup>1</sup>H NMR (200 MHz, CDCl<sub>3</sub>) δ: 3.34 (3H, s), 3.59 (3H, s), 4.67 (2H, brs), 6.59 (1H, d, <i>J</i> = 8.4 Hz), 7.26 (2H, dd, <i>J</i> = 2.6, 8.8 Hz), 7.50 (1H, d, <i>J</i> = 2.4 Hz).</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> (2-Amino-5-bromophenyl)(4-methylphenyl)methanone (<b>5</b>)</h3><div class="NLM_p last">To a solution of <b>4</b> (5.0 g, 19.3 mmol) in diethyl ether (50 mL) and THF (10 mL) was added 1 M <i>p</i>-tolyl magnesium bromide THF solution (60 mL, 60 mmol) dropwise at 0 °C, and the mixture was stirred for 30 min. The reaction mixture was quenched with water and extracted with AcOEt. The organic layer was washed with brine, separated, dried over anhydrous MgSO<sub>4</sub> and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (hexane/AcOEt = 75/25) to give <b>5</b> (3.54 g, 63.2%) as a yellow powder. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 2.44 (3H, s), 5.98 (2H, brs), 6.64 (1H, d, <i>J</i> = 8.9 Hz), 7.28 (2H, d, <i>J</i> = 7.9 Hz), 7.35 (1H, dd, <i>J</i> = 2.3, 8.9 Hz), 7.55−7.60 (3H, m).</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> 6-Bromo-4-(4-methylphenyl)-2-(2-methylpropyl)quinoline-3-carbonitrile (<b>6</b>)</h3><div class="NLM_p last">A mixture of <b>5</b> (3.4 g, 11.7 mmol), <b>11A</b> (1.76 g, 14.1 mmol), methanesulfonic acid (1.13 g, 11.7 mmol) and toluene (200 mL) was heated under reflux for 17 h using a Dean−Stark trap. The reaction mixture was allowed to cool to room temperature, washed with saturated NaHCO<sub>3</sub> solution, dried over anhydrous MgSO<sub>4</sub> and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (hexane/AcOEt = 5/1) to give <b>6</b> (2.72 g, 61.2%) as colorless crystals. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 1.05 (6H, d, <i>J</i> = 6.8 Hz), 2.30−2.50 (1H, m), 2.50 (3H, s), 3.10 (2H, d, <i>J</i> = 7.4 Hz), 7.34 (2H, d, <i>J</i> = 8.2 Hz), 7.42 (2H, d, <i>J</i> = 8.2 Hz), 7.80−7.90 (2H, m), 7.99 (1H, d, <i>J</i> = 9.0 Hz). mp 168.9−169.1 °C.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> 6-Hydroxy-4-(4-methylphenyl)-2-(2-methylpropyl)quinoline-3-carbonitrile (<b>7</b>)</h3><div class="NLM_p last">A mixture of racemic BINAP (1.0 g, 1.6 mmol) and palladium acetate (121 mg, 0.54 mmol) in toluene (200 mL) was stirred at 50 °C for 30 min under argon atmosphere. The reaction mixture was cooled to room temperature, and then <b>6</b> (20.5 g, 54 mmol), <i>tert</i>-BuOH (10.5 mL, 110 mmol) and sodium <i>tert</i>-butoxide (7.7 g, 80 mmol) were added. The mixture was stirred at 70 °C for 15 h under argon atmosphere. The reaction mixture was allowed to cool to room temperature, washed with 1 M HCl, dried over anhydrous MgSO<sub>4</sub> and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (hexane/AcOEt = 85/15) to give 6-<i>tert</i>-butoxy-4-(4-methylphenyl)-2-(2-methylpropyl)quinoline-3-carbonitrile (19.9 g, 99%) as colorless crystals. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 1.06 (6H, d, <i>J</i> = 6.6 Hz), 1.34 (9H, s), 2.31−2.44 (1H, m), 2.49 (3H, s), 3.09 (2H, d, <i>J</i> = 7.2 Hz), 7.20 (1H, d, <i>J</i> = 2.1 Hz), 7.33−7.36 (2H, m), 7.37−7.40 (2H, m), 7.48 (1H, dd, <i>J</i> = 2.1, 9.0 Hz), 8.02 (1H, d, <i>J</i> = 9.0 Hz). A mixture of 6-<i>tert</i>-butoxy-4-(4-methylphenyl)-2-(2-methylpropyl)quinoline-3-carbonitrile (19.9 g, 54 mmol), trifluoroacetic acid (50 mL) and THF (10 mL) was stirred at room temperature for 4 h. The reaction mixture was concentrated under reduced pressure. The residue was partitioned between AcOEt and water. The organic layer was washed with brine, dried over anhydrous MgSO<sub>4</sub> and concentrated under reduced pressure. The residue was crystallized from diisopropyl ether to give <b>7</b> (10.4 g, 61%) as a white powder. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 1.03 (6H, d, <i>J</i> = 6.6 Hz), 2.20−2.45 (1H, m), 2.46 (3H, s), 3.06 (2H, d, <i>J</i> = 7.3 Hz), 6.28 (1H, brs), 6.97 (1H, d, <i>J</i> = 2.9 Hz), 7.25−7.40 (4H, m), 7.41 (1H, dd, <i>J</i> = 2.9, 9.2 Hz), 8.02 (1H, d, <i>J</i> = 9.2 Hz). mp 247.7−249.1 °C.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> <i>tert</i>-Butyl {[6-Hydroxy-4-(4-methylphenyl)-2-(2-methylpropyl)quinolin-3-yl]methyl}carbamate (<b>8</b>)</h3><div class="NLM_p last">A mixture of <b>7</b> (10 g, 33 mmol), 25% NH<sub>3</sub> solution (10 mL), Raney-Ni (10 mL), THF (50 mL) and MeOH (50 mL) was stirred at 70 °C under H<sub>2</sub> atmosphere (0.5 MPa) for 8 h and filtered through a Celite pad. The filtrate was partitioned between AcOEt and water. The organic layer was separated, dried over anhydrous MgSO<sub>4</sub> and concentrated under reduced pressure. The residue was dissolved in THF (100 mL), and to the solution was added (Boc)<sub>2</sub>O (7.8 g, 36 mmol). After stirring at room temperature for 3 h, the mixture was concentrated under reduced pressure. The residue was crystallized from diisopropyl ether to give <b>8</b> (7.5 g, 54%) as a pale yellow powder. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 0.97 (6H, d, <i>J</i> = 6.6 Hz), 1.40 (9H, s), 2.22−2.27 (2H, m), 2.43 (3H, s), 2.91 (2H, d, <i>J</i> = 7.2 Hz), 4.27 (2H, s), 6.63 (1H, d, <i>J</i> = 3.0 Hz), 7.08 (1H, dd, <i>J</i> = 3.0, 9.0 Hz), 7.09 (1H, br), 7.21−7.29 (3H, m), 7.89 (1H, d, <i>J</i> = 9.0 Hz).</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> 3-{[(<i>tert</i>-Butoxycarbonyl)amino]methyl}-4-(4-methylphenyl)-2-(2-methylpropyl)quinolin-6-yl Trifluoromethanesulfonate (<b>9</b>)</h3><div class="NLM_p last">To a solution of <b>8</b> (1.5 g, 3.6 mmol) in DMF (10 mL) was added sodium hydride (60% in oil) (0.21 g, 5.4 mmol) at 0 °C, and the mixture was stirred for 10 min. To the reaction mixture was added <i>N</i>-phenyl-bis(trifluoromethanesulfonimide) (1.9 g, 5.4 mmol), and the mixture was stirred at room temperature for 30 min. The mixture was partitioned between AcOEt and water. The organic layer was separated, dried over anhydrous MgSO<sub>4</sub> and concentrated under reduced pressure. The residue was crystallized from diisopropyl ether to give <b>9</b> (1.5 g, 75%) as a pale yellow powder. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 1.01 (6H, d, <i>J</i> = 6.6 Hz), 1.41 (9H, s), 2.33−2.420 (1H, m), 2.49 (3H, s), 2.97−3.01 (2H, m), 4.33 (2H, s), 7.12 (2H, d, <i>J</i> = 8.0 Hz), 7.25 (1H, d, <i>J</i> = 3.0 Hz), 7.36 (2H, d, <i>J</i> = 8.0 Hz), 7.52 (1H, dd, <i>J</i> = 3.0, 7.4 Hz), 8.13 (1H, d, <i>J</i> = 7.4 Hz).</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> 5-Methyl-3-oxohexanenitrile (<b>11A</b>)</h3><div class="NLM_p last">Compound <b>11A</b> was prepared by procedures described in the references.<a onclick="showRef(event, 'ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref11 ref12">(11, 12)</a> To a suspension of sodium hydride (60% in oil) (30.2 g, 666 mmol) in THF (300 mL) was added a mixture of methyl 3-methylbutanoate <b>10A</b> (50 mL, 333 mmol) and acetonitrile (39 mL, 666 mmol) dropwise at 70 °C. The mixture was stirred at 70 °C for 15 h. The reaction mixture was quenched with water and washed with hexane. The aqueous layer was acidified with concentrated HCl and extracted with AcOEt. The organic layer was separated, dried over anhydrous MgSO<sub>4</sub> and concentrated under reduced pressure to give <b>11A</b> (41 g, 98%) as a pale yellow oil. Compound <b>11A</b> was used for the next reaction without further purifications. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 0.96 (6H, d, <i>J</i> = 6.6 Hz), 2.11−2.28 (1H, m), 2.50 (2H, d, <i>J</i> = 6.8 Hz), 3.42 (2H, s).</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> 3-Oxohexanenitrile (<b>11B</b>)</h3><div class="NLM_p last">A suspension of sodium hydride (60% in oil) (18 g, 0.44 mol) in THF (160 mL) was stirred at 70 °C, and a solution of methyl butyrate (<b>10B</b>) (26 mL, 0.22 mol) and acetonitrile (23 mL, 0.44 mol) in THF (50 mL) was added dropwise. The mixture was stirred at 70 °C for 8 h. Water was added to the reaction mixture and filtered. The filtrate was washed with hexane and hexane−diethyl ether (1:1). The aqueous layer was separated, acidified with concentrated HCl and extracted with AcOEt. The extract was washed with brine and dried over anhydrous MgSO<sub>4</sub>. The solvent was evaporated to give <b>11B</b> (20 g, 82%) as a pale yellow oil. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ: 0.95 (3H, t, <i>J</i> = 7.2 Hz), 1.60−1. 72 (2H, m), 2.59 (2H, t, <i>J</i> = 7.2 Hz), 3.50 (2H, s).</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> 3-Oxoheptanenitrile (<b>11C</b>)</h3><div class="NLM_p last">Compound <b>11C</b> was prepared in a manner similar to that described for <b>11A</b> in quantitative yield (crude). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ:0.92 (3H, t, <i>J</i> = 7.3 Hz), 1.31−1.33 (2H, m), 1.58−1.62 (2H, m), 2.60−2.64 (2H, m), 3.46 (2H, s).</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> 5,5-Dimethyl-3-oxohexanenitrile (<b>11D</b>)</h3><div class="NLM_p last">Compounds <b>11D</b> was prepared in a manner similar to that described for <b>11A</b> in quantitative yield (crude). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 1.05 (9H, s), 2.49 (2H, s), 3.43 (2H, s).</div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> Ethyl (2<i>E</i>)-3-[3-{[(<i>tert</i>-Butoxycarbonyl)amino]methyl}-4-(4-methylphenyl)-2-(2-methylpropyl)quinolin-6-yl]prop-2-enoate (<b>12</b>)</h3><div class="NLM_p last">To a solution of <b>9</b> (1.5 g, 2.8 mmol) in DMF (10 mL) were added ethyl acrylate (0.65 mL, 6.0 mmol), triethylamine (4.2 mL, 30 mmol) and Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub> (21 mg, 0.030 mmol), and the resulting mixture was stirred at 70 °C for 6 h. The reaction mixture was cooled to room temperature, and water was added. The mixture was extracted with AcOEt. The organic layer was separated, dried over anhydrous MgSO<sub>4</sub> and concentrated under reduced pressure. The residue was purified by basic silica gel column chromatography (AcOEt) to give <b>12</b> (0.87 g, 62%) as a pale yellow powder. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 1.05 (6H, d, <i>J</i> = 6.6 Hz), 1.32 (3H, t, <i>J</i> = 7.2 Hz), 1.41 (9H, s), 2.34−2.39 (1H, m), 2.51 (3H, s), 4.25 (2H, q, <i>J</i> = 7.2 Hz), 4.33−4.36 (4H, m), 6.41 (1H, d, <i>J</i> = 15.9 Hz), 7.12 (2H, d, <i>J</i> = 7.8 Hz), 7.36 (2H, d, <i>J</i> = 7.8 Hz), 7.41 (1H, s), 7.63 (1H, d, <i>J</i> = 15.9 Hz), 7.89−7.91 (1H, m), 8.13−8.14 (1H, m).</div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> 4-(4-Methylphenyl)-2-(2-methylpropyl)-6-[(1<i>E</i>)-3-oxoprop-1-en-1-yl]quinoline-3-carbonitrile (<b>13</b>)</h3><div class="NLM_p last">To a solution of <b>6</b> (5 g, 13.2 mmol) in DMF (40 mL) were added acrolein (2.22 g, 6.0 mmol), triethylamine (5.5 mL, 39.6 mmol), benzyltriethylammonium chloride (3 g, 13.2 mmol) and palladium acetate (150 mg, 0.66 mmol), and the resulting mixture was stirred at 70 °C for 3 h. To the reaction mixture were added acrolein (2.22 g, 6.0 mmol) and palladium acetate (150 mg, 0.66 mmol), and the resulting mixture was stirred at 70 °C for 17 h. The reaction mixture was cooled to room temperature, and water was added. The mixture was extracted with AcOEt. The organic layer was separated, dried over anhydrous MgSO<sub>4</sub> and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (hexane/AcOEt = 75/25) to give <b>13</b> (3.26 g, 70%) as a white powder. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 1.07 (1H, d, <i>J</i> = 6.0 Hz), 2.36−2.47 (1H, m), 2.52 (3H, s), 3.14 (2H, d, <i>J</i> = 9.0 Hz), 6.74 (1H, dd, <i>J</i> = 9.0, 15.0 Hz), 7.37 (2H, d, <i>J</i> = 9.0 Hz), 7.44 (2H, d, <i>J</i> = 9.0 Hz), 7.52 (1H, d, <i>J</i> = 15.0 Hz), 7.84 (1H, d, <i>J</i> = 3.0 Hz), 8.01 (1H, d, <i>J</i> = 9.0 Hz), 8.06 (1H, d, <i>J</i> = 9.0 Hz), 9.71 (1H, d, <i>J</i> = 9.0 Hz).</div></div><div id="sec5_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> <i>tert</i>-Butyl {[6-(5-Cyanopropyl)-4-(4-methylphenyl)-2-(2-methylpropyl)quinolin-3-yl]methyl}carbamate (<b>14</b>)</h3><div class="NLM_p last">To a solution of <b>13</b> (4.04 g, 11.4 mmol) in THF (30 mL) and MeOH (30 mL) was added sodium borohydride (216 mg, 5.69 mmol) at 0 °C, and the mixture was stirred for 10 min. The reaction mixture was quenched with saturated ammonium chloride solution and extracted with AcOEt. The extract was washed with brine, dried over anhydrous MgSO<sub>4</sub> and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (hexane/AcOEt = 60/40) to give a yellow powder. The obtained yellow powder was dissolved in THF (20 mL) and MeOH (60 mL), and then 25% NH<sub>3</sub> solution (5 mL) and Raney-Ni (10 mL) were added. The mixture was stirred at 70 °C under H<sub>2</sub> atmosphere (0.5 MPa) for 3 h and filtered through a Celite pad. The filtrate was partitioned between AcOEt and water. The organic layer was separated, dried over anhydrous MgSO<sub>4</sub> and concentrated under reduced pressure. The residue was dissolved in THF (100 mL), and to the solution was added (Boc)<sub>2</sub>O (2.28 g, 10.4 mmol). After stirring at room temperature for 3 h, the reaction mixture was concentrated under reduced pressure. The residue was crystallized from hexane−diisopropyl ether to give <i>tert</i>-butyl {[6-(3-hydroxypropyl)-4-(4-methylphenyl)-2-(2-methylpropyl)quinolin-3-yl]methyl}carbamate (2.85 g, 54%) as a pale yellow powder. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 1.02 (6H, d, <i>J</i> = 6.0 Hz), 1.41 (9H, s), 1.79−1.89 (2H, m), 2.29−2.41 (1H, m), 2.48 (3H, s), 2.72 (2H, t, <i>J</i> = 6.0 Hz), 2.95 (2H, d, <i>J</i> = 6.0 Hz), 3.64 (2H, q, <i>J</i> = 6.0 Hz), 4.24−4.34 (3H, m), 7.09 (1H, brs), 7.12 (2H, d, <i>J</i> = 9.0 Hz), 7.33 (2H, d, <i>J</i> = 9.0 Hz), 7.52 (1H, dd, <i>J</i> = 3.0, 9.0 Hz), 7.99 (1H, d, <i>J</i> = 9.0 Hz). To a solution of <i>tert</i>-butyl {[6-(3-hydroxypropyl)-4-(4-methylphenyl)-2-(2-methylpropyl)quinolin-3-yl]methyl}carbamate (400 mg, 0.865 mmol) and triethylamine (175 mg, 1.73 mmol) in THF (15 mL) was added methanesulfonyl chloride (150 mg, 1.30 mmol) at 0 °C, and the resulting solution was stirred at 0 °C for 30 min. The reaction mixture was quenched with saturated NaHCO<sub>3</sub> solution and extracted with AcOEt. The organic layer was separated, washed with brine, dried over anhydrous MgSO<sub>4</sub> and concentrated under reduced pressure to give a brown oil. The brown oil was dissolved in DMSO (10 mL), and potassium cyanide (380 mg, 5.8 mmol) was added. The mixture was stirred at 60 °C for 1.5 h. The reaction mixture was diluted with AcOEt and washed with saturated NaHCO<sub>3</sub> solution and brine, sequentially. The organic layer was separated, dried over anhydrous MgSO<sub>4</sub> and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (hexane/AcOEt = 70/30) to give <b>14</b> (370 mg, 90.6% for two steps) as a yellow powder. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 1.03 (6H, d, <i>J</i> = 9.0 Hz), 1.42 (9H, s), 1.89−1.98 (2H, m), 2.28 (2H, t, <i>J</i> = 6.0 Hz), 2.32−2.43 (1H, m), 2.49 (3H, m), 2.49 (3H, s), 2.79 (2H, t, <i>J</i> = 6.0 Hz), 2.96 (2H, d, <i>J</i> = 6.0 Hz), 4.26−4.36 (3H, m), 7.09 (1H, d, <i>J</i> = 3.0 Hz), 7.12 (2H, d, <i>J</i> = 9.0 Hz), 7.34 (2H, d, <i>J</i> = 6.0 Hz), 7.48 (1H, dd, <i>J</i> = 3.0, 9.0 Hz), 8.02 (1H, d, <i>J</i> = 9.0 Hz).</div></div><div id="sec5_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Ethyl (2<i>E</i>,4<i>E</i>)-5-[3-Cyano-4-(4-methylphenyl)-2-(2-methylpropyl)quinolin-6-yl]penta-2,4-dienoate (<b>15</b>)</h3><div class="NLM_p last">To a solution of ethyl diethylphosphonoacetate (1.90 g, 10.2 mmol) in THF (50 mL) was added sodium hydride (60% in oil) (408 mg, 10.2 mmol) at 0 °C, and the resulting mixture was stirred for 10 min. To the reaction mixture was added <b>13</b>, and the mixture was stirred at room temperature for 10 min. The reaction mixture was diluted with a mixture of THF and AcOEt, and the mixture was washed with 2 M NaOH solution, 1 M HCl, saturated NaHCO<sub>3</sub> solution and brine, sequentially. The organic layer was separated, dried over anhydrous MgSO<sub>4</sub> and concentrated under reduced pressure. The residue was crystallized from diisopropyl ether to give <b>15</b> (2.71 g, 75%) as a yellow powder. The mother liquor was concentrated under reduced pressure and purified by silica gel column chromatography (hexane/AcOEt = 50/50) to give <b>15</b> (320 mg, 9%) as a yellow powder. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 1.06 (6H, d, <i>J</i> = 6.0 Hz), 1.31 (3H, t, <i>J</i> = 6.0 Hz), 2.33−2.45 (1H, m), 2.51 (3H, s), 3.12 (2H, d, <i>J</i> = 9.0 Hz), 4.23 (2 H, q, <i>J</i> = 6.0 Hz), 6.03 (1H, d, <i>J</i> = 15.0 Hz), 6.90−6.92 (2H, m), 7.35−7.45 (5H, m), 7.63 (1H, d, <i>J</i> = 3.0 Hz), 7.99 (1H, dd, <i>J</i> = 3.0, 9.0 Hz), 8.10 (1H, d, <i>J</i> = 9.0 Hz).</div></div><div id="sec5_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> <i>tert</i>-Butyl {[6-(5-Cyanopentyl)-4-(4-methylphenyl)-2-(2-methylpropyl)quinolin-3-yl]methyl}carbamate (<b>16</b>)</h3><div class="NLM_p last">To a mixture of <b>9</b> (3.03 g, 6.13 mmol), copper iodide (176 mg, 0.92 mmol), triethylamine (10 mL) and hex-5-ynenitrile (2.86 g, 30.7 mmol) was added Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub> (21 mg, 0.030 mmol), and the resulting mixture was stirred at 80 °C for 10 min under argon atmosphere. The reaction mixture was cooled to room temperature and quenched with saturated ammonium chloride solution. The mixture was extracted with AcOEt. The organic layer was separated, dried over anhydrous MgSO<sub>4</sub> and concentrated under reduced pressure to give a black powder. The black powder was recrystallized from AcOEt and hexane to give a white powder (2.56 g). A mixture of the obtained white powder (2.56 g), 10% Pd/C (50% wet, 550 mg), THF (35 mL) and EtOH (200 mL) was stirred at room temperature under H<sub>2</sub> atmosphere for 3.5 h. The reaction mixture was filtered, and the filtrate was concentrated under reduced pressure to give <b>16</b> (2.37 g, 92%) as a white powder. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 1.02 (6H, d, <i>J</i> = 6.0 Hz), 1.41 (9H, s), 1.56−1.69 (6H, m), 2.29 (2H, t, <i>J</i> = 6.0 Hz), 2.32−2.39 (1H, m), 2.49 (3H, s), 2.64 (2H, t, <i>J</i> = 6.0 Hz), 2.95 (2H, d, <i>J</i> = 6.0 Hz), 4.24−4.36 (3H, m), 7.05 (1H, d, <i>J</i> = 3.0 Hz), 7.13 (2H, d, <i>J</i> = 9.0 Hz), 7.34 (2H, d, <i>J</i> = 6.0 Hz), 7.49 (1H, d, <i>J</i> = 9.0 Hz), 7.99 (1H, d, <i>J</i> = 9.0 Hz).</div></div><div id="sec5_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> 3-[3-(Aminomethyl)-4-(4-methylphenyl)-2-(2-methylpropyl)quinolin-6-yl]propanoic Acid Dihydrochloride (<b>17a</b>)</h3><div class="NLM_p last">A mixture of <b>12</b> (12.57 g, 25 mmol), 10% Pd/C (50% wet, 6.1 g), THF (150 mL) and EtOH (150 mL) was stirred at room temperature under H<sub>2</sub> atmosphere for 2 h. The reaction mixture was filtered, and the filtrate was concentrated under reduced pressure. The residue was crystallized from THF and diisopropyl ether to give ethyl 3-[3-{[(<i>tert</i>-butoxycarbonyl)amino]methyl}-4-(4-methylphenyl)-2-(2-methylpropyl)quinolin-6-yl]propanoate (11.59 g, 92%) as a white powder. The obtained white powder was dissolved in THF (100 mL) and EtOH (100 mL), and 1 M NaOH solution (45 mL) was added. The mixture was stirred at room temperature for 4 h. The reaction mixture was neutralized with 1 M HCl and extracted with AcOEt. The organic layer was separated, dried over anhydrous MgSO<sub>4</sub> and concentrated under reduced pressure. The residue was crystallized from AcOEt and diisopropyl ether to give 3-[3-{[(<i>tert</i>-butoxycarbonyl)amino]methyl}-4-(4-methylphenyl)-2-(2-methylpropyl)quinolin-6-yl]propanoic acid as a white powder (10.21 g, 93%). The obtained white powder (0.47 g, 0.99 mmol) was added to 4 M HCl in 1,4-dioxane (5 mL). The mixture was stirred at room temperature for 1 h. After evaporation of the solvent, the residue was dissolved in EtOH (5 mL). To the solution was added propylene oxide, and the resulting mixture was stirred at room temperature for 10 h. The reaction mixture was concentrated under reduced pressure, and the residue was crystallized from AcOEt to give <b>17a</b> (210 mg, 57%) as a pale yellow powder. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 1.01 (6H, d, <i>J</i> = 6.8 Hz), 2.33−2.42 (1H, m), 2.46 (3H, s), 2.85 (2H, t, <i>J</i> = 7.3 Hz), 2.96 (2H, d, <i>J</i> = 6.8 Hz), 3.93 (2H, s), 7.06 (1H, d, <i>J</i> = 1.3 Hz), 7.27 (2H, d, <i>J</i> = 7.7 Hz), 7.43 (1H, d, <i>J</i> = 7.9 Hz), 7.66 (1H, dd, <i>J</i> = 8.6, 1.8 Hz), 7.95 (1H, d, <i>J</i> = 8.7 Hz). LC/MS <i>m</i>/<i>z</i> 377.2 (M + H). HPLC purity 97.61% (220 nm), 98.45% (254 nm). ESI-HRMS calcd for C<sub>24</sub>H<sub>28</sub>N<sub>2</sub>O<sub>2</sub><i>m</i>/<i>z</i> 377.2224 (M + H), found 377.2206 (M + H).</div></div><div id="sec5_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> 4-[3-(Aminomethyl)-4-(4-methylphenyl)-2-(2-methylpropyl)quinolin-6-yl]butanoic acid Dihydrochloride (<b>17b</b>)</h3><div class="NLM_p last">A mixture of <b>14</b> (3.10 g, 6.57 mmol), 2 M NaOH solution (16.5 mL) and EtOH (60 mL) was refluxed for 13 h. The mixture was acidified with 6 M HCl and extracted with AcOEt. The organic layer was separated, dried over anhydrous MgSO<sub>4</sub> and concentrated under reduced pressure. The residue was crystallized from diisopropyl ether to give a yellow powder (2.68 g, 83%). The yellow powder (400 mg, 0.815 mmol) was dissolved in 1,4-dioxane (5 mL) and added to 4 M HCl in 1,4-dioxane (10 mL). The mixture was stirred at room temperature for 20 min. The reaction mixture was concentrated under reduced pressure to give <b>17b</b> (347 mg, 99%) as a pale yellow powder. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ: 1.14 (6H, d, <i>J</i> = 6.0 Hz), 1.83−1.93 (2H, m), 2.28 (2H, t, <i>J</i> = 6.0 Hz), 2.30−2.36 (1H, m), 2.54 (3H, s), 2.82 (2H, t, <i>J</i> = 6.0 Hz), 4.33 (2H, brs), 7.35−7.44 (3H, m), 7.58 (2H, d, <i>J</i> = 9.0 Hz), 8.11 (1H, d, <i>J</i> = 9.0 Hz), 8.25−8.33 (1H, m). LC/MS <i>m</i>/<i>z</i> 391.3 (M + H). HPLC purity 100% (220 nm), 100% (254 nm). ESI-HRMS calcd for C<sub>25</sub>H<sub>30</sub>N<sub>2</sub>O<sub>2</sub><i>m</i>/<i>z</i> 391.2380 (M + H), found 391.2368 (M + H).</div></div><div id="sec5_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> 5-[3-(Aminomethyl)-4-(4-methylphenyl)-2-(2-methylpropyl)quinolin-6-yl]pentanoic Acid Dihydrochloride (<b>17c</b>)</h3><div class="NLM_p last">Compound <b>15</b> (1.51 g, 3.55 mmoL) was dissolved in <i>N</i>,<i>N</i>-dimethyl acetamide (DMA) (150 mL), and 25% NH<sub>3</sub> solution (5 mL) and Raney-Ni (4 mL) were added. The mixture was stirred at room temperature under H<sub>2</sub> atmosphere (0.5 MPa) for 4 h and filtered through a Celite pad. The filtrate was partitioned between AcOEt and water. The organic layer was separated, dried over anhydrous MgSO<sub>4</sub> and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (hexane/AcOEt = 70/30) to give ethyl 5-[3-cyano-4-(4-methylphenyl)-2-(2-methylpropyl)quinolin-6-yl]pentanoate (840 mg, 55%) as a yellow oil. The obtained ethyl 5-[3-cyano-4-(4-methylphenyl)-2-(2-methylpropyl)quinolin-6-yl]pentanoate (840 mg, 1.96 mmol) was dissolved in MeOH (150 mL), and 25% NH<sub>3</sub> solution (5 mL) and Raney-Ni (5 mL) were added. The mixture was stirred at room temperature under H<sub>2</sub> atmosphere (0.5 MPa) for 3 h and filtered through a Celite pad. To the filtrate was partitioned between AcOEt and water. The organic layer was separated, dried over anhydrous MgSO<sub>4</sub> and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (AcOEt/MeOH = 90/10) to give ethyl 5-[3-(aminomethyl)-4-(4-methylphenyl)-2-(2-methylpropyl)quinolin-6-yl]pentanoate (815 mg, 97%) as a yellow oil. The obtained ethyl 5-[3-(aminomethyl)-4-(4-methylphenyl)-2-(2-methylpropyl)quinolin-6-yl]pentanoate (815 mg, 1.9 mmol) was dissolved in THF (100 mL), and to the mixture was added (Boc)<sub>2</sub>O (2.28 g, 10.4 mmol). After stirring at room temperature for 3 h, the reaction mixture was concentrated under reduced pressure. The residue was crystallized from hexane−diisopropyl ether to give ethyl 5-[3-{[(<i>tert</i>-butoxycarbonyl)amino]methyl}-4-(4-methylphenyl)-2-(2-methylpropyl)quinolin-6-yl]pentanoate (940 mg, 95%) as a pale yellow powder. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 1.03 (6H, d, <i>J</i> = 6.0 Hz), 1.22 (2H, t, <i>J</i> = 6.0 Hz), 1.20−1.28 (2H, m), 1.55 (2H, brs), 1.59−1.62 (2H, m), 2.27 (2H, t, <i>J</i> = 6.0 Hz), 2.33−2.39 (1H, m), 2.49 (3H, s), 2.60−2.66 (2H, m), 3.00 (2H, d, <i>J</i> = 9.0 Hz), 3.77 (2H, brs), 4.06−4.16 (2H, m), 7.03 (1H, brs), 7.17 (2H, d, <i>J</i> = 9.0 Hz), 7.34 (2H, d, <i>J</i> = 9.0 Hz), 7.47 (1H, dd, <i>J</i> = 3.0, 9.0 Hz), 7.97 (1H, d, <i>J</i> = 9.0 Hz). Ethyl 5-[3-{[(<i>tert</i>-butoxycarbonyl)amino]methyl}-4-(4-methylphenyl)-2-(2-methylpropyl)quinolin-6-yl]pentanoate (940 mg, 1.81 mmol) was dissolved in THF (30 mL) and EtOH (20 mL), and 2 M NaOH solution (8.2 mL) was added. The mixture was stirred at room temperature for 40 min. The reaction mixture was neutralized with 6 M HCl and extracted with AcOEt. The organic layer was separated, dried over anhydrous MgSO<sub>4</sub>, and concentrated under reduced pressure to give 5-[3-{[(<i>tert</i>-butoxycarbonyl)amino]methyl}-4-(4-methylphenyl)-2-(2-methylpropyl)quinolin-6-yl]pentanoic acid as a colorless amorphous. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 1.03 (6H, d, <i>J</i> = 6.0 Hz), 1.41 (9H, s), 1.59−1.67 (4H, m), 2.27−2.37 (3H, m), 2.48 (3H, s), 2.61−2.69 (2H, m), 2.99−3.06 (2H, m), 4.30 (2H, brs), 7.08 (1H, d, <i>J</i> = 3.0 Hz), 7.13 (2H, d, <i>J</i> = 9.0 Hz), 7.34 (2H, d, <i>J</i> = 6.0 Hz), 7.53 (1H, dd, <i>J</i> = 3.0, 9.0 Hz), 8.10 (1H, brs). The obtained 5-[3-{[(<i>tert</i>-butoxycarbonyl)amino]methyl}-4-(4-methylphenyl)-2-(2-methylpropyl)quinolin-6-yl]pentanoic acid was dissolved in 1,4-dioxane (10 mL), and 4 M HCl in 1,4-dioxane (10 mL) was added. The mixture was stirred at room temperature for 3 h. The reaction mixture was concentrated under reduced pressure to give <b>17c</b> (578 mg, 69% for two steps) as a pale yellow powder. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ: 1.11−1.15 (6H, m), 1.50−1.69 (4H, m), 2.27 (2H, t, <i>J</i> = 6.0 Hz), 2.31−2.36 (1H, m), 2.55 (3H, s), 2.80 (2H, t, <i>J</i> = 6.0 Hz), 3.32−3.34 (2H, m), 4.33 (2H, brs), 7.39 (2H, d, <i>J</i> = 9.0 Hz), 7.41 (1H, s), 7.58 (2H, d, <i>J</i> = 6.0 Hz), 8.10 (1H, dd, <i>J</i> = 3.0, 9.0 Hz), 8.28 (1H, d, <i>J</i> = 9.0 Hz). LC/MS <i>m</i>/<i>z</i> 405.3 (M + H). HPLC purity 100% (220 nm), 100% (254 nm). ESI-HRMS calcd for C<sub>26</sub>H<sub>32</sub>N<sub>2</sub>O<sub>2</sub><i>m</i>/<i>z</i> 405.2537 (M + H), found 405.2523 (M + H).</div></div><div id="sec5_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 6-[3-(Aminomethyl)-4-(4-methylphenyl)-2-(2-methylpropyl)quinolin-6-yl]hexanoic Acid Dihydrochloride (<b>17d</b>)</h3><div class="NLM_p last">A mixture of <b>16</b> (2.37 g, 4.74 mmol), 2 M NaOH solution (12 mL) and EtOH (40 mL) was refluxed for 6 h. The mixture was acidified with 6 M HCl and extracted with AcOEt. The organic layer was separated, dried over anhydrous MgSO<sub>4</sub>, and concentrated under reduced pressure. The residue was crystallized from diisopropyl ether to give 6-[3-{[(<i>tert</i>-butoxycarbonyl)amino]methyl}-4-(4-methylphenyl)-2-(2-methylpropyl)quinolin-6-yl]hexanoic acid as a white powder (2.37 g, 96%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 1.13 (6H, d, <i>J</i> = 6.0 Hz), 1.40 (9H, s), 1.45−1.98 (6H, m), 2.30 (2H, t, <i>J</i> = 6.0 Hz), 2.34−2.43 (1H, m), 2.52 (3H, s), 2.69 (2H, d, <i>J</i> = 6.0 Hz), 3.38−3.57 (2H, m), 4.30−4.48 (2H, m), 7.10−7.20 (3H, m), 7.43 (2H, <i>J</i> = 6.0 Hz), 7.69−7.78 (1H, m), 8.85−8.99 (1H, m). A mixture of 6-[3-{[(<i>tert</i>-butoxycarbonyl)amino]methyl}-4-(4-methylphenyl)-2-(2-methylpropyl)quinolin-6-yl]hexanoic acid (310 mg, 0.598 mmol), 4 M HCl in 1,4-dioxane (5 mL) and 1,4-dioxane (10 mL) was stirred at room temperature for 4 h. The reaction mixture was concentrated under reduced pressure to give <b>17d</b> (294 mg, 99%) as a pale yellow powder. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ: 1.14 (6H, d, <i>J</i> = 6.0 Hz), 1.27−1.38 (2H, m), 1.51−1.70 (4H, m), 2.24 (2H, t, <i>J</i> = 6.0 Hz), 2.27−2.35 (1H, m), 2.55 (3H, s), 2.79 (2H, t, <i>J</i> = 6.0 Hz), 3.32−3.34 (2H, m), 4.33 (2H, brs), 7.36−7.43 (3H, m), 7.58 (2H, d, <i>J</i> = 6.0 Hz), 8.10 (1H, dd, <i>J</i> = 3.0, 9.0 Hz), 8.29 (1H, d, <i>J</i> = 9.0 Hz). LC/MS <i>m</i>/<i>z</i> 419.3 (M + H). HPLC purity 99.35% (220 nm), 99.32% (254 nm). ESI-HRMS calcd for C<sub>27</sub>H<sub>34</sub>N<sub>2</sub>O<sub>2</sub><i>m</i>/<i>z</i> 419.2693 (M + H), found 419.2684 (M + H).</div></div><div id="sec5_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 5-Methyl-2-[(4-methylphenyl)methylidene]-3-oxohexanenitrile (<b>18B</b>)</h3><div class="NLM_p last">A mixture of <b>11B</b> (60 g, 500 mmol), <i>p</i>-tolualdehyde (58.2 mL, 500 mmol), piperidine (5 mL, 50 mmol), AcOH (5.7 mL, 100 mmol) and toluene (300 mL) was heated under reflux for 8 h using a Dean−Stark trap. The reaction mixture was allowed to cool to room temperature, washed with brine and dried over anhydrous MgSO<sub>4</sub>. The solvent was concentrated under reduced pressure to afford <b>18B</b> (197 g, crude) as a brown oil. The obtained oil was used for the next reaction without further purifications.</div></div><div id="sec5_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> 5-Methyl-2-[(4-methylphenyl)methylidene]-3-oxohexanenitrile (<b>18A</b>)</h3><div class="NLM_p last">Compound <b>18A</b> was prepared in a manner similar to that described for <b>18B</b> in quantitative yield (crude). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 0.89−1.10 (6H, m), 2.18−2.38 (1H, m), 2.44 (3H, s), 2.77 (2H, d, <i>J</i> = 6.8 Hz), 7.31 (2H, d, <i>J</i> = 8.3 Hz), 7.92 (2H, d, <i>J</i> = 8.3 Hz), 8.14 (1H, s).</div></div><div id="sec5_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> 2-(3,3-Dimethylbutanoyl)-3-(4-methylphenyl)acrylonitrile (<b>18D</b>)</h3><div class="NLM_p last">Compound <b>18D</b> was prepared in a manner similar to that described for <b>18B</b> in 75% yield. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 1.10 (9H, s), 2.44 (3H, s), 2.81 (2H, s), 7.31 (2H, d, <i>J</i> = 8.1 Hz), 7.92 (2H, d, <i>J</i> = 8.3 Hz), 8.13 (1H, s). mp 76.4−78.0 °C.</div></div><div id="sec5_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> 5-(1-Hydroxy-2-methylpropylidene)-2,2-dimethyl-1,3-dioxane-4,6-dione (<b>21C</b>)</h3><div class="NLM_p">To an ice-cooled solution of Meldrum’s acid (<b>20</b>) (14.41 g, 0.10 mol) and pyridine (16.2 mL, 0.2 mol) in dichloromethane (100 mL) was added dropwise 2-methylpropanoyl chloride (13.4 mL, 0.11 mol). The obtained mixture was stirred under ice-cooling for 2 h. The reaction mixture was poured into 0.5 M HCl and extracted with AcOEt. The organic layer was washed with brine, dried over MgSO<sub>4</sub> and concentrated under reduced pressure to give crude <b>21C</b> (21.4 g, quantitative) as a brown oil. The crude <b>21C</b> was used for the next reaction without further purifications. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 1.25 (6H, d, <i>J</i> = 6.3 Hz), 1.74 (6H, s), 4.05−4.14 (1H, m).</div><div class="NLM_p last">Compounds <b>21A</b>, <b>B</b>, <b>D</b> and <b>E</b> were prepared in a manner similar to that described for <b>21C</b>.</div></div><div id="sec5_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> 5-(1-Hydroxybutylidene)-2,2-dimethyl-1,3-dioxane-4,6-dione (<b>21B</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 1.03 (3H, t, <i>J</i> = 8.9 Hz), 1.66−1.81 (2H, m), 1.74 (6H, s), 3.04−3.10 (2H, m).</div></div><div id="sec5_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> 5-(1-Hydroxy-3-methylbutylidene)-2,2-dimethyl-1,3-dioxane-4,6-dione (<b>21D</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 1.01 (6H, d, <i>J</i> = 6.8 Hz), 1.73 (6H, s), 2.09−2.22 (1H, m), 2.99 (2H, d, <i>J</i> = 6.3 Hz).</div></div><div id="sec5_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> 5-(1-Hydroxy-2-phenylethylidene)-2,2-dimethyl-1,3-dioxane-4,6-dione (<b>21E</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 1.72 (9H, s), 4.43 (2H, s), 7.02−7.42 (5H, m), 15.33 (1H, brs).</div></div><div id="sec5_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> <i>tert</i>-Butyl (2<i>E</i>)-3-Aminobut-2-enoate (<b>22B</b>)</h3><div class="NLM_p last">A mixture of <i>tert</i>-butyl acetoacetate <b>19A</b> (253 g, 1.94 mol), 25% ammonia solution (500 mL) and MeOH (500 mL) was stirred at room temperature for 15 h. The reaction mixture was extracted with AcOEt. The organic layer was washed with brine, dried over MgSO<sub>4</sub> and concentrated under reduced pressure to give crude <b>22B</b> (253 g, quantitative) as a brown oil. Compound <b>22B</b> was used for the next reaction without further purifications. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 1.47 (9H, s), 1.87 (3H, s), 4.46 (1H, s).</div></div><div id="sec5_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> <i>tert</i>-Butyl (2<i>E</i>)-3-Amino-4-methylpent-2-enoate (<b>22E</b>)</h3><div class="NLM_p">Compound <b>21C</b> (22.7 g, 122 mmol) was added to toluene (100 mL) and <i>tert</i>-butyl alcohol (11.2 g, 150 mmol) and stirred under reflux for 6 h. The reaction mixture was cooled to room temperature. The mixture was extracted with AcOEt. The organic layer was washed with brine, dried over anhydrous MgSO<sub>4</sub>, and concentrated under reduced pressure to give a brown oil (9.31 g). The obtained brown oil was added to MeOH (100 mL) and 25% ammonia solution (100 mL), and stirred at room temperature for 12 h. The reaction mixture was concentrated under reduced pressure and extracted with AcOEt and water. The organic layer was washed with brine, dried over anhydrous MgSO<sub>4</sub> and concentrated under reduced pressure to give <b>22E</b> (9.26 g, 41%) as a brown oil. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ:1.14 (6H, d, <i>J</i> = 6.8 Hz), 1.48 (9H, s), 2.18−2.37 (1H, m), 4.49 (1H, s).</div><div class="NLM_p last">Compounds <b>22C</b>, <b>22D</b>, <b>22F</b> and <b>22G</b> were prepared in a manner similar to that described for <b>22E</b>.</div></div><div id="sec5_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> <i>tert</i>-Butyl (2<i>E</i>)-3-Aminopent-2-enoate (<b>22C</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 1.13 (3H, t, <i>J</i> = 7.6 Hz), 1.47 (9H, s), 2.13 (2H, q, <i>J</i> = 7.6 Hz), 4.48 (1H, s).</div></div><div id="sec5_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> <i>tert</i>-Butyl (2<i>E</i>)-3-Aminohex-2-enoate (<b>22D</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 0.95 (3H, t, <i>J</i> = 7.3 Hz), 1.47 (9H, s), 1.49−1.68 (2H, m), 1.92−2.17 (2H, m), 4.47 (1H, s).</div></div><div id="sec5_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> <i>tert</i>-Butyl (2<i>E</i>)-3-Amino-4-methylpent-2-enoate (<b>22F</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 0.95 (6H, d, <i>J</i> = 7.2 Hz), 1.47 (9H, s), 1.86−1.95 (3H, m), 4.44 (1H, s).</div></div><div id="sec5_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> <i>tert</i>-Butyl (2<i>E</i>)-3-Amino-4-phenylbut-2-enoate (<b>22G</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 1.47 (9H, s), 3.43 (2H, s), 4.58 (1H, s), 7.02−7.38 (5H, m).</div></div><div id="sec5_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> Methyl 5-Cyano-2-methyl-4-(4-methylphenyl)-6-propyl-1,4-dihydropyridine-3-carboxylate (<b>23a</b>)</h3><div class="NLM_p last">A mixture of <b>18B</b> (197 g, crude), <b>22A</b> (commercially available) (57.5 g, 500 mmol) and AcOH (500 mL) was stirred at 80 °C for 30 min. The reaction mixture was ice-cooled and the precipitated crystals were collected by filtration, washed with 75% aqueous ethanol and dried to afford <b>23a</b> (60 g, 39%) as a brown oil. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 0.96 (3H, t, <i>J</i> = 7.4 Hz), 1.54−1.66 (2H, m), 2.30 (3H, s), 2.32−2.41 (2H, m), 2.35 (3H, s), 3.58 (3H, s), 4.56 (1H, s), 5.80 (1H, s), 7.09 (2H, d, <i>J</i> = 8.1 Hz), 7.13 (2H, d, <i>J</i> = 8.1 Hz).</div></div><div id="sec5_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> Methyl 6-Butyl-5-cyano-2-methyl-4-(4-methylphenyl)-1,4-dihydropyridine-3-carboxylate (<b>23b</b>)</h3><div class="NLM_p last">Compound <b>23b</b> was prepared in a manner similar to that described for <b>23a</b> in 24% yield. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 0.92 (3H, t, <i>J</i> = 7.3 Hz), 1.30−1.42 (2H, m), 1.49−1.60 (2H, m), 2.30 (3H, s), 2.34−2.39 (2H, m), 2.35 (3H, s), 3.58 (3H, s), 4.56 (1H, s), 5.77 (1H, s), 7.07−7.14 (4H, m).</div></div><div id="sec5_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> <i>tert</i>-Butyl 5-Cyano-6-(2,2-dimethylpropyl)-2-methyl-4-(4-methylphenyl)-1,4-dihydropyridine-3-carboxylate (<b>23d</b>)</h3><div class="NLM_p last">Compound <b>23d</b> was prepared in a manner similar to that described for <b>23a</b> in 53% yield. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 1.01 (9H, s), 1.29 (9H, s), 2.17 (1H, d, <i>J</i> = 13.9 Hz), 2.30 (3H, s), 2.32 (3H, s), 2.34 (1H, d, <i>J</i> = 13.9 Hz), 4.52 (1H, s), 5.43 (1H, brs), 7.06−7.10 (2H, m), 7.11−7.15 (2H, m).</div></div><div id="sec5_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> Methyl 5-Cyano-2-methyl-4-(4-methylphenyl)-6-propylpyridine-3-carboxylate (<b>24a</b>)</h3><div class="NLM_p last">To an ice-cooled solution of <b>23a</b> (152 g, 0.40 mol) in acetone (500 mL) was added dropwise a solution of CAN (550 g, 1 mol) in water (300 mL). The obtained mixture was stirred under ice-cooling for 1 h and concentrated under reduced pressure. The residue was partitioned between AcOEt and water, and the organic layer was washed sequentially with saturated NaHCO<sub>3</sub> solution and brine, dried over MgSO<sub>4</sub> and concentrated under reduced pressure. The residue was crystallized from hexane to afford <b>24a</b> (134 g, 89%) as a white powder. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ:1.05 (3H, t, <i>J</i> = 7.4 Hz), 1.79−1.91 (2H, m), 2.41 (3H, s), 2.62 (3H, s), 3.02−3.07 (2H, m), 3.60 (3H, s), 7.23−7.29 (4H, m).</div></div><div id="sec5_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> Methyl 6-Butyl-5-cyano-2-methyl-4-(4-methylphenyl)pyridine-3-carboxylate (<b>24b</b>)</h3><div class="NLM_p last">Compound <b>24b</b> was prepared in a manner similar to that described for <b>24a</b> in 65% yield. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 0.97 (3H, t, <i>J</i> = 7.3 Hz), 1.40−1.52 (2H, m), 1.74−1.84 (2H, m), 2.41 (3H, s), 2.62 (3H, s), 3.04−3.09 (2H, m), 3.60 (3H, s), 7.23−7.29 (4H, m).</div></div><div id="sec5_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> Methyl 5-Cyano-2-methyl-4-(4-methylphenyl)-6-(2-methylpropyl)pyridine-3-carboxylate (<b>24c</b>)</h3><div class="NLM_p last">Compound <b>24c</b> was prepared in a manner similar to that described for <b>24a</b> in 82% yield. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 1.01 (6H, d, <i>J</i> = 6.6 Hz), 1.32 (3H, t, <i>J</i> = 7.5 Hz), 2.24−2.36 (1H, m), 2.41 (3H, s), 2.85 (2H, q, <i>J</i> = 7.5 Hz), 2.96 (2H, d, <i>J</i> = 6.9 Hz), 3.59 (3H, s), 7.24−7.30 (4H, m). LC/MS <i>m</i>/<i>z</i> 337 (M + H). Mp: 87.1−87.4 °C.</div></div><div id="sec5_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> <i>tert</i>-Butyl 5-Cyano-6-(2,2-dimethylpropyl)-2-methyl-4-(4-methylphenyl)pyridine-3-carboxylate (<b>24d</b>)</h3><div class="NLM_p last">Compound <b>24d</b> was prepared in a manner similar to that described for <b>24a</b> in 96% yield. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 1.06 (9H, s), 1.26 (9H, s), 2.41 (3H, s), 2.64 (3H, s), 2.99 (2H, s), 7.21−7.31 (4H, m).</div></div><div id="sec5_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> <i>tert</i>-Butyl 5-Cyano-6-(2,2-dimethylpropyl)-2-ethyl-4-(4-methylphenyl)pyridine-3-carboxylate (<b>24e</b>)</h3><div class="NLM_p last">Compound <b>24e</b> was prepared in a manner similar to that described for <b>24a</b> in 42% yield. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 1.07 (9H, s), 1.25 (9H, s), 1.30−1.38 (3H, m), 2.41 (3H, s), 2.89 (2H, q, <i>J</i> = 7.5 Hz), 3.01 (2H, s), 7.26 (4H, s).</div></div><div id="sec5_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> <i>tert</i>-Butyl 5-Cyano-6-(2,2-dimethylpropyl)-4-(4-methylphenyl)-2-propylpyridine-3-carboxylate (<b>24f</b>)</h3><div class="NLM_p last">Compound <b>24f</b> was prepared in a manner similar to that described for <b>24a</b> in 59% yield. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 0.98 (3H, t, <i>J</i> = 7.3 Hz), 1.02 (9H, s), 1.14 (2H, brs), 1.14 (9H, s), 1.73−1.86 (2H, m), 2.39 (3H, s), 2.72−2.77 (2H, m), 2.87 (2H, s), 3.68 (2H, s), 7.13 (2H, d, <i>J</i> = 8.1 Hz), 7.21 (2H, d, <i>J</i> = 8.1 Hz).</div></div><div id="sec5_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> <i>tert</i>-Butyl 5-Cyano-6-(2,2-dimethylpropyl)-2-(1-methylethyl)-4-(4-methylphenyl)pyridine-3-carboxylate (<b>24g</b>)</h3><div class="NLM_p last">Compound <b>24g</b> was prepared in a manner similar to that described for <b>24a</b> in 51% yield. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 1.06 (9H, s), 1.11 (6H, d, <i>J</i> = 6.6 Hz), 1.25 (9H, s), 2.40 (3H, s), 3.00 (2H, s), 3.14−3.23 (1H, m), 7.07 (2H, d, <i>J</i> = 7.2 Hz), 7.31 (2H, d, <i>J</i> = 7.2 Hz).</div></div><div id="sec5_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> <i>tert</i>-Butyl 5-Cyano-6-(2,2-dimethylpropyl)-4-(4-methylphenyl)-2-(2-methylpropyl)pyridine-3-carboxylate (<b>24h</b>)</h3><div class="NLM_p last">Compound <b>24h</b> was prepared in a manner similar to that described for <b>24a</b> in 49% yield. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 0.95 (6H, d, <i>J</i> = 6.6 Hz), 1.06 (9H, s), 1.24 (9H, s), 2.22−2.35 (1H, m), 2.40 (3H, s), 2.76 (2H, d, <i>J</i> = 7.2 Hz), 3.00 (2H, s), 7.19−7.35 (4H, m).</div></div><div id="sec5_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> <i>tert</i>-Butyl 2-Benzyl-5-cyano-6-(2,2-dimethylpropyl)-4-(4-methylphenyl)pyridine-3-carboxylate (<b>24i</b>)</h3><div class="NLM_p last">Compound <b>24i</b> was prepared in a manner similar to that described for <b>24a</b>. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 1.00 (9H, s), 1.13 (9H, s), 1.24 (9H, s), 2.40 (3H, s), 2.76 (2H, d, <i>J</i> = 7.2 Hz), 2.99 (2H, s), 4.26 (2H, s), 7.12−7.40 (9H, m).</div></div><div id="sec5_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> Methyl 5-(Aminomethyl)-2-methyl-4-(4-methylphenyl)-6-propylpyridine-3-carboxylate (<b>25a</b>)</h3><div class="NLM_p last">A mixture of <b>24a</b> (22 g, 71.3 mmol), Raney-Ni (22 mL), 25% NH<sub>3</sub> solution (22 mL), THF (100 mL) and MeOH (100 mL) was stirred at room temperature for 5 h in a sealed tube under a hydrogen atmosphere at 0.5 MPa. The reaction mixture was filtered, and the filtrate was concentrated under reduced pressure. The residue was partitioned between AcOEt and 10% aqueous potassium carbonate solution. The organic layer was washed with brine, dried over anhydrous MgSO<sub>4</sub> and concentrated under reduced pressure. The residue was purified by NH silica gel column chromatography (AcOEt) to afford <b>25a</b> (15 g, 67%) as pale yellow crystals. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 1.02 (3H, t, <i>J</i> = 7.3 Hz), 1.64−1.85 (2H, m), 2.37 (3H, s), 2.53 (3H, s), 2.93−3.05 (2H, m), 3.47 (3H, s), 3.82 (2H, d, <i>J</i> = 5.5 Hz), 7.19 (2H, d, <i>J</i> = 8.1 Hz), 7.31 (2H, d, <i>J</i> = 8.1 Hz), 8.38 (3H, s).</div></div><div id="sec5_47" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> Methyl 5-(Aminomethyl)-6-butyl-2-methyl-4-(4-methylphenyl)pyridine-3-carboxylate (<b>25b</b>)</h3><div class="NLM_p last">Compound <b>25b</b> was prepared in a manner similar to that described for <b>25a</b> in 68% yield as a colorless oil. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 0.95 (3H, t, <i>J</i> = 7.3 Hz), 1.35−1.54 (2H, m), 1.61−1.81 (2H, m), 2.37 (3H, s), 2.53 (3H, s), 2.94−3.09 (2H, m), 3.47 (3H, s), 3.82 (2H, d, <i>J</i> = 5.5 Hz), 7.19 (2H, d, <i>J</i> = 8.1 Hz), 7.30 (2H, d, <i>J</i> = 8.1 Hz), 8.38 (3H, s).</div></div><div id="sec5_48" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> Methyl 5-(Aminomethyl)-2-methyl-4-(4-methylphenyl)-6-(2-methylpropyl)pyridine-3-carboxylate (<b>25c</b>)</h3><div class="NLM_p last">Compound <b>25c</b> was prepared in a manner similar to that described for <b>25a</b> in 95% yield as a white powder. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 0.98 (6H, d, <i>J</i> = 6.6 Hz), 1.39 (2H, brs), 2.15−2.30 (1H, m), 2.39 (3H, s), 2.53 (3H, s), 2.80 (2H, d, <i>J</i> = 7.2 Hz), 3.50 (3H, s), 3.66 (2H, s), 7.11 (2H, d, <i>J</i> = 8.0 Hz), 7.21 (2H, d, <i>J</i> = 8.0 Hz). LC/MS <i>m</i>/<i>z</i> 327 (M + H). Mp: 56.7−56.8 °C.</div></div><div id="sec5_49" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> <i>tert</i>-Butyl 5-(Aminomethyl)-6-(2,2-dimethylpropyl)-2-methyl-4-(4-methylphenyl)pyridine-3-carboxylate (<b>25d</b>)</h3><div class="NLM_p last">Compound <b>25d</b> was prepared in a manner similar to that described for <b>25a</b> in 92% yield as a white powder. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 1.02 (9H, s), 1.19 (9H, s), 2.40 (3H, s), 2.54 (3H, s), 2.86 (2H, s), 3.68 (2H, s), 7.13 (2H, d, <i>J</i> = 8.1 Hz), 7.22 (2H, d, <i>J</i> = 7.9 Hz).</div></div><div id="sec5_50" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> <i>tert</i>-Butyl 5-(Aminomethyl)-6-(2,2-dimethylpropyl)-2-ethyl-4-(4-methylphenyl)pyridine-3-carboxylate (<b>25e</b>)</h3><div class="NLM_p last">Compound <b>25e</b> was prepared in a manner similar to that described for <b>25a</b> in 74% yield as a white powder. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 0.98 (3H, t, <i>J</i> = 7.3 Hz), 1.02 (9H, s), 1.14 (2H, brs), 1.14 (9H, s), 1.73−1.86 (2H, m), 2.39 (3H, s), 2.72−2.77 (2H, m), 2.87 (2H, s), 3.68 (2H, s), 7.13 (2H, d, <i>J</i> = 8.1 Hz), 7.21 (2H, d, <i>J</i> = 8.1 Hz).</div></div><div id="sec5_51" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> <i>tert</i>-Butyl 5-(Aminomethyl)-6-(2,2-dimethylpropyl)-4-(4-methylphenyl)-2-propylpyridine-3-carboxylate (<b>25f</b>)</h3><div class="NLM_p last">Compound <b>25f</b> was prepared in a manner similar to that described for <b>25a</b> in 74% yield as a white powder. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 0.98 (3H, t, <i>J</i> = 7.3 Hz), 1.02 (9H, s), 1.14 (2H, brs), 1.14 (9H, s), 1.73−1.86 (2H, m), 2.39 (3H, s), 2.72−2.77 (2H, m), 2.87 (2H, s), 3.68 (2H, s), 7.13 (2H, d, <i>J</i> = 8.1 Hz), 7.21 (2H, d, <i>J</i> = 8.1 Hz).</div></div><div id="sec5_52" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> <i>tert</i>-Butyl 5-(Aminomethyl)-6-(2,2-dimethylpropyl)-2-(1-methylethyl)-4-(4-methylphenyl)pyridine-3-carboxylate (<b>25g</b>)</h3><div class="NLM_p last">Compound <b>25g</b> was prepared in a manner similar to that described for <b>25a</b> in 51% yield as a white powder. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 1.04 (9H, s), 1.18 (9H, s), 1.30 (6H, d, <i>J</i> = 6.9 Hz), 1.32 (2H, brs), 2.39 (3H, s), 2.85 (2H, s), 3.04−3.13 (1H, m), 3.66 (2H, s), 7.13 (2H, d, <i>J</i> = 8.0 Hz), 7.20 (2H, d, <i>J</i> = 8.0 Hz).</div></div><div id="sec5_53" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> <i>tert</i>-Butyl 5-(Aminomethyl)-6-(2,2-dimethylpropyl)-4-(4-methylphenyl)-2-(2-methylpropyl)pyridine-3-carboxylate (<b>25h</b>)</h3><div class="NLM_p last">Compound <b>25h</b> was prepared in a manner similar to that described for <b>25a</b> in 89% yield as a white powder. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 0.93 (6H, d, <i>J</i> = 6.6 Hz), 1.02 (9H, s), 1.17 (9H, s), 1.24 (2H, brs), 2.22−2.31 (1H, m), 2.39 (3H, s), 2.66 (2H, d, <i>J</i> = 7.5 Hz), 2.87 (2H, s), 3.68 (2H, s), 7.13 (2H, d, <i>J</i> = 8.0 Hz), 7.21 (2H, d, <i>J</i> = 8.0 Hz).</div></div><div id="sec5_54" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> <i>tert</i>-Butyl 5-(Aminomethyl)-2-benzyl-6-(2,2-dimethylpropyl)-4-(4-methylphenyl)pyridine-3-carboxylate (<b>25i</b>)</h3><div class="NLM_p last">Compound <b>25i</b> was prepared in a manner similar to that described for <b>25a</b> in 15% yield as a white powder (2 steps from compound <b>23i</b>). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 0.96 (9H, s), 1.07 (9H, s), 2.39 (3H, s), 2.85 (2H, s), 3.67 (2H, s), 4.18 (2H, s), 7.11−7.32 (9H, m).</div></div><div id="sec5_55" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> Methyl 5-{[(<i>tert</i>-Butoxycarbonyl)amino]methyl}-2-methyl-4-(4-methylphenyl)-6-propylpyridine-3-carboxylate (<b>26a</b>)</h3><div class="NLM_p last">Compound <b>25a</b> (13 g, 41.6 mmol) was dissolved in THF (100 mL), and to the mixture was added (Boc)<sub>2</sub>O (9.8 g, 45 mmol). After stirring at room temperature for 3 h, the mixture was concentrated under reduced pressure. The residue was purified by silica gel column chromatography (hexane/AcOEt = 50/50) to give <b>26a</b> (12 g, 70%) as a pale yellow powder. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 1.03 (3H, t, <i>J</i> = 7.4 Hz), 1.39 (9H, s), 1.72−1.79 (2H, m), 2.38 (3H, s), 2.53 (3H, s), 2.84−2.90 (2H, m), 3.49 (3H, s), 4.15 (2H, d, <i>J</i> = 5.1 Hz), 4.25 (1H, s), 7.05 (2H, d, <i>J</i> = 8.1 Hz), 7.20 (2H, d, <i>J</i> = 8.1 Hz).</div></div><div id="sec5_56" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> Methyl 5-{[(<i>tert</i>-Butoxycarbonyl)amino]methyl}-6-butyl-2-methyl-4-(4-methylphenyl)pyridine-3-carboxylate (<b>26b</b>)</h3><div class="NLM_p last">Compound <b>26b</b> was prepared in a manner similar to that described for <b>26a</b> in 60% yield as a white powder. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 0.95 (3H, t, <i>J</i> = 7.2 Hz), 1.39 (9H, s), 1.41−1.52 (2H, m), 1.63−1.77 (2H, m), 2.38 (3H, s), 2.53 (3H, s), 2.83−2.94 (2H, m), 3.49 (3H, s), 4.14 (2H, d, <i>J</i> = 4.9 Hz), 4.25 (1H, brs), 7.05 (2H, d, <i>J</i> = 8.0 Hz), 7.20 (2H, d, <i>J</i> = 8.0 Hz).</div></div><div id="sec5_57" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> Methyl 5-{[(<i>tert</i>-Butoxycarbonyl)amino]methyl}-2-methyl-4-(4-methylphenyl)-6-(2-methylpropyl)pyridine-3-carboxylate (<b>26c</b>)</h3><div class="NLM_p last">Compound <b>26c</b> was prepared in a manner similar to that described for <b>26a</b> in 93% yield as a white powder. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 0.97 (6H, d, <i>J</i> = 6.8 Hz), 1.39 (9H, s), 2.10−2.30 (1H, m), 2.39 (3H, s), 2.54 (3H, s), 2.78 (2H, d, <i>J</i> = 7.2 Hz), 3.50 (3H, s), 4.15 (2H, d, <i>J</i> = 4.9 Hz), 4.24 (1H, t, <i>J</i> = 4.9 Hz), 7.06 (2H, d, <i>J</i> = 7.9 Hz), 7.20 (2H, d, <i>J</i> = 7.9 Hz).</div></div><div id="sec5_58" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> 5-(Aminomethyl)-2-methyl-4-(4-methylphenyl)-6-propylpyridine-3-carboxylic Acid Dihydrochloride (<b>27a</b>)</h3><div class="NLM_p last">To a solution of <b>26a</b> (2 g, 4.8 mmol) in MeOH (10 mL) and THF (10 mL) was added 1 M NaOH solution (10 mL). The mixture was stirred at room temperature for 3 days. The reaction mixture was neutralized with 0.5 M HCl and extracted with AcOEt. The organic layer was washed with brine, dried over anhydrous MgSO<sub>4</sub>, and concentrated under reduced pressure to give a white powder. The obtained white powder was dissolved in 1,4-dioxane (4 mL) and added to 4 M HCl in 1,4-dioxane (4 mL, 16 mmol). The mixture was stirred at room temperature for 2 h. The reaction mixture was concentrated under reduced pressure and crystallized from diisopropyl ether to give <b>27a</b> (1.7 g, 80%) as a white powder. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 1.02 (3H, t, <i>J</i> = 7.4 Hz), 1.69−1.82 (2H, m), 2.37 (3H, s), 2.62 (3H, s), 3.01−3.07 (2H, m), 3.82 (2H, d, <i>J</i> = 5.3 Hz), 7.24 (2H, d, <i>J</i> = 8.1 Hz), 7.31 (2H, d, <i>J</i> = 8.1 Hz), 8.41 (3H, s). LC/MS <i>m</i>/<i>z</i> 299.2 (M + H). HPLC purity 98.07% (220 nm), 100% (254 nm). ESI-HRMS calcd for C<sub>18</sub>H<sub>22</sub>N<sub>2</sub>O<sub>2</sub><i>m</i>/<i>z</i> 299.1754 (M + H), found 299.1742 (M + H).</div></div><div id="sec5_59" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> 5-(Aminomethyl)-6-butyl-2-methyl-4-(4-methylphenyl)pyridine-3-carboxylic Acid Dihydrochloride (<b>27b</b>)</h3><div class="NLM_p last">Compound <b>27b</b> was prepared in a manner similar to that described for <b>27a</b> in 66% yield as a white powder. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 0.95 (3H, t, <i>J</i> = 7.4 Hz), 1.39−1.49 (2H, m), 1.65−1.75 (2H, m), 2.37 (3H, s), 2.61 (3H, s), 3.03−3.08 (2H, m), 3.81 (2H, d, <i>J</i> = 5.3 Hz), 7.24 (2H, d, <i>J</i> = 8.1 Hz), 7.31 (2H, d, <i>J</i> = 8.1 Hz), 8.40 (3H, s). LC/MS <i>m</i>/<i>z</i> 313.2 (M + H). HPLC purity 100% (220 nm), 100% (254 nm). ESI-HRMS calcd for C<sub>19</sub>H<sub>24</sub>N<sub>2</sub>O<sub>2</sub><i>m</i>/<i>z</i> 313.1911 (M + H), found 313.1896 (M + H).</div></div><div id="sec5_60" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77"> 5-(Aminomethyl)-2-methyl-4-(4-methylphenyl)-6-(2-methylpropyl)pyridine-3-carboxylic Acid Dihydrochloride (<b>27c</b>)</h3><div class="NLM_p last">Compound <b>27c</b> was prepared in a manner similar to that described for <b>27a</b> in 57% yield as a white powder. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 0.97 (6 H, d, <i>J</i> = 6.59 Hz), 2.12−2.29 (1 H, m), 2.37 (3 H, s), 2.56 (3 H, s), 2.89 (2 H, s), 3.81 (2 H, d, <i>J</i> = 4.33 Hz), 7.23 (2 H, d, <i>J</i> = 7.72 Hz), 7.30 (2 H, d, <i>J</i> = 7.91 Hz), 8.23 (3 H, s). Anal. Calcd for C<sub>19</sub>H<sub>24</sub>N<sub>2</sub>O<sub>2</sub>·2HCl·2H<sub>2</sub>O: C, 54.16; H, 7.18; N, 6.65. Found: C, 54.57; H, 7.31; N, 6.12. LC/MS <i>m</i>/<i>z</i> 313.2 (M + H). HPLC purity 100% (220 nm), 100% (254 nm).</div></div><div id="sec5_61" class="NLM_sec NLM_sec_level_2"><div id="ac_i78" class="anchor-spacer"></div><h3 class="article-section__title" id="_i78"> 5-(Aminomethyl)-6-(2,2-dimethylpropyl)-2-methyl-4-(4-methylphenyl)pyridine-3-carboxylic Acid Dihydrochloride (<b>27d</b>)</h3><div class="NLM_p last">A mixture of <b>25d</b> (0.4 g, 1 mmol) in TFA (4 mL) was stirred at room temperature for 4 h. The reaction mixture was concentrated under reduced pressure. The residue was dissolved in 1,4-dioxane (4 mL) and added to 4 M HCl in 1,4-dioxane (4 mL, 16 mmol). The mixture was concentrated under reduced pressure to give a white powder. The white powder was recrystallized from distilled water and acetonitrile to give <b>27d</b> (281 mg, 71%) as a white powder. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 1.02 (9H, s), 2.37 (3H, s), 2.59 (3H, s), 3.04 (2H, s), 3.86 (2H, d, <i>J</i> = 5.5 Hz), 7.23 (2H, d, <i>J</i> = 8.1 Hz), 7.30 (2H, d, <i>J</i> = 8.1 Hz), 8.24 (3H, brs). LC/MS <i>m</i>/<i>z</i> 327.2 (M + H). HPLC purity 95.34% (220 nm), 94.55% (254 nm). ESI-HRMS calculated for C<sub>20</sub>H<sub>26</sub>N<sub>2</sub>O<sub>2</sub><i>m</i>/<i>z</i> 327.2067 (M + H), found 327.2054 (M + H).</div></div><div id="sec5_62" class="NLM_sec NLM_sec_level_2"><div id="ac_i79" class="anchor-spacer"></div><h3 class="article-section__title" id="_i79"> 5-(Aminomethyl)-6-(2,2-dimethylpropyl)-2-ethyl-4-(4-methylphenyl)pyridine-3-carboxylic Acid Dihydrochloride (<b>27e</b>)</h3><div class="NLM_p last">Compound <b>27e</b> was prepared in a manner similar to that described for <b>27d</b> in 90% yield as a white powder. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 1.02 (9H, s), 1.26 (3H, t, <i>J</i> = 7.5 Hz), 2.37 (3H, s), 2.78 (2H, q, <i>J</i> = 7.5 Hz), 2.92 (2H, s), 3.83 (2H, d, <i>J</i> = 5.4 Hz), 7.21 (2H, d, <i>J</i> = 8.0 Hz), 7.29 (2H, d, <i>J</i> = 8.0 Hz), 8.13 (3H, brs). LC/MS <i>m</i>/<i>z</i> 341.2 (M + H). HPLC purity 96.18% (220 nm), 96.73% (254 nm). ESI-HRMS calcd for C<sub>21</sub>H<sub>28</sub>N<sub>2</sub>O<sub>2</sub><i>m</i>/<i>z</i> 341.2224 (M + H), found 341.2213 (M + H).</div></div><div id="sec5_63" class="NLM_sec NLM_sec_level_2"><div id="ac_i80" class="anchor-spacer"></div><h3 class="article-section__title" id="_i80"> 5-(Aminomethyl)-6-(2,2-dimethylpropyl)-4-(4-methylphenyl)-2-propylpyridine-3-carboxylic Acid Dihydrochloride (<b>27f</b>)</h3><div class="NLM_p last">Compound <b>27f</b> was prepared in a manner similar to that described for <b>27d</b> in 90% yield as a white powder. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 0.93 (3H, t, <i>J</i> = 7.3 Hz), 1.02 (9H, s), 1.69−1.81 (2H, m), 2.37 (3H, s), 2.74−2.79 (2H, m), 2.94 (2H, brs), 3.84 (2H, d, <i>J</i> = 5.1 Hz), 7.22 (2H, d, <i>J</i> = 8.0 Hz), 7.29 (2H, d, <i>J</i> = 8.0 Hz), 8.14 (3H, brs). LC/MS <i>m</i>/<i>z</i> 355.2 (M + H). HPLC purity 100% (220 nm), 100% (254 nm). ESI-HRMS calcd for C<sub>22</sub>H<sub>30</sub>N<sub>2</sub>O<sub>2</sub><i>m</i>/<i>z</i> 355.2380 (M + H), found 355.2365 (M + H).</div></div><div id="sec5_64" class="NLM_sec NLM_sec_level_2"><div id="ac_i81" class="anchor-spacer"></div><h3 class="article-section__title" id="_i81"> 5-(Aminomethyl)-6-(2,2-dimethylpropyl)-2-(1-methylethyl)-4-(4-methylphenyl)pyridine-3-carboxylic Acid Dihydrochloride (<b>27g</b>)</h3><div class="NLM_p last">Compound <b>27g</b> was prepared in a manner similar to that described for <b>27d</b> in 88% yield as a white powder. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 1.04 (9H, s), 1.25 (6H, d, <i>J</i> = 6.6 Hz), 2.36 (3H, s), 2.90 (2H, s), 3.03−3.13 (1H, m), 3.81 (2H, d, <i>J</i> = 5.4 Hz), 7.22 (2H, d, <i>J</i> = 8.2 Hz), 7.28 (2H, d, <i>J</i> = 8.2 Hz), 8.18 (3H, brs). LC/MS <i>m</i>/<i>z</i> 355.2 (M + H). HPLC purity 95.90% (220 nm), 98.54% (254 nm). ESI-HRMS calcd for C<sub>22</sub>H<sub>30</sub>N<sub>2</sub>O<sub>2</sub><i>m</i>/<i>z</i> 355.2380 (M + H), found 355.2361 (M + H).</div></div><div id="sec5_65" class="NLM_sec NLM_sec_level_2"><div id="ac_i82" class="anchor-spacer"></div><h3 class="article-section__title" id="_i82"> 5-(Aminomethyl)-6-(2,2-dimethylpropyl)-4-(4-methylphenyl)-2-(2-methylpropyl)pyridine-3-carboxylic Acid Dihydrochloride (<b>27h</b>)</h3><div class="NLM_p last">Compound <b>27h</b> was prepared in a manner similar to that described for <b>27d</b> in 93% yield as a white powder. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 0.89 (6H, d, <i>J</i> = 6.6 Hz), 1.02 (9H, s), 2.18−2.31 (1H, m), 2.37 (3H, s), 2.66 (2H, d, <i>J</i> = 7.2 Hz), 2.91 (2H, s), 3.84 (2H, d, <i>J</i> = 5.1 Hz), 7.21 (2H, d, <i>J</i> = 8.1 Hz), 7.29 (2H, d, <i>J</i> = 8.1 Hz), 8.08 (3H, brs). LC/MS <i>m</i>/<i>z</i> 369.2 (M + H). HPLC purity 100% (220 nm), 100% (254 nm). ESI-HRMS calcd for C<sub>23</sub>H<sub>32</sub>N<sub>2</sub>O<sub>2</sub><i>m</i>/<i>z</i> 369.2527 (M + H), found 369.2527 (M + H).</div></div><div id="sec5_66" class="NLM_sec NLM_sec_level_2"><div id="ac_i83" class="anchor-spacer"></div><h3 class="article-section__title" id="_i83"> 5-(Aminomethyl)-2-benzyl-6-(2,2-dimethylpropyl)-4-(4-methylphenyl)pyridine-3-carboxylic Acid Dihydrochloride (<b>27i</b>)</h3><div class="NLM_p last">Compound <b>27i</b> was prepared in a manner similar to that described for <b>27d</b> in 91% yield as a white powder. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 0.95 (9H, s), 2.37 (3H, s), 2.89 (2H, s), 3.82 (2H, d, <i>J</i> = 5.4 Hz), 4.14 (2H, s), 7.18−7.31 (9H, m), 8.17 (3H, brs). LC/MS <i>m</i>/<i>z</i> 403.2 (M + H). HPLC purity 99.85% (220 nm), 99.73% (254 nm). ESI-HRMS calcd for C<sub>26</sub>H<sub>30</sub>N<sub>2</sub>O<sub>2</sub><i>m</i>/<i>z</i> 403.2380 (M + H), found 403.2369 (M + H).</div></div><div id="sec5_67" class="NLM_sec NLM_sec_level_2"><div id="ac_i84" class="anchor-spacer"></div><h3 class="article-section__title" id="_i84"> <i>tert</i>-Butyl {[5-(Hydroxymethyl)-6-methyl-4-(4-methylphenyl)-2-(2-methylpropyl)pyridin-3-yl]methyl}carbamate (<b>28a</b>)</h3><div class="NLM_p last">A solution of <b>25c</b> (9.3 g, 29 mmol) in toluene (150 mL) was cooled to −78 °C, and 1 M DIBAL-H toluene solution (100 mL, 100 mmol) was added dropwise over 30 min. The obtained mixture was allowed to warm, and acetone (10 mL) and sodium sulfate decahydrate (40 g) were added at 0 °C. The reaction mixture was stirred for 15 h at room temperature, and insoluble materials were filtered off and washed with AcOEt. The filtrate and the wash were combined, and 1 M NaOH solution (30 mL, 30 mmol) and (Boc)<sub>2</sub>O (6.9 mL, 30 mmol) were added. The mixture was stirred at room temperature for 30 min. The reaction mixture was washed sequentially with water and brine, dried over anhydrous MgSO<sub>4</sub> and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (hexane/AcOEt = 50/50) to afford <b>28a</b> (8.5 g, 75%) as colorless crystals. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 0.97 (6H, d, <i>J</i> = 6.6 Hz), 1.32 (9H, s), 2.13−2.25 (1H, m), 2.42 (3H, s), 2.68 (3H, s), 2.75 (2H, d, <i>J</i> = 7.4 Hz), 4.05 (2H, d, <i>J</i> = 4.7 Hz), 4.19 (1H, brs), 4.36 (2H, d, <i>J</i> = 5.7 Hz), 7.05 (2H, d, <i>J</i> = 7.9 Hz), 7.24−7.26 (2H, m). LC/MS <i>m</i>/<i>z</i> 399 (M + H). Mp: 140.0−141.0 °C.</div></div><div id="sec5_68" class="NLM_sec NLM_sec_level_2"><div id="ac_i85" class="anchor-spacer"></div><h3 class="article-section__title" id="_i85"> <i>tert</i>-Butyl {[2-(2,2-Dimethylpropyl)-5-(hydroxymethyl)-6-methyl-4-(4-methylphenyl)pyridin-3-yl]methyl}carbamate (<b>28b</b>)</h3><div class="NLM_p last">Compound <b>28b</b> was prepared in a manner similar to that described for <b>28a</b> in 80% yield as a white powder. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 1.01 (9H, s), 1.29 (1H, t, <i>J</i> = 5.7 Hz), 1.37 (9H, s), 2.42 (3H, s), 2.68 (3H, s), 2.84 (2H, s), 4.10 (2H, d, <i>J</i> = 4.9 Hz), 4.10−4.25 (1H, m), 4.36 (2H, d, <i>J</i> = 5.7 Hz), 7.05 (2H, d, <i>J</i> = 8.1 Hz), 7.26 (2H, d, <i>J</i> = 8.1 Hz). LC/MS <i>m</i>/<i>z</i> 413.2 (M + H). Mp 168.4−168.6 °C.</div></div><div id="sec5_69" class="NLM_sec NLM_sec_level_2"><div id="ac_i86" class="anchor-spacer"></div><h3 class="article-section__title" id="_i86"> <i>tert</i>-Butyl {[2-(2,2-Dimethylpropyl)-6-ethyl-5-(hydroxymethyl)-4-(4-methylphenyl)pyridin-3-yl]methyl}carbamate (<b>28c</b>)</h3><div class="NLM_p last">Compound <b>28c</b> was prepared in a manner similar to that described for <b>28a</b> in 80% yield as a white powder. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 1.02 (9H, s), 1.28 (1H, t, <i>J</i> = 5.8 Hz), 1.35 (3H, t, <i>J</i> = 7.5 Hz), 1.37 (9H, s), 2.41 (3H, s), 2.85 (2H, s), 2.97 (2H, q, <i>J</i> = 7.5 Hz), 4.09 (2H, brd, <i>J</i> = 5.1 Hz), 4.15−4.20 (1H, m), 4.36 (2H, d, <i>J</i> = 5.8 Hz), 7.06 (2H, d, <i>J</i> = 8.1 Hz), 7.25 (2H, d, <i>J</i> = 8.1 Hz). LC/MS <i>m</i>/<i>z</i> 427 (M + H). mp 138.5−138.9 °C.</div></div><div id="sec5_70" class="NLM_sec NLM_sec_level_2"><div id="ac_i87" class="anchor-spacer"></div><h3 class="article-section__title" id="_i87"> <i>tert</i>-Butyl {[5-(Cyanomethyl)-6-methyl-4-(4-methylphenyl)-2-(2-methylpropyl)pyridin-3-yl]methyl}carbamate (<b>29a</b>)</h3><div class="NLM_p last">To an ice-cooled mixture of <b>28a</b> (17.4 g, 43 mmol), triethylamine (15 mL, 108 mmol) and THF (150 mL) was added dropwise methanesulfonyl chloride (4.0 mL, 52 mmol), and the mixture was stirred at 0 °C for 30 min. Water was added to the reaction mixture, and the mixture was extracted with AcOEt. The extract was washed with brine, dried over anhydrous MgSO<sub>4</sub> and concentrated under reduced pressure to afford [5-{[(<i>tert</i>-butoxycarbonyl)amino]methyl}-2-methyl-4-(4-methylphenyl)-6-(2-methylpropyl)pyridin-3-yl]methyl methanesulfonate as a crude product (20 g). The crude product (20 g) was dissolved in acetonitrile (300 mL), and trimethylsilyl cyanide (6.7 mL, 50 mmol) and then 1 M TBAF THF solution (50 mL, 50 mmol) were sequentially added. The obtained mixture was stirred at room temperature for 1 h and concentrated under reduced pressure. Water was added to the residue, and the mixture was extracted with AcOEt. The extract was washed with brine, dried over anhydrous MgSO<sub>4</sub> and concentrated under reduced pressure. The residual solid was washed with a mixture of hexane and Et<sub>2</sub>O to afford <b>29a</b> (15.6 g, 89%) as a white powder. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 0.97 (6H, d, <i>J</i> = 6.8 Hz), 1.38 (9H, s), 2.16−2.25 (1H, m), 2.43 (3H, s), 2.66 (3H, s), 2.77 (2H, d, <i>J</i> = 7.2 Hz), 3.31 (2H, s), 4.07 (2H, d, <i>J</i> = 4.7 Hz), 7.04 (2H, d, <i>J</i> = 8.0 Hz), 7.31 (2H, d, <i>J</i> = 8.0 Hz). LC/MS <i>m</i>/<i>z</i> 408.2 (M + H). Mp: 130.3−131.3 °C.</div></div><div id="sec5_71" class="NLM_sec NLM_sec_level_2"><div id="ac_i88" class="anchor-spacer"></div><h3 class="article-section__title" id="_i88"> <i>tert</i>-Butyl {[5-(Cyanomethyl)-2-(2,2-dimethylpropyl)-6-methyl-4-(4-methylphenyl)pyridin-3-yl]methyl}carbamate (<b>29b</b>)</h3><div class="NLM_p last">Compound <b>29b</b> was prepared in a manner similar to that described for <b>29a</b> in 93% yield as a white powder. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 1.02 (9H, s), 1.37 (9H, s), 2.43 (3H, s), 2.65 (3H, s), 2.85 (2H, s), 3.30 (2H, s), 4.11 (2H, d, <i>J</i> = 4.7 Hz), 4.15−4.20 (1H, m), 7.05 (2H, d, <i>J</i> = 7.91 Hz), 7.30 (2H, d, <i>J</i> = 7.9 Hz). LC/MS <i>m</i>/<i>z</i> 422.1 (M + H).</div></div><div id="sec5_72" class="NLM_sec NLM_sec_level_2"><div id="ac_i89" class="anchor-spacer"></div><h3 class="article-section__title" id="_i89"> <i>tert</i>-Butyl {[5-(Cyanomethyl)-2-(2,2-dimethylpropyl)-6-ethyl-4-(4-methylphenyl)pyridin-3-yl]methyl}carbamate (<b>29c</b>)</h3><div class="NLM_p last">Compound <b>29c</b> was prepared in a manner similar to that described for <b>29a</b> in 92% yield as a white powder. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 1.03 (9H, s), 1.37 (9H, s), 1.38 (3H, t, <i>J</i> = 7.4 Hz), 2.43 (3H, s), 2.86 (3H, s), 2.90 (2H, q, <i>J</i> = 7.4 Hz), 3.32 (2H, s), 4.10 (2H, brd, <i>J</i> = 4.9 Hz), 4.10−4.25 (1H, m), 7.05 (2H, d, <i>J</i> = 7.9 Hz), 7.30 (2H, d, <i>J</i> = 7.9 Hz). LC/MS <i>m</i>/<i>z</i> 436.3 (M + H).</div></div><div id="sec5_73" class="NLM_sec NLM_sec_level_2"><div id="ac_i90" class="anchor-spacer"></div><h3 class="article-section__title" id="_i90"> [5-(Aminomethyl)-2-methyl-4-(4-methylphenyl)-6-(2-methylpropyl)pyridin-3-yl]acetic Acid Dihydrochloride (<b>30a</b>)</h3><div class="NLM_p last">Compound <b>29a</b> (14.5 g, 36 mmol) was suspended in 6 M HCl (150 mL) and the suspension was stirred at 90 °C for 20 h. The reaction mixture was allowed to cool to room temperature and washed with Et<sub>2</sub>O. The aqueous layer was alkalified (pH 8) with 8 M NaOH solution, and then AcOEt (200 mL) and (Boc)<sub>2</sub>O (10 mL, 44 mmol) were added. The mixture was stirred at room temperature for 1 h. The reaction mixture was neutralized with HCl and partitioned. The aqueous layer was extracted with AcOEt, and the organic layer and the extract were combined. The mixture was washed with brine, dried over anhydrous MgSO<sub>4</sub> and concentrated under reduced pressure to afford [5-{[(<i>tert</i>-butoxycarbonyl)amino]methyl}-2-methyl-4-(4-methylphenyl)-6-(2-methylpropyl)pyridin-3-yl]acetic acid (14.0 g, 92%) as a white powder. A mixture of [5-{[(<i>tert</i>-butoxycarbonyl)amino]methyl}-2-methyl-4-(4-methylphenyl)-6-(2-methylpropyl)pyridin-3-yl]acetic acid (0.050 g, 0.11 mmol) and 4 M HCl 1,4-dioxane solution (5 mL) was stirred at room temperature for 2 h. The reaction mixture was concentrated under reduced pressure, and the residue was triturated with diisopropyl ether to afford <b>30a</b> (48 mg, 100%) as a pale yellow powder. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ: 1.10 (6H, d, <i>J</i> = 6.4 Hz), 2.09−2.25 (1H, m), 2.48 (3H, s), 2.84 (3H, s), 3.10 (2H, d, <i>J</i> = 7.4 Hz), 3.60 (2H, s), 4.09 (2H, s), 7.20 (2H, d, <i>J</i> = 7.9 Hz), 7.49 (2H, d, <i>J</i> = 7.7 Hz). Anal. Calcd for C<sub>20</sub>H<sub>26</sub>N<sub>2</sub>O<sub>2</sub>·2HCl·2H<sub>2</sub>O: C, 55.17; H, 7.41; N, 6.43. Found: C, 55.47; H, 7.29; N, 5.85. mp 203 °C. LC/MS <i>m</i>/<i>z</i> 327.2 (M + H). HPLC purity 100% (220 nm), 99.25% (254 nm).</div></div><div id="sec5_74" class="NLM_sec NLM_sec_level_2"><div id="ac_i91" class="anchor-spacer"></div><h3 class="article-section__title" id="_i91"> [5-(Aminomethyl)-6-(2,2-dimethylpropyl)-2-methyl-4-(4-methylphenyl)pyridin-3-yl]acetic Acid Dihydrochloride (<b>30b</b>)</h3><div class="NLM_p last">Compound <b>29b</b> (15.5 g, 36.8 mmol) was suspended in 6 M HCl (200 mL), and the suspension was stirred at 90 °C for 24 h. The reaction mixture was allowed to cool to room temperature and washed with Et<sub>2</sub>O. The aqueous layer was alkalified (pH 9) with 4 M NaOH solution, and THF (100 mL) and (Boc)<sub>2</sub>O (8.45 mL, 36.8 mmol) were added. The mixture was stirred at room temperature for 17 h. The reaction mixture was neutralized with HCl and partitioned. The aqueous layer was extracted with AcOEt, and the organic layer and the extract were combined. The mixture was washed with brine, dried over anhydrous MgSO<sub>4</sub> and concentrated under reduced pressure to afford [5-{[(<i>tert</i>-butoxycarbonyl)amino]methyl}-6-(2,2-dimethylpropyl)-2-methyl-4-(4-methylphenyl)pyridin-3-yl]acetic acid (13 g, 80%) as a white powder. A mixture of [5-{[(<i>tert</i>-butoxycarbonyl)amino]methyl}-6-(2,2-dimethylpropyl)-2-methyl-4-(4-methylphenyl)pyridin-3-yl]acetic acid (0.628 g, 1.43 mmol) and 4 M HCl 1,4-dioxane solution (4 mL) was stirred at room temperature for 3 h. The reaction mixture was concentrated under reduced pressure, and the residue was triturated with diisopropyl ether to afford <b>30b</b> (557 mg, 94.2%) as a white powder. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 1.03 (9H, s), 2.41 (3H, s), 2.73 (3H, brs), 3.19 (2H, brs), 3.35−3.45 (2H, m), 3.75−3.90 (2H, m), 7.16 (2H, d, <i>J</i> = 7.4 Hz), 7.38 (2H, d, <i>J</i> = 7.4 Hz), 8.16 (3 h, brs). Anal. Calcd for C<sub>21</sub>H<sub>28</sub>N<sub>2</sub>O<sub>2</sub>·2HCl·2H<sub>2</sub>O: C, 58.47; H, 7.48; N, 6.49. Found: C, 58.33; H, 7.80; N, 5.80. mp 157.0−163.7 °C. LC/MS <i>m</i>/<i>z</i> 341.0 (M + H). HPLC purity 98.41% (220 nm), 97.99% (254 nm).</div></div><div id="sec5_75" class="NLM_sec NLM_sec_level_2"><div id="ac_i92" class="anchor-spacer"></div><h3 class="article-section__title" id="_i92"> [5-(Aminomethyl)-6-(2,2-dimethylpropyl)-2-ethyl-4-(4-methylphenyl)pyridin-3-yl]acetic acid hydrate (<b>30c</b>)</h3><div class="NLM_p last">Compound <b>29c</b> (1.9 g, 4.3 mmol) was suspended in 6 M HCl (100 mL), and the suspension was stirred at 90 °C for 24 h. The reaction mixture was allowed to cool to room temperature and washed with Et<sub>2</sub>O. The aqueous layer was alkalified (pH 8) with 8 M NaOH solution, and AcOEt (200 mL) and (Boc)<sub>2</sub>O (1.5 mL, 6.5 mmol) were added. The mixture was stirred at room temperature for 1 h. The reaction mixture was neutralized with 1 M HCl and partitioned. The aqueous layer was extracted with AcOEt, and the organic layer and the extract were combined. The mixture was washed with brine, dried over anhydrous MgSO<sub>4</sub> and concentrated under reduced pressure to afford [5-{[(<i>tert</i>-butoxycarbonyl)amino]methyl}-6-(2,2-dimethylpropyl)-2-ethyl-4-(4-methylphenyl)pyridin-3-yl]acetic acid (1.8 g, yield 94%) as a white powder. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ: 1.04 (9H, s), 1.24−1.47 (12H, m), 2.31−2.43 (3H, m), 2.67−2.94 (4H, m), 3.19−3.49 (2H, m), 3.93−4.16 (2H, m), 4.28 (1H, s), 6.85−7.36 (4H, m). The obtained [5-{[(<i>tert</i>-butoxycarbonyl)amino]methyl}-6-(2,2-dimethylpropyl)-2-ethyl-4-(4-methylphenyl)pyridin-3-yl]acetic acid (0.14 g, 0.31 mmol) was suspended in 6 M HCl (5 mL), and the suspension was stirred at room temperature for 3 h. The reaction mixture was concentrated under reduced pressure, and the residual solid was triturated with diisopropyl ether to afford [5-(aminomethyl)-6-(2,2-dimethylpropyl)-2-ethyl-4-(4-methylphenyl)pyridin-3-yl]acetic acid dihydrochloride (0.13 g, 99%) as a white powder. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 1.03 (9H, s), 1.27 (3H, t, <i>J</i> = 7.4 Hz), 2.41 (3H,s), 2.90−3.25 (4H, m), 3.43 (2H, brs), 3.82 (2H, brs), 7.17 (2H, d, <i>J</i> = 7.7 Hz), 7.37 (2H, d, <i>J</i> = 7.7 Hz), 8.27 (3H, brs). LC/MS <i>m</i>/<i>z</i> 355.2 (M + H). Anal. Calcd for C<sub>22</sub>H<sub>30</sub>N<sub>2</sub>O<sub>2</sub>·2HCl·0.5H<sub>2</sub>O: C, 60.55; H, 7.62; N, 6.42. Found: C, 68.68; H, 7.58; N, 6.40. mp 224.5−225.8 °C. [5-(Aminomethyl)-6-(2,2-dimethylpropyl)-2-ethyl-4-(4-methylphenyl)pyridin-3-yl]acetic acid dihydrochloride (1.0 g, 2.3 mmol) was dissolved in water (2 mL), and the solution was neutralized with 1 M NaOH solution under ice-cooling. The obtained suspension was stirred at 5 °C for 1 h, and the resulting crystals were collected by filtration. The obtained crystals were washed with cold water and dried to afford <b>30c</b> (0.69 g, 83%) as a white powder. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 1.00 (9H, s), 1.20 (3H, t, <i>J</i> = 7.2 Hz), 2.36 (3H, s), 2.65 (2H, d, <i>J</i> = 7.2 Hz), 2.79 (2H, s), 3.16 (2H, s), 3.42 (2H, s), 7.05 (2H, d, <i>J</i> = 7.8 Hz), 7.23 (2H, d, <i>J</i> = 7.8 Hz). Anal. Calcd for C<sub>22</sub>H<sub>30</sub>N<sub>2</sub>O<sub>2</sub>·H<sub>2</sub>O: C, 69.20; H, 8.60; N, 11.96. Found: C, 69.23; H, 8.54; N, 11.53. mp 186 °C. LC/MS <i>m</i>/<i>z</i> 355.2 (M + H). HPLC purity 98.24% (220 nm), 97.95% (254 nm).</div></div><div id="sec5_76" class="NLM_sec NLM_sec_level_2"><div id="ac_i93" class="anchor-spacer"></div><h3 class="article-section__title" id="_i93"> Ethyl (2<i>E</i>)-3-[5-{[(<i>tert</i>-Butoxycarbonyl)amino]methyl}-2-methyl-4-(4-methylphenyl)-6-(2-methylpropyl)pyridin-3-yl]prop-2-enoate (<b>31</b>)</h3><div class="NLM_p last">To a solution of <b>28a</b> (1.95 g, 4.9 mmol) in THF (50 mL) was added MnO<sub>2</sub> (4.9 g, 56 mmol) and stirred at room temperature for 19 h. The reaction mixture was filtered, and the filtrate was concentrated under reduced pressure. The residue was purified by silica gel column chromatography to afford <i>tert</i>-butyl {[5-formyl-6-methyl-4-(4-methylphenyl)-2-(2-methylpropyl)pyridin-3-yl]methyl}carbamate (1.25 g, 65%) as yellow crystals. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 0.98 (6H, d, <i>J</i> = 6.6 Hz), 1.39 (9H, s), 2.21−2.35 (1H, m), 2.43 (3H, s), 2.79 (3H, s), 2.82 (2H, d, <i>J</i> = 7.2 Hz), 4.15 (2H, d, <i>J</i> = 4.9 Hz), 4.38 (1H, brs), 7.10 (2H, d, <i>J</i> = 8.1 Hz), 7.29 (2H, d, <i>J</i> = 8.1 Hz), 9.71 (1H, s). To a solution of ethyl (diethoxyphosphoryl)acetate (0.033 g, 1.5 mmol) in THF (10 mL) was added sodium hydride (60% in oil) (60 mg, 1.5 mmol) at 0 °C, and the mixture was stirred for 20 min. To the reaction mixture was added a solution of <i>tert</i>-butyl {[5-formyl-6-methyl-4-(4-methylphenyl)-2-(2-methylpropyl)pyridin-3-yl]methyl}carbamate (0.38 g, 0.98 mmol) in THF (5 mL). The mixture was stirred at room temperature for 45 min. The residue was partitioned between AcOEt and water. The organic layer was washed with brine, dried over anhydrous MgSO<sub>4</sub> and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (hexane/AcOEt = 50/50) to afford <b>31</b> (0.44 g, 96%) as a colorless oil. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 0.98 (6H, d, <i>J</i> = 6.6 Hz), 1.23 (3H, t, <i>J</i> = 7.2 Hz), 1.39 (9H, s), 2.16−2.27 (1H, m), 2.40 (3H, s), 2.64 (3H, s), 2.77 (2H, d, <i>J</i> = 7.4 Hz), 4.08−4.17 (4H, m), 4.21 (1H, brs), 5.76 (1H, d, <i>J</i> = 16.4 Hz), 6.95 (2H, d, <i>J</i> = 8.1 Hz), 7.23 (2H, d, <i>J</i> = 8.1 Hz), 7.37 (1H, d, <i>J</i> = 16.4 Hz).</div></div><div id="sec5_77" class="NLM_sec NLM_sec_level_2"><div id="ac_i94" class="anchor-spacer"></div><h3 class="article-section__title" id="_i94"> (2<i>E</i>)-3-[5-(Aminomethyl)-2-methyl-4-(4-methylphenyl)-6-(2-methylpropyl)pyridin-3-yl]prop-2-enoic Acid Dihydrochloride (<b>32</b>)</h3><div class="NLM_p last">To a solution of <b>31</b> (320 mg, 0.687 mmol) in THF (10 mL) was added 1 M NaOH solution (3.4 mL). The mixture was stirred at 60 °C for 12 h. The reaction mixture was neutralized with 0.5 M HCl and extracted with AcOEt. The organic layer was washed with brine, dried over anhydrous MgSO<sub>4</sub>, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (hexane/AcOEt = 25/75) to afford (2<i>E</i>)-3-[5-{[(<i>tert</i>-butoxycarbonyl)amino]methyl}-2-methyl-4-(4-methylphenyl)-6-(2-methylpropyl)pyridin-3-yl]prop-2-enoic acid (280 mg, 93%) as a white powder. The obtained (2<i>E</i>)-3-[5-{[(<i>tert</i>-butoxycarbonyl)amino]methyl}-2-methyl-4-(4-methylphenyl)-6-(2-methylpropyl)pyridin-3-yl]prop-2-enoic acid (90.3 mg, 0.206 mmol) was dissolved in 4 M HCl in 1,4-dioxane (4 mL, 16 mmol). The mixture was stirred at room temperature for 15 min. The reaction mixture was concentrated under reduced pressure and crystallized from diisopropyl ether to give <b>32</b> (76.6 mg, 90%) as a white powder. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ: 1.10 (6H, d, <i>J</i> = 6.6 Hz), 2.12−2.27 (1H, m), 2.46 (3H, brs), 2.84 (3H, s), 3.05 (2H, d, <i>J</i> = 7.5 Hz), 4.13 (2H, s), 5.98 (1H, d, <i>J</i> = 16.3 Hz), 7.20 (2H, d, <i>J</i> = 8.0 Hz), 7.25 (1H, d, <i>J</i> = 16.3 Hz), 7.46 (2H, d, <i>J</i> = 8.0 Hz). LC/MS <i>m</i>/<i>z</i> 339.2 (M + H). HPLC purity 98.66% (220 nm), 98.95% (254 nm). ESI-HRMS calcd for C<sub>21</sub>H<sub>26</sub>N<sub>2</sub>O<sub>2</sub><i>m</i>/<i>z</i> 339.2067 (M + H), found 339.2060 (M + H).</div></div><div id="sec5_78" class="NLM_sec NLM_sec_level_2"><div id="ac_i95" class="anchor-spacer"></div><h3 class="article-section__title" id="_i95"> 3-[5-(Aminomethyl)-2-methyl-4-(4-methylphenyl)-6-(2-methylpropyl)pyridin-3-yl]propanoic Acid Dihydrochloride (<b>33</b>)</h3><div class="NLM_p last">A mixture of <b>31</b> (700 mg, 1.5 mmol), 10% Pd/C (50% wet, 160 mg) and EtOH (15 mL) was stirred at room temperature under H<sub>2</sub> atmosphere for 1 h. The mixture was filtered, and the filtrate was concentrated under reduced pressure. The residue was purified by silica gel column chromatography (hexane/AcOEt = 50/50) to afford ethyl 3-[5-{[(<i>tert</i>-butoxycarbonyl)amino]methyl}-2-methyl-4-(4-methylphenyl)-6-(2-methylpropyl)pyridin-3-yl]propanoate (480 mg, 68%) as a white powder. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 0.96 (6H, d, <i>J</i> = 6.6 Hz), 1.18 (3H, t, <i>J</i> = 7.2 Hz), 1.38 (9H, s), 2.11−2.30 (3H, m), 2.40 (3H, s), 2.57 (3H, s), 2.62−2.68 (2H, m), 2.72 (2H, d, <i>J</i> = 7.4 Hz), 3.96−4.07 (4H, m), 4.18 (1H, brs), 6.98 (2H, d, <i>J</i> = 7.91), 7.24 (2H, d, <i>J</i> = 7.9 Hz). Compound <b>33</b> was prepared from ethyl 3-[5-{[(<i>tert</i>-butoxycarbonyl)amino]methyl}-2-methyl-4-(4-methylphenyl)-6-(2-methylpropyl)pyridin-3-yl]propanoate in a manner similar to that described for <b>32</b> in 55% yield as a white powder. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ: 1.09 (6H, d, <i>J</i> = 6.6 Hz), 2.09−2.22 (1H, m), 2.30−2.38 (2H, m), 2.48 (3H, s), 2.80−2.88 (2H, m), 2.90 (3H, s), 3.05 (2H, d, <i>J</i> = 7.5 Hz), 4.05 (2H, s), 7.26 (2H, d, <i>J</i> = 7.9 Hz), 7.51 (2H, d, <i>J</i> = 8.1 Hz). LC/MS <i>m</i>/<i>z</i> 341.2 (M + H). HPLC purity 99.18% (220 nm), 100% (254 nm). ESI-HRMS calcd for C<sub>21</sub>H<sub>28</sub>N<sub>2</sub>O<sub>2</sub><i>m</i>/<i>z</i> 341.2224 (M + H), found 341.2215 (M + H).</div></div><div id="sec5_79" class="NLM_sec NLM_sec_level_2"><div id="ac_i96" class="anchor-spacer"></div><h3 class="article-section__title" id="_i96"> DPP-4 + <b>27c</b> or <b>30c</b> Crystal Structure Determination</h3><div class="NLM_p">The cDNA encoding human DPP-4 was isolated by PCR from spleen cDNA (Clontech), and the extracellular domain (residues 39−766) was cloned into a modified pFastBacHTb vector (Invitrogen). The final construct contains a baculovirus gp67 signal peptide followed by a His6 tag fused to the coding sequence corresponding to residues 39−766 of DPP-4. Recombinant baculovirus was generated by transposition using the Bac-to-Bac system (Gibco-BRL). Large-scale production of recombinant protein was performed by infection of <i>Trichoplusia ni</i> (Hi5) insect cells (Gibco-BRL) for 48 h in 5 L Wave Bioreactors (Wave Biotech). The secreted glycosylated recombinant protein was isolated from the cell culture medium by diafiltration using cross-flow ultrafiltration followed by passage over a nickel chelate resin (Binding buffer: 25 mM Tris, pH 7.9; 400 mM NaCl). The column was washed overnight (0.2 mL/min) with 50 mM K<sub>2</sub>HPO<sub>4</sub> pH 7.9; 400 mM NaCl; 20 mM imidazole-HCl and 0.25 mM TCEP followed by 5 column volumes (1 mL/min) of 50 mM Tris HCl pH 7.9; 400 mM NaCl and 0.25 mM TCEP. Protein bound was eluted with 4 column volumes of 50 mM Tris-HCl, pH 7.9, 400 mM NaCl, 200 mM imidazole-HCl and 0.25 mM TCEP. To remove oligomeric forms, the sample was further purified over a size exclusion column (BioSep SEC S3000, 300 × 21.2 mm, Phenomenex) equilibrated with 25 mM Tris pH 7.6; 150 mM NaCl; 0.25 M TCEP and 1 mM EDTA. Wild-type DPP-4 in free form was concentrated to ∼14 mg/mL and crystallized at 4 °C. The reservoir solution was 20% PEG MME 2000, 100 mM bicine (pH 8.0−8.5). Thick plate shaped crystals appeared in about 5 days that grew to about 0.5 mm in longest dimension and varying width and thickness. All protein−inhibitor complexes were obtained by soaking preformed DPP-4 crystals in a solution containing 1 mM of compound of interest. Crystals were then cryoprotected with ethylene glycol and flash frozen in liquid nitrogen. X-ray diffraction data were collected at Advanced Light Source (ALS) beamlines 5.0.2 and 5.0.3, and processed using the program HKL2000.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> The structures of DPP-4 inhibitor complexes were determined by molecular replacement using MOLREP, utilizing the previously determined coordinates of DPP-4 with accession code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1R9M">1R9M</a>.<a onclick="showRef(event, 'ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref19 ref20">(19, 20)</a> Subsequent structure refinement and model building were performed utilizing REFMAC and XtalView.<a onclick="showRef(event, 'ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref20 ref21">(20, 21)</a> Bound inhibitors were clearly visible in the electron density maps. Data-collection and model refinement statistics are summarized in Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Data Collection and Model Refinement Statistics<a class="ref internalNav" href="#tbl7-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="left"> </th><th class="colsep0 rowsep0" align="center"><b>27c</b></th><th class="colsep0 rowsep0" align="center"><b>30c</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left" valign="bottom">PDI code</td><td class="colsep0 rowsep0" align="left" valign="bottom"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3O9V">3O9V</a></td><td class="colsep0 rowsep0" align="left" valign="bottom"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3O95">3O95</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="3" align="center">Data Collection</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">space group</td><td class="colsep0 rowsep0" align="left">P21</td><td class="colsep0 rowsep0" align="left">P21</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">unit cell lengths (Å)</td><td class="colsep0 rowsep0" align="left">122.2;122.9;144.4</td><td class="colsep0 rowsep0" align="left">121.7;123.3;144.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">unit cell angles (deg)</td><td class="colsep0 rowsep0" align="left">91;114.6;90.0</td><td class="colsep0 rowsep0" align="left">90;114.8;90.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">resolution (Å)</td><td class="colsep0 rowsep0" align="left">2.75</td><td class="colsep0 rowsep0" align="left">2.85</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">observations</td><td class="colsep0 rowsep0" align="left">317,105</td><td class="colsep0 rowsep0" align="left">291,608</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">unique</td><td class="colsep0 rowsep0" align="left">100,525</td><td class="colsep0 rowsep0" align="left">89,585</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">completeness (%)</td><td class="colsep0 rowsep0" align="left">98.9 (98.6)</td><td class="colsep0 rowsep0" align="left">99.3 (92.4)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>I</i>/σ<sub><i>I</i></sub></td><td class="colsep0 rowsep0" align="left">13.4 (2.2)</td><td class="colsep0 rowsep0" align="left">10.7 (1.9)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>R</i><sub>sym</sub> (%)</td><td class="colsep0 rowsep0" align="left">0.087 (0.514)</td><td class="colsep0 rowsep0" align="left">0.106 (0.510)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="3" align="center">Model Refinement</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">reflections (work/free)</td><td class="colsep0 rowsep0" align="left">100346/5026</td><td class="colsep0 rowsep0" align="left">89524/4489</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>R</i><sub>factor</sub> (work/free %)</td><td class="colsep0 rowsep0" align="left">20.33/26.15</td><td class="colsep0 rowsep0" align="left">18.70/24.85</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">protein molecules per ASU</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">solvent molecules</td><td class="colsep0 rowsep0" align="left">451</td><td class="colsep0 rowsep0" align="left">487</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mean B value (Å<sup>2</sup>)</td><td class="colsep0 rowsep0" align="left">50.7</td><td class="colsep0 rowsep0" align="left">49.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rmsd ideal bond lengths (Å)</td><td class="colsep0 rowsep0" align="left">0.009</td><td class="colsep0 rowsep0" align="left">0.009</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rmsd ideal bond angles (deg)</td><td class="colsep0 rowsep0" align="left">1.20</td><td class="colsep0 rowsep0" align="left">1.24</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl7-fn1"><div class="footnote" id="tbl7-fn1"><sup>a</sup><p class="last">R<sub>sym</sub> = ∑|<i>I</i> − ⟨<i>I</i>⟩|/∑<i>I</i>, where <i>I</i> is the integrated intensity for a reflection. <i>R</i><sub>factor</sub> = ∑|<i>F</i><sub>P</sub> − <i>F</i><sub>c</sub>|/∑<i>F</i><sub>P</sub>, where <i>F</i><sub>p</sub> and <i>F</i><sub>c</sub> are the observed and calculated structure factor amplitudes, while <i>R</i><sub>free</sub> is calculated on 5% of the data excluded from refinement. Values in parentheses are for the highest resolution shell.</p></div></div></div></div><div id="sec5_80" class="NLM_sec NLM_sec_level_2"><div id="ac_i98" class="anchor-spacer"></div><h3 class="article-section__title" id="_i98"> Docking Study in DPP-4</h3><div class="NLM_p last">The X-ray crystal structure of DPP-4 complexed with 2-{[3-(aminomethyl)-2-(2-methylpropyl)-1-oxo-4-phenyl-1,2-dihydroisoquinolin-6-yl]oxy}acetamide was utilized in the docking calculations. The compounds were docked into DPP-4 using Gold 3.0.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> After the automatic docking, the conformations of the substituents in the docked compounds were aligned to the corresponding moiety of 2-{[3-(aminomethyl)-2-(2-methylpropyl)-1-oxo-4-phenyl-1,2-dihydroisoquinolin-6-yl]oxy}acetamide and then energy-minimized at the MMFF94s force field using MOE 2005.06.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a></div></div><div id="sec5_81" class="NLM_sec NLM_sec_level_2"><div id="ac_i99" class="anchor-spacer"></div><h3 class="article-section__title" id="_i99"> In Vitro DPP-4, DPP-2, DPP-8 and DPP-9 Enzyme Assay</h3><div class="NLM_p">Human DPP-4 was partially purified from Caco-2 cells (ATCC No. HTB-37). The compounds (1 μL in DMSO) at each concentration were added to 79 μL of assay buffer (0.25 mol/L Tris-HCl pH 7.5, 0.25% bovine serum albumin, 0.125% CHAPS) and mixed with 20 μL of the DPP-IV fraction. After the mixture was incubated at room temperature for 15 min, the reaction was initiated by adding 100 μL of 1 mmol/L of Gly-Pro-pNA·Tos as a substrate and run for 60 min at 37 °C.</div><div class="NLM_p">Rat DPP-2 was partially purified from rat kidney according to the method previously reported.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> 1 μL of compounds dissolved in DMSO was mixed with 29 μL of distilled water, 10 μL of 1 mol/L 3,3-dimethylglutamic acid buffer (pH 5.5), and 10 μL of the DPP-2 fraction. After the mixture was incubated at room temperature for 20 min, the reaction was initiated by adding 50 μL of 1 mmol/L of H-Lys-Ala-pNA·2HCl and run at 37 °C for 60 min.</div><div class="NLM_p">Human DPP-8 and DPP-9 were purified respectively by affinity chromatography from the 293-F cells expressing each FLAG-tagged protein. 1 μL of compounds dissolved in DMSO was mixed with 29 μL of distilled water, 10 μL of 1 mol/L Tris-HCl buffer (pH 7.5), and 10 μL of the enzyme fraction. After the mixture was incubated at room temperature for 20 min, the reaction was initiated by adding 50 μL of 2 mmol/L of Gly-Pro-pNA·Tos for DPP-8 or 4 mmol/L of Gly-Pro-pNA·Tos for DPP-9 and run at 37 °C for 90 min.</div><div class="NLM_p last">Absorbance at 405 nm of each reaction mixture was measured using a microplate reader at the initial time and the end of the reaction. The well containing substrate alone was used as a basal control. The well containing the substrate and the enzyme without the compound was used as a total reaction.</div></div><div id="sec5_82" class="NLM_sec NLM_sec_level_2"><div id="ac_i100" class="anchor-spacer"></div><h3 class="article-section__title" id="_i100"> Incubation of Compound <b>30c</b> with Hepatic Microsomes</h3><div class="NLM_p last">In vitro oxidative metabolic studies of compound <b>30c</b> were carried out using hepatic microsomes obtained from rats, dogs and humans. The incubation mixtures were prepared under ice-cold conditions by adding the microsomes (0.2 μg protein/mL), and compound <b>30c</b> solution (1 μmol/L) at the final concentrations indicated. The reactions were initiated by adding the solution containing NADPH to the incubation mixtures. Incubations were conducted at 37 °C for 20 min and terminated by adding the ice-cold acetonitrile. The zero-time incubations which served as the controls were terminated by adding the ice-cold acetonitrile before adding compound <b>30c</b> solution. After the samples were mixed and centrifuged, the supernatant fractions were subjected to high performance liquid chromatography with UV detector.</div></div><div id="sec5_83" class="NLM_sec NLM_sec_level_2"><div id="ac_i101" class="anchor-spacer"></div><h3 class="article-section__title" id="_i101"> Solubility Determination</h3><div class="NLM_p last">The compounds were added to each buffer solution. After incubation, precipitates were separated by filtration. The thermodynamic solubility was determined by HPLC analysis of each filtrate.</div></div><div id="sec5_84" class="NLM_sec NLM_sec_level_2"><div id="ac_i102" class="anchor-spacer"></div><h3 class="article-section__title" id="_i102"> Pharmacokinetic Profile in Rats and Dogs</h3><div class="NLM_p last">Compound <b>30c</b> was administered to rats and dogs. After oral and intravenous administration, blood samples were collected. The blood samples were centrifuged to obtain the plasma fraction. The plasma samples were deproteinized with acetonitrile containing an internal standard. After centrifugation, the supernatant was diluted with 0.01 mol/L ammonium acetate and centrifuged again. The compound concentrations in the supernatant were measured by LC/MS/MS.</div></div><div id="sec5_85" class="NLM_sec NLM_sec_level_2"><div id="ac_i103" class="anchor-spacer"></div><h3 class="article-section__title" id="_i103"> Effects of Single Administration of Compound <b>30c</b> on Glucose Tolerance in Female Wistar Fatty Rats</h3><div class="NLM_p last">Female Wistar fatty rats were obtained from Takeda Rabics, Ltd. Each animal was fed a commercial diet (CE-2) and tap water ad libitum. At the age of 13 weeks, the rats were fasted overnight and divided into 5 groups based on PG levels and body weights (6 rats in each group). PG levels and plasma insulin levels at the grouping point were used as the data of initial point. Each group was orally administered vehicle (0.5% methylcellulose) or compound <b>30c</b> at doses of 0.03, 0.1, 0.3, and 1 mg/kg as free base form of compound <b>30c</b>. One hour later, all animals received an oral glucose load (1 g/kg). Blood samples were collected from tail vein at 0, 10, 30, and 60 min after the glucose load (time 0; 40 min after administration of compound <b>30c</b>). Heparin/EDTA was used as anticoagulant, and 100 μM DPP-4 inhibitor (Linco Research Inc.) as final concentration was added to the blood sample for measurement of active GLP-1 concentration in plasma (0 and 10 min). PG level was determined by an enzyme assay method (L-type Glucose 2; Wako Pure Chemical Ind., Ltd.). Plasma insulin level was determined by ELISA kit (Morinaga, Japan).</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i105"><a href="/doi/suppl/10.1021/jm101236h">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11713" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11713" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Experimental procedure for compound <b>25j</b>. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm101236h/suppl_file/jm101236h_si_001.pdf">jm101236h_si_001.pdf (58.84 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm101236h" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25604" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25604" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hironobu Maezaki</span> - <span class="hlFld-Affiliation affiliation">Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 17-85, Jusohonmachi 2-Chome, Yodogawa-ku, Osaka 532-8686, Japan</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#bbf6dadec1dad0d2e4f3d2c9d4d5d4d9cefbcfdad0dedfda95d8d495d1cb"><span class="__cf_email__" data-cfemail="ca87abafb0aba1a39582a3b8a5a4a5a8bf8abeaba1afaeabe4a9a5e4a0ba">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yasufumi Miyamoto</span> - <span class="hlFld-Affiliation affiliation">Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 17-85, Jusohonmachi 2-Chome, Yodogawa-ku, Osaka 532-8686, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yoshihiro Banno</span> - <span class="hlFld-Affiliation affiliation">Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 17-85, Jusohonmachi 2-Chome, Yodogawa-ku, Osaka 532-8686, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tohru Yamashita</span> - <span class="hlFld-Affiliation affiliation">Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 17-85, Jusohonmachi 2-Chome, Yodogawa-ku, Osaka 532-8686, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tatsuhiko Fujimoto</span> - <span class="hlFld-Affiliation affiliation">Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 17-85, Jusohonmachi 2-Chome, Yodogawa-ku, Osaka 532-8686, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Satoru Oi</span> - <span class="hlFld-Affiliation affiliation">Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 17-85, Jusohonmachi 2-Chome, Yodogawa-ku, Osaka 532-8686, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yusuke Moritoh</span> - <span class="hlFld-Affiliation affiliation">Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 17-85, Jusohonmachi 2-Chome, Yodogawa-ku, Osaka 532-8686, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tomoko Asakawa</span> - <span class="hlFld-Affiliation affiliation">Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 17-85, Jusohonmachi 2-Chome, Yodogawa-ku, Osaka 532-8686, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Osamu Kataoka</span> - <span class="hlFld-Affiliation affiliation">Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 17-85, Jusohonmachi 2-Chome, Yodogawa-ku, Osaka 532-8686, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hiroaki Yashiro</span> - <span class="hlFld-Affiliation affiliation">Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 17-85, Jusohonmachi 2-Chome, Yodogawa-ku, Osaka 532-8686, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Koji Takeuchi</span> - <span class="hlFld-Affiliation affiliation">Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 17-85, Jusohonmachi 2-Chome, Yodogawa-ku, Osaka 532-8686, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nobuhiro Suzuki</span> - <span class="hlFld-Affiliation affiliation">Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 17-85, Jusohonmachi 2-Chome, Yodogawa-ku, Osaka 532-8686, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Koji Ikedo</span> - <span class="hlFld-Affiliation affiliation">Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 17-85, Jusohonmachi 2-Chome, Yodogawa-ku, Osaka 532-8686, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Takuo Kosaka</span> - <span class="hlFld-Affiliation affiliation">Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 17-85, Jusohonmachi 2-Chome, Yodogawa-ku, Osaka 532-8686, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shigetoshi Tsubotani</span> - <span class="hlFld-Affiliation affiliation">Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 17-85, Jusohonmachi 2-Chome, Yodogawa-ku, Osaka 532-8686, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Akiyoshi Tani</span> - <span class="hlFld-Affiliation affiliation">Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 17-85, Jusohonmachi 2-Chome, Yodogawa-ku, Osaka 532-8686, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Masako Sasaki</span> - <span class="hlFld-Affiliation affiliation">Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 17-85, Jusohonmachi 2-Chome, Yodogawa-ku, Osaka 532-8686, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Miyuki Funami</span> - <span class="hlFld-Affiliation affiliation">Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 17-85, Jusohonmachi 2-Chome, Yodogawa-ku, Osaka 532-8686, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michiko Amano</span> - <span class="hlFld-Affiliation affiliation">Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 17-85, Jusohonmachi 2-Chome, Yodogawa-ku, Osaka 532-8686, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yoshio Yamamoto</span> - <span class="hlFld-Affiliation affiliation">Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 17-85, Jusohonmachi 2-Chome, Yodogawa-ku, Osaka 532-8686, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kathleen Aertgeerts</span> - <span class="hlFld-Affiliation affiliation">Takeda San Diego, Inc., 10410, Science Center Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jason Yano</span> - <span class="hlFld-Affiliation affiliation">Takeda San Diego, Inc., 10410, Science Center Drive, San Diego, California 92121, United States</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i104">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83248" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83248" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors thank Dr. Yu Momose, Dr. Yuji Ishihara, Dr. Akio Miyake and Dr. Takashi Sohda for their helpful discussions; Dr. Jyunichi Sakamoto for the evaluation of enzyme activities; Dr. Yukihiro Ikeda and Mr. Seiji Yamasaki for measuring the solubility highlighted in Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i106">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72327" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72327" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 24 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Gorrell, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gysbers, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCaughan, G. W.</span><span> </span><span class="NLM_article-title">CD26: A multifunctional integral membrane and secreted protein of activated lymphocytes</span> <span class="citation_source-journal">Scand. J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">249</span><span class="NLM_x">–</span> <span class="NLM_lpage">264</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Fjm101236h&amp;key=10.1046%2Fj.1365-3083.2001.00984.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Fjm101236h&amp;key=11555388" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Fjm101236h&amp;key=1%3ACAS%3A528%3ADC%252BD3MXnt1Sru7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2001&pages=249-264&author=M.+D.+Gorrellauthor=V.+Gysbersauthor=G.+W.+McCaughan&title=CD26%3A+A+multifunctional+integral+membrane+and+secreted+protein+of+activated+lymphocytes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">CD26: a multifunctional integral membrane and secreted protein of activated lymphocytes</span></div><div class="casAuthors">Gorrell, M. D.; Gysbers, V.; McCaughan, G. W.</div><div class="citationInfo"><span class="NLM_cas:title">Scandinavian Journal of Immunology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">249-264</span>CODEN:
                <span class="NLM_cas:coden">SJIMAX</span>;
        ISSN:<span class="NLM_cas:issn">0300-9475</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">A review.  CD26 has proved interesting in the fields of immunol., endocrinol., cancer biol. and nutrition owing to its ubiquitous and unusual enzyme activity.  This dipeptidyl aminopeptidase (DPP IV) activity generally inactivates but sometimes alters or enhances the biol. activities of its peptide substrates, which include several chemokines.  CD26 costimulates both the CD3 and the CD2 dependent T-cell activation and tyrosine phosphorylation of TCR/CD3 signal transduction pathway proteins.  CD26 in vivo has integral membrane protein and sol. forms.  Sol. CD26 is at significant levels in serum, these levels alter in many diseases and sol. CD26 can modulate in vitro T-cell proliferation.  CD26, being an adenosine deaminase binding protein (ADAbp), functions as a receptor for ADA on lymphocytes.  The focus of this review is the structure and function of CD26 and the influence of its ligand binding activity on T-cell proliferation and the T cell costimulatory activity of CD26.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBV_U3MaLyFbVg90H21EOLACvtfcHk0lhDBFQpqPRMRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXnt1Sru7c%253D&md5=caa68f661699756a7cbce01dfe5c76e3</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1046%2Fj.1365-3083.2001.00984.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1365-3083.2001.00984.x%26sid%3Dliteratum%253Aachs%26aulast%3DGorrell%26aufirst%3DM.%2BD.%26aulast%3DGysbers%26aufirst%3DV.%26aulast%3DMcCaughan%26aufirst%3DG.%2BW.%26atitle%3DCD26%253A%2520A%2520multifunctional%2520integral%2520membrane%2520and%2520secreted%2520protein%2520of%2520activated%2520lymphocytes%26jtitle%3DScand.%2520J.%2520Immunol.%26date%3D2001%26volume%3D54%26spage%3D249%26epage%3D264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Meester, I. De; Durinx, C.; Proost, P.; Scharpe, S.; Lambier, A. M</span>. In  <span class="citation_source-book">Ectopeptidases: CD13/Aminopeptidase N and CD26/Dipeptidylpeptidase IV in Medicine and Biology</span>; <span class="NLM_contrib-group">Langner, J.; Ansore, S.</span>; Eds.; <span class="NLM_publisher-name">Kluwer Academic/Pleneu Publisher</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2002</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">223</span>− <span class="NLM_lpage">257</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Fjm101236h&amp;key=10.1007%2F978-1-4615-0619-5_9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&pages=223-257&author=I.+De+Meester&author=C.+Durinx&author=P.+Proost&author=S.+Scharpe&author=A.+M+Lambierauthor=J.+Langner&author=S.+Ansore&title=Ectopeptidases%3A+CD13%2FAminopeptidase+N+and+CD26%2FDipeptidylpeptidase+IV+in+Medicine+and+Biology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1007%2F978-1-4615-0619-5_9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-1-4615-0619-5_9%26sid%3Dliteratum%253Aachs%26aulast%3DMeester%26aufirst%3DI.%2BDe%26btitle%3DEctopeptidases%253A%2520CD13%252FAminopeptidase%2520N%2520and%2520CD26%252FDipeptidylpeptidase%2520IV%2520in%2520Medicine%2520and%2520Biology%26aulast%3DLangner%26aufirst%3DJ.%26pub%3DKluwer%2520Academic%252FPleneu%2520Publisher%26date%3D2002%26spage%3D223%26epage%3D257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Mentlein, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballwitz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, W. E.</span><span> </span><span class="NLM_article-title">Dipeptidylpeptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1 (7−36) amide, peptide histidine methionine and is responsible for their degradation in human serum</span> <span class="citation_source-journal">Eur. J. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">214</span><span class="NLM_x">, </span> <span class="NLM_fpage">829</span><span class="NLM_x">–</span> <span class="NLM_lpage">835</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Fjm101236h&amp;key=10.1111%2Fj.1432-1033.1993.tb17986.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=8&amp;doi=10.1021%2Fjm101236h&amp;key=8100523" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Fjm101236h&amp;key=1%3ACAS%3A528%3ADyaK3sXks1elsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=214&publication_year=1993&pages=829-835&author=R.+Mentleinauthor=B.+Ballwitzauthor=W.+E.+Schmidt&title=Dipeptidylpeptidase+IV+hydrolyses+gastric+inhibitory+polypeptide%2C+glucagon-like+peptide-1+%287%E2%88%9236%29+amide%2C+peptide+histidine+methionine+and+is+responsible+for+their+degradation+in+human+serum"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2a</span><div class="casTitle"><span class="NLM_cas:atitle">Dipeptidyl-peptidase IV hydrolyzes gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum</span></div><div class="casAuthors">Mentlein, Rolf; Gallwitz, Baptist; Schmidt, Wolfgang E.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">214</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">829-35</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    </div><div class="casAbstract">Peptides of the glucagon/VIP family share a considerable sequence similarity at their N-terminus.  They either start with Tyr-Ala, His-Ala or His-Ser which might be in part potential targets for dipeptidyl-peptidase IV, a highly specialized aminopeptidase removing dipeptides only from peptides with N-terminal penultimate proline or alanine.  GH-releasing factor(1-29)amide and gastric inhibitory peptide/glucose-dependent insulinotropic peptide (GIP) with terminal Tyr-Ala as well as glucagon-like peptide-1(7-36)amide/insulinotropin [GLP-1(7-36)amide] and peptide histidine methionine (PHM) with terminal His-Ala were hydrolyzed to their des-Xaa-Ala derivs. by dipeptidyl-peptidase IV purified from human placenta.  VIP with terminal His-Ser was not degraded by the peptidase.  The kinetics of the hydrolysis of GIP, GLP-1(7-36)amide and PHM were analyzed in detail.  For these peptides Km values of 4-34 μM and Vmax values of 0.6-3.8 μmol/min/mg protein were detd. for the purified peptidase which should allow their enzymic degrdn. also at physiol., nanomolar concns.  When human serum was incubated with GIP or GLP-1(7-36)amide the same fragments as with the purified dipeptidyl-peptidase IV, namely the des-Xaa-Ala peptides and Tyr-Ala in the case of GIP or His-Ala in the case of GLP-1(7-36)amide, were identified as the main degrdn. products of these peptide hormones.  Incorporation of inhibitors specific for dipeptidyl-peptidase IV, 1 mM Lys-pyrrolidide or 0.1 mM diprotin A (Ile-Pro-Ile), completely abolished the prodn. of these fragments by serum.  It is concluded that dipeptidyl-peptidase IV initiates the metab. of GIP and GLP-1(7-36)amide in human serum.  Since an intact N-terminus is obligate for the biol. activity of the members of the glucagon/VIP peptide family [e.g., GIP(3-42) is known to be inactive to release insulin in the presence of glucose as is intact GIP], dipeptidyl-peptidase-IV action inactivates these peptide hormones.  The relevance of this finding for their inactivation and their detn. by immunoassays is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaIzMbUUoh9LVg90H21EOLACvtfcHk0lhDBFQpqPRMRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXks1elsLs%253D&md5=dd06411585d4e8bb42d5b093e895b900</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1111%2Fj.1432-1033.1993.tb17986.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1432-1033.1993.tb17986.x%26sid%3Dliteratum%253Aachs%26aulast%3DMentlein%26aufirst%3DR.%26aulast%3DBallwitz%26aufirst%3DB.%26aulast%3DSchmidt%26aufirst%3DW.%2BE.%26atitle%3DDipeptidylpeptidase%2520IV%2520hydrolyses%2520gastric%2520inhibitory%2520polypeptide%252C%2520glucagon-like%2520peptide-1%2520%25287%25E2%2588%259236%2529%2520amide%252C%2520peptide%2520histidine%2520methionine%2520and%2520is%2520responsible%2520for%2520their%2520degradation%2520in%2520human%2520serum%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D1993%26volume%3D214%26spage%3D829%26epage%3D835" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kieffer, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntosh, C. H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pederson, T. A.</span><span> </span><span class="NLM_article-title">Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">136</span><span class="NLM_x">, </span> <span class="NLM_fpage">3585</span><span class="NLM_x">–</span> <span class="NLM_lpage">3596</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=1995&pages=3585-3596&author=T.+J.+Kiefferauthor=C.+H.+S.+McIntoshauthor=T.+A.+Pederson&title=Degradation+of+glucose-dependent+insulinotropic+polypeptide+and+truncated+glucagon-like+peptide+1+in+vitro+and+in+vivo+by+dipeptidyl+peptidase+IV"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKieffer%26aufirst%3DT.%2BJ.%26aulast%3DMcIntosh%26aufirst%3DC.%2BH.%2BS.%26aulast%3DPederson%26aufirst%3DT.%2BA.%26atitle%3DDegradation%2520of%2520glucose-dependent%2520insulinotropic%2520polypeptide%2520and%2520truncated%2520glucagon-like%2520peptide%25201%2520in%2520vitro%2520and%2520in%2520vivo%2520by%2520dipeptidyl%2520peptidase%2520IV%26jtitle%3DEndocrinology%26date%3D1995%26volume%3D136%26spage%3D3585%26epage%3D3596" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Vilsbøll, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knop, F. K.</span><span> </span><span class="NLM_article-title">DPP IV inhibitors-current evidence and future directions</span> <span class="citation_source-journal">Br. J. Diabetes Vasc. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">69</span><span class="NLM_x">–</span> <span class="NLM_lpage">74</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Fjm101236h&amp;key=10.1177%2F14746514070070020401" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=69-74&author=T.+Vilsb%C3%B8llauthor=F.+K.+Knop&title=DPP+IV+inhibitors-current+evidence+and+future+directions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1177%2F14746514070070020401&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F14746514070070020401%26sid%3Dliteratum%253Aachs%26aulast%3DVilsb%25C3%25B8ll%26aufirst%3DT.%26aulast%3DKnop%26aufirst%3DF.%2BK.%26atitle%3DDPP%2520IV%2520inhibitors-current%2520evidence%2520and%2520future%2520directions%26jtitle%3DBr.%2520J.%2520Diabetes%2520Vasc.%2520Dis.%26date%3D2007%26volume%3D7%26spage%3D69%26epage%3D74" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Wiedeman, P. E.</span><span> </span><span class="NLM_article-title">DPPIV inhibition: Promising therapy for the treatment of type 2 diabetes</span> <span class="citation_source-journal">Prog. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">63</span><span class="NLM_x">–</span> <span class="NLM_lpage">109</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Fjm101236h&amp;key=10.1016%2FS0079-6468%2806%2945502-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=8&amp;doi=10.1021%2Fjm101236h&amp;key=17280902" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Fjm101236h&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1Wltbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2007&pages=63-109&author=P.+E.+Wiedeman&title=DPPIV+inhibition%3A+Promising+therapy+for+the+treatment+of+type+2+diabetes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3b</span><div class="casTitle"><span class="NLM_cas:atitle">DPPIV inhibition: promising therapy for the treatment of type 2 diabetes</span></div><div class="casAuthors">Wiedeman, Paul E.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">63-109</span>CODEN:
                <span class="NLM_cas:coden">PMDCAY</span>;
        ISSN:<span class="NLM_cas:issn">0079-6468</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review on dipeptidyl peptidase IV (DPPIV) inhibition as a promising therapy for the treatment of type 2 diabetes.  The prevalence of type 2 diabetes is discussed, along with inhibition of DPPIV as a strategy to enhance the incretin effect, potential for disease modification with DPPIV inhibitors, importance of DPPIV selectivity, and structural biol. of DPPIV.  The medicinal chem. and preclin. studies on DPPIV inhibitors are also considered, together with clin. data for oral DPPIV inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrof7HCUTdzTLVg90H21EOLACvtfcHk0ljNmVWmrCEAvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1Wltbo%253D&md5=42622df89ac83d586bb6bcfc0e184da9</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.1016%2FS0079-6468%2806%2945502-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0079-6468%252806%252945502-8%26sid%3Dliteratum%253Aachs%26aulast%3DWiedeman%26aufirst%3DP.%2BE.%26atitle%3DDPPIV%2520inhibition%253A%2520Promising%2520therapy%2520for%2520the%2520treatment%2520of%2520type%25202%2520diabetes%26jtitle%3DProg.%2520Med.%2520Chem.%26date%3D2007%26volume%3D45%26spage%3D63%26epage%3D109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Ahrén, B.</span><span> </span><span class="NLM_article-title">Emerging dipeptidyl peptidase-4 inhibitors for the treatment of diabetes</span> <span class="citation_source-journal">Expert Opin. Emerging Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">593</span><span class="NLM_x">–</span> <span class="NLM_lpage">607</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=16&amp;doi=10.1021%2Fjm101236h&amp;key=10.1517%2F14728210802584126" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=8&amp;doi=10.1021%2Fjm101236h&amp;key=19046129" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=32&amp;doi=10.1021%2Fjm101236h&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVCnurjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2008&pages=593-607&issue=4&author=B.+Ahr%C3%A9n&title=Emerging+dipeptidyl+peptidase-4+inhibitors+for+the+treatment+of+diabetes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3cR"><div class="casContent"><span class="casTitleNuber">3c</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging dipeptidyl peptidase-4 inhibitors for the treatment of diabetes</span></div><div class="casAuthors">Ahren, Bo</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Emerging Drugs</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">593-607</span>CODEN:
                <span class="NLM_cas:coden">EOEDA3</span>;
        ISSN:<span class="NLM_cas:issn">1472-8214</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Inhibition of dipeptidyl peptidase-4 (DPP-4) prevents the inactivation of glucagon-like peptide-1 (GLP-1).  This increases circulating levels of active GLP-1, stimulates insulin secretion and inhibits glucagon secretion, resulting in lowering of glucose levels and improvement of glycemic control in patients with type 2 diabetes.  Several DPP-4 inhibitors are emerging for therapeutic use.  Most experience exists for sitagliptin, vildagliptin, saxagliptin and alogliptin.  They all improve metabolic control in type 2 diabetes in monotherapy and in combination therapy with metformin, sulfonylurea and thiazolidinediones.  Vildagliptin and alogliptin have also been shown to improve glycemic control when added to insulin therapy, and sitagliptin improves glycemic control in triple therapy with metformin plus thiazolidinedione.  DPP-4 inhibition also shows a favorable safety profile, high tolerability, only a minimal risk of hypoglycemia, and body-wt. neutrality.  The main clin. indication for DPP-4 inhibitors will be in the early stage of type 2 diabetes, in combination with metformin or other treatments in subjects with inadequate glycemic control on these treatments alone.  The durability and long-term safety of DPP-4 inhibition, as well as clin. positioning in relation to GLP-1 mimetics, remain now to be established.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoc18qdMIDGU7Vg90H21EOLACvtfcHk0ljNmVWmrCEAvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVCnurjE&md5=47f973c7343e215dd6d06e770936f5ba</span></div><a href="/servlet/linkout?suffix=cit3c&amp;dbid=16384&amp;doi=10.1517%2F14728210802584126&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728210802584126%26sid%3Dliteratum%253Aachs%26aulast%3DAhr%25C3%25A9n%26aufirst%3DB.%26atitle%3DEmerging%2520dipeptidyl%2520peptidase-4%2520inhibitors%2520for%2520the%2520treatment%2520of%2520diabetes%26jtitle%3DExpert%2520Opin.%2520Emerging%2520Drugs%26date%3D2008%26volume%3D13%26issue%3D4%26spage%3D593%26epage%3D607" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Drucker, D. J.</span><span> </span><span class="NLM_article-title">Dipeptidyl peptidase-4 inhibition and the treatment of type 2 diabetes. Preclinical biology and mechanisms of action</span> <span class="citation_source-journal">Diabetes Care</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">1335</span><span class="NLM_x">–</span> <span class="NLM_lpage">1343</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2007&pages=1335-1343&issue=6&author=D.+J.+Drucker&title=Dipeptidyl+peptidase-4+inhibition+and+the+treatment+of+type+2+diabetes.+Preclinical+biology+and+mechanisms+of+action"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDrucker%26aufirst%3DD.%2BJ.%26atitle%3DDipeptidyl%2520peptidase-4%2520inhibition%2520and%2520the%2520treatment%2520of%2520type%25202%2520diabetes.%2520Preclinical%2520biology%2520and%2520mechanisms%2520of%2520action%26jtitle%3DDiabetes%2520Care%26date%3D2007%26volume%3D30%26issue%3D6%26spage%3D1335%26epage%3D1343" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Ahrén, B.</span><span> </span><span class="NLM_article-title">Dipeptidyl Peptidase-4 Inhibitors. Clinical data and clinical implications</span> <span class="citation_source-journal">Diabetes Care</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">1344</span><span class="NLM_x">–</span> <span class="NLM_lpage">1350</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2007&pages=1344-1350&issue=6&author=B.+Ahr%C3%A9n&title=Dipeptidyl+Peptidase-4+Inhibitors.+Clinical+data+and+clinical+implications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAhr%25C3%25A9n%26aufirst%3DB.%26atitle%3DDipeptidyl%2520Peptidase-4%2520Inhibitors.%2520Clinical%2520data%2520and%2520clinical%2520implications%26jtitle%3DDiabetes%2520Care%26date%3D2007%26volume%3D30%26issue%3D6%26spage%3D1344%26epage%3D1350" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Kim, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beconi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eiermann, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickey, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kowalchick, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leiting, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyons, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marisilio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCann, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scapin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roy, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyvratt, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thornberry, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, A. E.</span><span> </span><span class="NLM_article-title">(2<i>R</i>)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-<i>a</i>]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine: A potent, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">141</span><span class="NLM_x">–</span> <span class="NLM_lpage">151</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0493156" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=141-151&author=D.+Kimauthor=L.+Wangauthor=M.+Beconiauthor=G.+J.+Eiermannauthor=M.+H.+Fisherauthor=H.+Heauthor=G.+J.+Hickeyauthor=J.+E.+Kowalchickauthor=B.+Leitingauthor=K.+Lyonsauthor=F.+Marisilioauthor=M.+E.+McCannauthor=R.+A.+Patelauthor=A.+Petrovauthor=G.+Scapinauthor=S.+B.+Patelauthor=R.+S.+Royauthor=J.+K.+Wuauthor=M.+J.+Wyvrattauthor=B.+B.+Zhangauthor=L.+Zhuauthor=N.+A.+Thornberryauthor=A.+E.+Weber&title=%282R%29-4-Oxo-4-%5B3-%28trifluoromethyl%29-5%2C6-dihydro%5B1%2C2%2C4%5Dtriazolo%5B4%2C3-a%5Dpyrazin-7%288H%29-yl%5D-1-%282%2C4%2C5-trifluorophenyl%29butan-2-amine%3A+A+potent%2C+orally+active+dipeptidyl+peptidase+IV+inhibitor+for+the+treatment+of+type+2+diabetes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1021%2Fjm0493156&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0493156%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DBeconi%26aufirst%3DM.%26aulast%3DEiermann%26aufirst%3DG.%2BJ.%26aulast%3DFisher%26aufirst%3DM.%2BH.%26aulast%3DHe%26aufirst%3DH.%26aulast%3DHickey%26aufirst%3DG.%2BJ.%26aulast%3DKowalchick%26aufirst%3DJ.%2BE.%26aulast%3DLeiting%26aufirst%3DB.%26aulast%3DLyons%26aufirst%3DK.%26aulast%3DMarisilio%26aufirst%3DF.%26aulast%3DMcCann%26aufirst%3DM.%2BE.%26aulast%3DPatel%26aufirst%3DR.%2BA.%26aulast%3DPetrov%26aufirst%3DA.%26aulast%3DScapin%26aufirst%3DG.%26aulast%3DPatel%26aufirst%3DS.%2BB.%26aulast%3DRoy%26aufirst%3DR.%2BS.%26aulast%3DWu%26aufirst%3DJ.%2BK.%26aulast%3DWyvratt%26aufirst%3DM.%2BJ.%26aulast%3DZhang%26aufirst%3DB.%2BB.%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DThornberry%26aufirst%3DN.%2BA.%26aulast%3DWeber%26aufirst%3DA.%2BE.%26atitle%3D%25282R%2529-4-Oxo-4-%255B3-%2528trifluoromethyl%2529-5%252C6-dihydro%255B1%252C2%252C4%255Dtriazolo%255B4%252C3-a%255Dpyrazin-7%25288H%2529-yl%255D-1-%25282%252C4%252C5-trifluorophenyl%2529butan-2-amine%253A%2520A%2520potent%252C%2520orally%2520active%2520dipeptidyl%2520peptidase%2520IV%2520inhibitor%2520for%2520the%2520treatment%2520of%2520type%25202%2520diabetes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D141%26epage%3D151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Gallwitz, B.</span><span> </span><span class="NLM_article-title">Review of sitagliptin phosphate: a novel treatment for type 2 diabetes</span> <span class="citation_source-journal">Vasc. Health. Risk Manage.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">203</span><span class="NLM_x">–</span> <span class="NLM_lpage">210</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm101236h&amp;key=10.2147%2Fvhrm.2007.3.2.203" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm101236h&amp;key=17580730" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm101236h&amp;key=1%3ACAS%3A528%3ADC%252BD2sXntFOmt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2007&pages=203-210&author=B.+Gallwitz&title=Review+of+sitagliptin+phosphate%3A+a+novel+treatment+for+type+2+diabetes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Review of sitagliptin phosphate: a novel treatment for type 2 diabetes</span></div><div class="casAuthors">Gallwitz, Baptist</div><div class="citationInfo"><span class="NLM_cas:title">Vascular Health and Risk Management</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">203-210</span>CODEN:
                <span class="NLM_cas:coden">VHRMAT</span>;
        ISSN:<span class="NLM_cas:issn">1176-6344</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press (NZ) Ltd.</span>)
        </div><div class="casAbstract">A review.  Sitagliptin (Januvia, Merck Pharmaceuticals) is a dipeptidyl-peptidase inhibitor (DPP-4 inhibitor) that has recently been approved for the therapy of type 2 diabetes.  Like other DPP-4 inhibitors its action is mediated by increasing levels of the incretin hormones glucagon-like peptide-1 (GLP-1) and gastric inhibitory polypeptide (GIP).  Sitagliptin is effective in lowering HbA1c, and fasting as well as postprandial glucose in monotherapy and in combination with other oral antidiabetic agents.  It stimulates insulin secretion when hyperglycemia is present and inhibits glucagon secretion.  In clin. studies it is wt. neutral.  This article gives an overview of the mechanism of action, the pharmacol., and the clin. efficacy and safety of Sitagliptin in type 2 diabetes therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpX7u730i9-AbVg90H21EOLACvtfcHk0liVlN6FCvUYCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXntFOmt74%253D&md5=7cc00fceff9c5fac317be5c83b74d8b2</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.2147%2Fvhrm.2007.3.2.203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252Fvhrm.2007.3.2.203%26sid%3Dliteratum%253Aachs%26aulast%3DGallwitz%26aufirst%3DB.%26atitle%3DReview%2520of%2520sitagliptin%2520phosphate%253A%2520a%2520novel%2520treatment%2520for%2520type%25202%2520diabetes%26jtitle%3DVasc.%2520Health.%2520Risk%2520Manage.%26date%3D2007%26volume%3D3%26spage%3D203%26epage%3D210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ahren, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simonsson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsson, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landin-Olsson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torgeirsson, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jansson, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandqvist, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bavenholm, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Efedic, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eriksson, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickinson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmes, D.</span><span> </span><span class="NLM_article-title">Inhibition of dipeptidyl peptidase IV improves metabolic control over a 4-week study period in type 2 diabetes</span> <span class="citation_source-journal">Diabetes Care</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">869</span><span class="NLM_x">–</span> <span class="NLM_lpage">875</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2002&pages=869-875&author=B.+Ahrenauthor=E.+Simonssonauthor=H.+Larssonauthor=M.+Landin-Olssonauthor=H.+Torgeirssonauthor=P.+A.+Janssonauthor=M.+Sandqvistauthor=P.+Bavenholmauthor=S.+Efedicauthor=J.+W.+Erikssonauthor=S.+Dickinsonauthor=D.+Holmes&title=Inhibition+of+dipeptidyl+peptidase+IV+improves+metabolic+control+over+a+4-week+study+period+in+type+2+diabetes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAhren%26aufirst%3DB.%26aulast%3DSimonsson%26aufirst%3DE.%26aulast%3DLarsson%26aufirst%3DH.%26aulast%3DLandin-Olsson%26aufirst%3DM.%26aulast%3DTorgeirsson%26aufirst%3DH.%26aulast%3DJansson%26aufirst%3DP.%2BA.%26aulast%3DSandqvist%26aufirst%3DM.%26aulast%3DBavenholm%26aufirst%3DP.%26aulast%3DEfedic%26aufirst%3DS.%26aulast%3DEriksson%26aufirst%3DJ.%2BW.%26aulast%3DDickinson%26aufirst%3DS.%26aulast%3DHolmes%26aufirst%3DD.%26atitle%3DInhibition%2520of%2520dipeptidyl%2520peptidase%2520IV%2520improves%2520metabolic%2520control%2520over%2520a%25204-week%2520study%2520period%2520in%2520type%25202%2520diabetes%26jtitle%3DDiabetes%2520Care%26date%3D2002%26volume%3D25%26spage%3D869%26epage%3D875" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ahren, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomis, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Standl, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schweizer, A.</span><span> </span><span class="NLM_article-title">Twelve and 52-week efficacy of the dipeptidyl peptidase IV inhibitor LAF237 in metformin-treated patients with type 2 diabetes</span> <span class="citation_source-journal">Diabetes Care</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">2874</span><span class="NLM_x">–</span> <span class="NLM_lpage">2880</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2004&pages=2874-2880&author=B.+Ahrenauthor=R.+Gomisauthor=E.+Standlauthor=D.+Millsauthor=A.+Schweizer&title=Twelve+and+52-week+efficacy+of+the+dipeptidyl+peptidase+IV+inhibitor+LAF237+in+metformin-treated+patients+with+type+2+diabetes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAhren%26aufirst%3DB.%26aulast%3DGomis%26aufirst%3DR.%26aulast%3DStandl%26aufirst%3DE.%26aulast%3DMills%26aufirst%3DD.%26aulast%3DSchweizer%26aufirst%3DA.%26atitle%3DTwelve%2520and%252052-week%2520efficacy%2520of%2520the%2520dipeptidyl%2520peptidase%2520IV%2520inhibitor%2520LAF237%2520in%2520metformin-treated%2520patients%2520with%2520type%25202%2520diabetes%26jtitle%3DDiabetes%2520Care%26date%3D2004%26volume%3D27%26spage%3D2874%26epage%3D2880" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Ahren, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landing-Olsson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jansson, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svensson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmes, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schweizer, A.</span><span> </span><span class="NLM_article-title">Inhibition of dipeptidyl peptidase-4 reduces glycemia, sustains insulin levels, and reduces glucagons levels in type 2 diabetes</span> <span class="citation_source-journal">J. Clin. Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">89</span><span class="NLM_x">, </span> <span class="NLM_fpage">2078</span><span class="NLM_x">–</span> <span class="NLM_lpage">2084</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=16&amp;doi=10.1021%2Fjm101236h&amp;key=10.1210%2Fjc.2003-031907" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=8&amp;doi=10.1021%2Fjm101236h&amp;key=15126524" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=32&amp;doi=10.1021%2Fjm101236h&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjvFyrsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2004&pages=2078-2084&author=B.+Ahrenauthor=L.+Landing-Olssonauthor=P.+A.+Janssonauthor=M.+Svenssonauthor=D.+Holmesauthor=A.+Schweizer&title=Inhibition+of+dipeptidyl+peptidase-4+reduces+glycemia%2C+sustains+insulin+levels%2C+and+reduces+glucagons+levels+in+type+2+diabetes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6cR"><div class="casContent"><span class="casTitleNuber">6c</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of dipeptidyl peptidase-4 reduces glycemia, sustains insulin levels, and reduces glucagon levels in type 2 diabetes</span></div><div class="casAuthors">Ahren, Bo; Landin-Olsson, Mona; Jansson, Per-Anders; Svensson, Maria; Holmes, David; Schweizer, Anja</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2078-2084</span>CODEN:
                <span class="NLM_cas:coden">JCEMAZ</span>;
        ISSN:<span class="NLM_cas:issn">0021-972X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">The stimulation of insulin vs. inhibition of glucagon secretion in relation to the antidiabetic action of glucagon-like peptide-1 (GLP-1) is not established.  Here, the influence of a 4-wk increase in circulating GLP-1 by inhibition of dipeptidyl peptidase-4 (DPP-4) on 24-h glucose and insulin and glucagon responses to breakfast was studied in subjects with dietary controlled diabetes [age: 65±8 yr (SD), body mass index: 27.3±3.3 kg/m2, fasting plasma glucose: 9.0±1.3 mmol/L].  Compared with placebo (n = 19), a specific DPP-4 inhibitor [(1-[[(3-hydroxy-1-adamantyl) amino] acetyl]-2-cyano-(S)-pyrrolidine) (LAF237); 100 mg daily, n = 18] reduced fasting glucose by 0.70 mmol/L (P = 0.037), 4-h prandial glucose excursion by 1.45 mmol/L (P < 0.001), and mean 24-h glucose by 0.93 mmol/L (P < 0.001).  Baseline and postprandial active GLP-1 were increased by LAF237.  The glucagon response to breakfast was reduced by LAF237 (glucagon levels at 60 min were 88±8 pg/mL before treatment vs. 77±5 pg/mL after; P = 0.001).  In contrast, the overall insulin levels were not altered.  The 4-wk redn. in glucagon correlated with the redn. in 2-h glucose (r = 0.61; P = 0.008).  No such assocn. was obsd. for insulin.  Thus, improved metabolic control by DPP-4 inhibition in type 2 diabetes is seen in assocn. with reduced glucagon levels and, despite the lower glycemia, unaltered insulin levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrn9NQIGNxS0bVg90H21EOLACvtfcHk0liVlN6FCvUYCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjvFyrsbs%253D&md5=170b2afd60510a01348c88aebc9e4aff</span></div><a href="/servlet/linkout?suffix=cit6c&amp;dbid=16384&amp;doi=10.1210%2Fjc.2003-031907&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fjc.2003-031907%26sid%3Dliteratum%253Aachs%26aulast%3DAhren%26aufirst%3DB.%26aulast%3DLanding-Olsson%26aufirst%3DL.%26aulast%3DJansson%26aufirst%3DP.%2BA.%26aulast%3DSvensson%26aufirst%3DM.%26aulast%3DHolmes%26aufirst%3DD.%26aulast%3DSchweizer%26aufirst%3DA.%26atitle%3DInhibition%2520of%2520dipeptidyl%2520peptidase-4%2520reduces%2520glycemia%252C%2520sustains%2520insulin%2520levels%252C%2520and%2520reduces%2520glucagons%2520levels%2520in%2520type%25202%2520diabetes%26jtitle%3DJ.%2520Clin.%2520Endocrinol.%2520Metab.%26date%3D2004%26volume%3D89%26spage%3D2078%26epage%3D2084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Ahren, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pacini, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forey, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schweizer, A.</span><span> </span><span class="NLM_article-title">Improved meal-related beta-cell function and insulin sensitivity by the dipeptidyl peptidase-IV inhibitor vildagliptin in metformin-treated patients with type 2 diabetes over 1 year</span> <span class="citation_source-journal">Diabetes Care</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">1936</span><span class="NLM_x">–</span> <span class="NLM_lpage">1940</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2005&pages=1936-1940&author=B.+Ahrenauthor=G.+Paciniauthor=J.+E.+Foreyauthor=A.+Schweizer&title=Improved+meal-related+beta-cell+function+and+insulin+sensitivity+by+the+dipeptidyl+peptidase-IV+inhibitor+vildagliptin+in+metformin-treated+patients+with+type+2+diabetes+over+1+year"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAhren%26aufirst%3DB.%26aulast%3DPacini%26aufirst%3DG.%26aulast%3DForey%26aufirst%3DJ.%2BE.%26aulast%3DSchweizer%26aufirst%3DA.%26atitle%3DImproved%2520meal-related%2520beta-cell%2520function%2520and%2520insulin%2520sensitivity%2520by%2520the%2520dipeptidyl%2520peptidase-IV%2520inhibitor%2520vildagliptin%2520in%2520metformin-treated%2520patients%2520with%2520type%25202%2520diabetes%2520over%25201%2520year%26jtitle%3DDiabetes%2520Care%26date%3D2005%26volume%3D28%26spage%3D1936%26epage%3D1940" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Croxtall, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keam, S. J.</span><span> </span><span class="NLM_article-title">Vildagliptin: a review of its use in the management of type 2 diabetes mellitus</span> <span class="citation_source-journal">Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">2387</span><span class="NLM_x">–</span> <span class="NLM_lpage">2409</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2008&pages=2387-2409&author=J.+D.+Croxtallauthor=S.+J.+Keam&title=Vildagliptin%3A+a+review+of+its+use+in+the+management+of+type+2+diabetes+mellitus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCroxtall%26aufirst%3DJ.%2BD.%26aulast%3DKeam%26aufirst%3DS.%2BJ.%26atitle%3DVildagliptin%253A%2520a%2520review%2520of%2520its%2520use%2520in%2520the%2520management%2520of%2520type%25202%2520diabetes%2520mellitus%26jtitle%3DDrugs%26date%3D2008%26volume%3D68%26spage%3D2387%26epage%3D2409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Augeri, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robl, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Betebenner, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnin, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khanna, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simpkins, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taunk, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abboa-Offei, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cap, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tozzo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welzel, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egan, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcinkeviciene, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biller, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirby, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamann, L. G.</span><span> </span><span class="NLM_article-title">Discovery and preclinical profile of saxagliptin (BMS-477118): A highly potent, long-acting, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">5025</span><span class="NLM_x">–</span> <span class="NLM_lpage">5037</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050261p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=32&amp;doi=10.1021%2Fjm101236h&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlsVeltb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=5025-5037&author=D.+J.+Augeriauthor=J.+A.+Roblauthor=D.+A.+Betebennerauthor=D.+R.+Magninauthor=A.+Khannaauthor=J.+G.+Robertsonauthor=A.+Wangauthor=L.+M.+Simpkinsauthor=P.+Taunkauthor=Q.+Huangauthor=S.+P.+Hanauthor=B.+Abboa-Offeiauthor=M.+Capauthor=L.+Xinauthor=L.+Taoauthor=E.+Tozzoauthor=G.+E.+Welzelauthor=D.+M.+Eganauthor=J.+Marcinkevicieneauthor=S.+Y.+Changauthor=S.+A.+Billerauthor=M.+S.+Kirbyauthor=R.+A.+Parkerauthor=L.+G.+Hamann&title=Discovery+and+preclinical+profile+of+saxagliptin+%28BMS-477118%29%3A+A+highly+potent%2C+long-acting%2C+orally+active+dipeptidyl+peptidase+IV+inhibitor+for+the+treatment+of+type+2+diabetes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7aR"><div class="casContent"><span class="casTitleNuber">7a</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Preclinical Profile of Saxagliptin (BMS-477118): A Highly Potent, Long-Acting, Orally Active Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes</span></div><div class="casAuthors">Augeri, David J.; Robl, Jeffrey A.; Betebenner, David A.; Magnin, David R.; Khanna, Ashish; Robertson, James G.; Wang, Aiying; Simpkins, Ligaya M.; Taunk, Prakash; Huang, Qi; Han, Song-Ping; Abboa-Offei, Benoni; Cap, Michael; Xin, Li; Tao, Li; Tozzo, Effie; Welzel, Gustav E.; Egan, Donald M.; Marcinkeviciene, Jovita; Chang, Shu Y.; Biller, Scott A.; Kirby, Mark S.; Parker, Rex A.; Hamann, Lawrence G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">5025-5037</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Efforts to further elucidate structure-activity relationships (SAR) within the authors previously disclosed series of β-quaternary amino acid linked L-cis-4,5-methanoprolinenitrile dipeptidyl peptidase IV (DPP-IV) inhibitors led to the investigation of vinyl substitution at the β-position of α-cycloalkyl-substituted glycines.  Despite poor systemic exposure, vinyl-substituted compds. showed extended duration of action in acute rat ex vivo plasma DPP-IV inhibition models.  Oxygenated putative metabolites were prepd. and were shown to exhibit the potency and extended duration of action of their precursors in efficacy models measuring glucose clearance in Zuckerfa/fa rats.  Extension of this approach to adamantylglycine-derived inhibitors led to the discovery of highly potent inhibitors, including hydroxyadamantyl compd. BMS-477118 (saxagliptin), a highly efficacious, stable, and long-acting DPP-IV inhibitor, which is currently undergoing clin. trials for treatment of type 2 diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGrIJX7K8p67Vg90H21EOLACvtfcHk0lhsrejzE9JTsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlsVeltb0%253D&md5=878355880133bb0ddd6bd14ecbf1d070</span></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.1021%2Fjm050261p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050261p%26sid%3Dliteratum%253Aachs%26aulast%3DAugeri%26aufirst%3DD.%2BJ.%26aulast%3DRobl%26aufirst%3DJ.%2BA.%26aulast%3DBetebenner%26aufirst%3DD.%2BA.%26aulast%3DMagnin%26aufirst%3DD.%2BR.%26aulast%3DKhanna%26aufirst%3DA.%26aulast%3DRobertson%26aufirst%3DJ.%2BG.%26aulast%3DWang%26aufirst%3DA.%26aulast%3DSimpkins%26aufirst%3DL.%2BM.%26aulast%3DTaunk%26aufirst%3DP.%26aulast%3DHuang%26aufirst%3DQ.%26aulast%3DHan%26aufirst%3DS.%2BP.%26aulast%3DAbboa-Offei%26aufirst%3DB.%26aulast%3DCap%26aufirst%3DM.%26aulast%3DXin%26aufirst%3DL.%26aulast%3DTao%26aufirst%3DL.%26aulast%3DTozzo%26aufirst%3DE.%26aulast%3DWelzel%26aufirst%3DG.%2BE.%26aulast%3DEgan%26aufirst%3DD.%2BM.%26aulast%3DMarcinkeviciene%26aufirst%3DJ.%26aulast%3DChang%26aufirst%3DS.%2BY.%26aulast%3DBiller%26aufirst%3DS.%2BA.%26aulast%3DKirby%26aufirst%3DM.%2BS.%26aulast%3DParker%26aufirst%3DR.%2BA.%26aulast%3DHamann%26aufirst%3DL.%2BG.%26atitle%3DDiscovery%2520and%2520preclinical%2520profile%2520of%2520saxagliptin%2520%2528BMS-477118%2529%253A%2520A%2520highly%2520potent%252C%2520long-acting%252C%2520orally%2520active%2520dipeptidyl%2520peptidase%2520IV%2520inhibitor%2520for%2520the%2520treatment%2520of%2520type%25202%2520diabetes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D5025%26epage%3D5037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Dhillon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, J.</span><span> </span><span class="NLM_article-title">Saxagliptin</span> <span class="citation_source-journal">Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">2103</span><span class="NLM_x">–</span> <span class="NLM_lpage">2114</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2009&pages=2103-2114&author=S.+Dhillonauthor=J.+Weber&title=Saxagliptin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDhillon%26aufirst%3DS.%26aulast%3DWeber%26aufirst%3DJ.%26atitle%3DSaxagliptin%26jtitle%3DDrugs%26date%3D2009%26volume%3D69%26spage%3D2103%26epage%3D2114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Feng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallace, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stafford, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaldor, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kassel, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navre, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skene, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asakawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeuchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gwaltney, S. L.</span><span> </span><span class="NLM_article-title">Discovery of alogliptin: a potent, selective, bioavailable, and efficacious inhibitor of dipeptidyl peptidase IV</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">2297</span><span class="NLM_x">–</span> <span class="NLM_lpage">2300</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070104l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=2297-2300&author=J.+Fengauthor=Z.+Zhangauthor=M.+B.+Wallaceauthor=J.+A.+Staffordauthor=S.+W.+Kaldorauthor=D.+B.+Kasselauthor=M.+Navreauthor=L.+Shiauthor=R.+J.+Skeneauthor=T.+Asakawaauthor=K.+Takeuchiauthor=R.+Xuauthor=D.+R.+Webbauthor=S.+L.+Gwaltney&title=Discovery+of+alogliptin%3A+a+potent%2C+selective%2C+bioavailable%2C+and+efficacious+inhibitor+of+dipeptidyl+peptidase+IV"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=10.1021%2Fjm070104l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070104l%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DWallace%26aufirst%3DM.%2BB.%26aulast%3DStafford%26aufirst%3DJ.%2BA.%26aulast%3DKaldor%26aufirst%3DS.%2BW.%26aulast%3DKassel%26aufirst%3DD.%2BB.%26aulast%3DNavre%26aufirst%3DM.%26aulast%3DShi%26aufirst%3DL.%26aulast%3DSkene%26aufirst%3DR.%2BJ.%26aulast%3DAsakawa%26aufirst%3DT.%26aulast%3DTakeuchi%26aufirst%3DK.%26aulast%3DXu%26aufirst%3DR.%26aulast%3DWebb%26aufirst%3DD.%2BR.%26aulast%3DGwaltney%26aufirst%3DS.%2BL.%26atitle%3DDiscovery%2520of%2520alogliptin%253A%2520a%2520potent%252C%2520selective%252C%2520bioavailable%252C%2520and%2520efficacious%2520inhibitor%2520of%2520dipeptidyl%2520peptidase%2520IV%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D2297%26epage%3D2300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Pratley, R. E.</span><span> </span><span class="NLM_article-title">Alogliptin: a new, highly selective dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes</span> <span class="citation_source-journal">Expert Opin. Pharmachother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">503</span><span class="NLM_x">–</span> <span class="NLM_lpage">512</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=16&amp;doi=10.1021%2Fjm101236h&amp;key=10.1517%2F14656560802694713" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=8&amp;doi=10.1021%2Fjm101236h&amp;key=19191685" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=32&amp;doi=10.1021%2Fjm101236h&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVaiurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=503-512&author=R.+E.+Pratley&title=Alogliptin%3A+a+new%2C+highly+selective+dipeptidyl+peptidase-4+inhibitor+for+the+treatment+of+type+2+diabetes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8bR"><div class="casContent"><span class="casTitleNuber">8b</span><div class="casTitle"><span class="NLM_cas:atitle">Alogliptin: a new, highly selective dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes</span></div><div class="casAuthors">Pratley, Richard E.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Pharmacotherapy</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">503-512</span>CODEN:
                <span class="NLM_cas:coden">EOPHF7</span>;
        ISSN:<span class="NLM_cas:issn">1465-6566</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Background: Alogliptin is a potent, highly selective dipeptidyl peptidase-4 inhibitor now undergoing clin. testing to support a new drug application for the treatment of type 2 diabetes.  Objective: To provide an overview of the mechanism by which alogliptin reduces hyperglycemia and to summarize the pharmacol., efficacy and safety of the drug.  Methods: A Medline search was conducted and abstrs. and presentations from recent American Diabetes Assocn. and European Assocn. for the Study of Diabetes (EASD) meetings were reviewed.  The results of phase II and phase III human studies were evaluated for clin. efficacy, safety and tolerability in patients with type 2 diabetes.  Results/conclusions: Alogliptin is effective as a treatment for type 2 diabetes, either as monotherapy or in combination with metformin, thiazolidinediones, sulfonylureas and insulin.  It is well tolerated and has an excellent safety profile.  Addnl. studies are needed to evaluate the long-term safety and efficacy of alogliptin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVASaAmsEezrVg90H21EOLACvtfcHk0liueuWxBU7zbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVaiurY%253D&md5=26b93655020e344a7a063a25aaed728d</span></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.1517%2F14656560802694713&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14656560802694713%26sid%3Dliteratum%253Aachs%26aulast%3DPratley%26aufirst%3DR.%2BE.%26atitle%3DAlogliptin%253A%2520a%2520new%252C%2520highly%2520selective%2520dipeptidyl%2520peptidase-4%2520inhibitor%2520for%2520the%2520treatment%2520of%2520type%25202%2520diabetes%26jtitle%3DExpert%2520Opin.%2520Pharmachother.%26date%3D2009%26volume%3D10%26spage%3D503%26epage%3D512" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Satoru, O.; Mitsuru, S.; Tohru, Y.; Yasufumi, M.; Yoshihiro, B.; Hironobu, M.; Koji, I.; Takuo, K.; Shigetoshi, T.; Koji, T.; Tomoko, A.; Osamu, K.; Nobuhiro, S.; Yoshio, Y.; Robert, S.; Jason, Y.; Kathleen, A.</span><span> </span><span class="NLM_article-title">Design and synthesis of isoquinolone and quinoline derivatives as a new class of dipeptidyl peptidase-4 inhibitors</span>. Poster presentation at the 27th Medicinal Chemistry Symposium of the pharmaceutical society of Japan, Osaka, Japan, November 26−28,<span class="NLM_x"> </span><span class="NLM_year">2008</span><span class="NLM_x">; </span>Abstract 2P05.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=O.+Satoru&author=S.+Mitsuru&author=Y.+Tohru&author=M.+Yasufumi&author=B.+Yoshihiro&author=M.+Hironobu&author=I.+Koji&author=K.+Takuo&author=T.+Shigetoshi&author=T.+Koji&author=A.+Tomoko&author=K.+Osamu&author=S.+Nobuhiro&author=Y.+Yoshio&author=S.+Robert&author=Y.+Jason&author=A.+Kathleen&title=Design+and+synthesis+of+isoquinolone+and+quinoline+derivatives+as+a+new+class+of+dipeptidyl+peptidase-4+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DSatoru%26aufirst%3DO.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520isoquinolone%2520and%2520quinoline%2520derivatives%2520as%2520a%2520new%2520class%2520of%2520dipeptidyl%2520peptidase-4%2520inhibitors%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Edmondson, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mastracchio, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beconi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colwell, L. F.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habulihaz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leiting, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyons, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsilio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reshma, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, L. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thornberry, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parmee, E. R.</span><span> </span><span class="NLM_article-title">Potent and selective proline derived dipeptidyl peptidase IV inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">5151</span><span class="NLM_x">–</span> <span class="NLM_lpage">5155</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=5151-5155&author=S.+D.+Edmondsonauthor=A.+Mastracchioauthor=M.+Beconiauthor=L.+F.+Colwellauthor=B.+Habulihazauthor=H.+Heauthor=S.+Kumarauthor=B.+Leitingauthor=K.+A.+Lyonsauthor=A.+Maoauthor=F.+Marsilioauthor=A.+Reshmaauthor=J.+K.+Patelauthor=L.+Z.+Wuauthor=N.+A.+Thornberryauthor=A.+E.+Weberauthor=E.+R.+Parmee&title=Potent+and+selective+proline+derived+dipeptidyl+peptidase+IV+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEdmondson%26aufirst%3DS.%2BD.%26aulast%3DMastracchio%26aufirst%3DA.%26aulast%3DBeconi%26aufirst%3DM.%26aulast%3DColwell%26aufirst%3DL.%2BF.%26aulast%3DHabulihaz%26aufirst%3DB.%26aulast%3DHe%26aufirst%3DH.%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DLeiting%26aufirst%3DB.%26aulast%3DLyons%26aufirst%3DK.%2BA.%26aulast%3DMao%26aufirst%3DA.%26aulast%3DMarsilio%26aufirst%3DF.%26aulast%3DReshma%26aufirst%3DA.%26aulast%3DPatel%26aufirst%3DJ.%2BK.%26aulast%3DWu%26aufirst%3DL.%2BZ.%26aulast%3DThornberry%26aufirst%3DN.%2BA.%26aulast%3DWeber%26aufirst%3DA.%2BE.%26aulast%3DParmee%26aufirst%3DE.%2BR.%26atitle%3DPotent%2520and%2520selective%2520proline%2520derived%2520dipeptidyl%2520peptidase%2520IV%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D5151%26epage%3D5155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Koo, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hur, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yim, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, H. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwon, O. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwon, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koh, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C. S.</span><span> </span><span class="NLM_article-title">Synthesis, SAR, and X-ray structure of novel potent DPPIV inhibitors: Oxadiazolyl ketones</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">4167</span><span class="NLM_x">–</span> <span class="NLM_lpage">4172</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=4167-4172&author=K.+D.+Kooauthor=M.+J.+Kimauthor=S.+Kimauthor=K.+S.+Kimauthor=S.+Y.+Hongauthor=G.+C.+Hurauthor=H.+J.+Yimauthor=G.+T.+Kimauthor=H.+O.+Hanauthor=O.+H.+Kwonauthor=T.+S.+Kwonauthor=J.+S.+Kohauthor=C.+S.+Lee&title=Synthesis%2C+SAR%2C+and+X-ray+structure+of+novel+potent+DPPIV+inhibitors%3A+Oxadiazolyl+ketones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKoo%26aufirst%3DK.%2BD.%26aulast%3DKim%26aufirst%3DM.%2BJ.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DK.%2BS.%26aulast%3DHong%26aufirst%3DS.%2BY.%26aulast%3DHur%26aufirst%3DG.%2BC.%26aulast%3DYim%26aufirst%3DH.%2BJ.%26aulast%3DKim%26aufirst%3DG.%2BT.%26aulast%3DHan%26aufirst%3DH.%2BO.%26aulast%3DKwon%26aufirst%3DO.%2BH.%26aulast%3DKwon%26aufirst%3DT.%2BS.%26aulast%3DKoh%26aufirst%3DJ.%2BS.%26aulast%3DLee%26aufirst%3DC.%2BS.%26atitle%3DSynthesis%252C%2520SAR%252C%2520and%2520X-ray%2520structure%2520of%2520novel%2520potent%2520DPPIV%2520inhibitors%253A%2520Oxadiazolyl%2520ketones%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D4167%26epage%3D4172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Yamada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okagaki, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higashijima, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohnuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugita, T.</span><span> </span><span class="NLM_article-title">A potent dipeptide inhibitor of dipeptidyl peptidase IV</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1537</span><span class="NLM_x">–</span> <span class="NLM_lpage">1540</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10c&amp;dbid=16&amp;doi=10.1021%2Fjm101236h&amp;key=10.1016%2FS0960-894X%2898%2900259-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10c&amp;dbid=8&amp;doi=10.1021%2Fjm101236h&amp;key=9873385" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10c&amp;dbid=32&amp;doi=10.1021%2Fjm101236h&amp;key=1%3ACAS%3A528%3ADyaK1cXkt1OgtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1998&pages=1537-1540&author=M.+Yamadaauthor=C.+Okagakiauthor=T.+Higashijimaauthor=S.+Tanakaauthor=T.+Ohnukiauthor=T.+Sugita&title=A+potent+dipeptide+inhibitor+of+dipeptidyl+peptidase+IV"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10cR"><div class="casContent"><span class="casTitleNuber">10c</span><div class="casTitle"><span class="NLM_cas:atitle">A potent dipeptide inhibitor of dipeptidyl peptidase IV</span></div><div class="casAuthors">Yamada, Masaki; Okagaki, Chieko; Higashijima, Takanori; Tanaka, Sumiko; Ohnuki, Tetsuo; Sugita, Takahisa</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1537-1540</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A series of novel potent inhibitors of dipeptidyl peptidase IV (DPP-IV) has been developed.  A brief structure-activity relation of the inhibitors was investigated.  The dipeptide TSL-225, tryptophyl-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid, was identified with the crit. structure for the inhibitory activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4Z9ZJ7DKaprVg90H21EOLACvtfcHk0lhvB4qOgbICRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXkt1OgtL8%253D&md5=592d3a566a8d3d2a9df518d311fecd56</span></div><a href="/servlet/linkout?suffix=cit10c&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2898%2900259-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252898%252900259-5%26sid%3Dliteratum%253Aachs%26aulast%3DYamada%26aufirst%3DM.%26aulast%3DOkagaki%26aufirst%3DC.%26aulast%3DHigashijima%26aufirst%3DT.%26aulast%3DTanaka%26aufirst%3DS.%26aulast%3DOhnuki%26aufirst%3DT.%26aulast%3DSugita%26aufirst%3DT.%26atitle%3DA%2520potent%2520dipeptide%2520inhibitor%2520of%2520dipeptidyl%2520peptidase%2520IV%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1998%26volume%3D8%26spage%3D1537%26epage%3D1540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><i>EP135252A2</i>. <span class="NLM_contrib-group">Hackler, R. E.; Wickiser, D. I.</span> Eli Lilly and Company; Process for preparing 3-substituted-3-aminonitrile.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=EP135252A2.+Hackler%2C+R.+E.%3B+Wickiser%2C+D.+I.+Eli+Lilly+and+Company%3B+Process+for+preparing+3-substituted-3-aminonitrile."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DHackler%26aufirst%3DR.%2BE." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Suzuki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanikawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakoda, R.</span><span> </span><span class="NLM_article-title">Practical synthesis of quinoline nucleus of NK-104</span> <span class="citation_source-journal">Heterocycles</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">479</span><span class="NLM_x">–</span> <span class="NLM_lpage">483</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1999&pages=479-483&issue=1&author=M.+Suzukiauthor=K.+Tanikawaauthor=R.+Sakoda&title=Practical+synthesis+of+quinoline+nucleus+of+NK-104"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DM.%26aulast%3DTanikawa%26aufirst%3DK.%26aulast%3DSakoda%26aufirst%3DR.%26atitle%3DPractical%2520synthesis%2520of%2520quinoline%2520nucleus%2520of%2520NK-104%26jtitle%3DHeterocycles%26date%3D1999%26volume%3D50%26issue%3D1%26spage%3D479%26epage%3D483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13a"><span><span class="NLM_contrib-group">Singer, A.; McElvain, S. M.</span><span> </span><span class="NLM_article-title">2.6-Dimethylpyridine</span>.  <span class="citation_source-book">Org. Synth., Coll. Vol. 2</span>, p  <span class="NLM_fpage">214</span><span class="NLM_x"> (</span><span class="NLM_year">1943</span><span class="NLM_x">) </span>;</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1943&pages=214&author=A.+Singer&author=S.+M.+McElvain&title=Org.+Synth.%2C+Coll.+Vol.+2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DSinger%26aufirst%3DA.%26atitle%3D2.6-Dimethylpyridine%26btitle%3DOrg.%2520Synth.%252C%2520Coll.%2520Vol.%25202%26spage%3D214%26date%3D1943" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit13b"><span>Vol.  <span class="NLM_volume">14</span>, p  <span class="NLM_fpage">30</span><span class="NLM_x"> (</span><span class="NLM_year">1934</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Vol.+14%2C+p+30+%281934%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26volume%3D14%26spage%3D30%26date%3D1934" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="note"><p class="first last">Refer to the <a class="ref internalNav" href="#notes-2" aria-label="Supporting Information">Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Leiting, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pryor, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsilio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craik, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellman, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummings, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thornberry, N. A.</span><span> </span><span class="NLM_article-title">Catalytic properties and inhibition of proline-specific dipeptidyl peptidases II, IV and VII</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">371</span><span class="NLM_x">, </span> <span class="NLM_fpage">525</span><span class="NLM_x">–</span> <span class="NLM_lpage">532</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=371&publication_year=2003&pages=525-532&author=B.+Leitingauthor=K.+D.+Pryorauthor=J.+K.+Wuauthor=F.+Marsilioauthor=R.+A.+Patelauthor=C.+S.+Craikauthor=J.+A.+Ellmanauthor=R.+T.+Cummingsauthor=N.+A.+Thornberry&title=Catalytic+properties+and+inhibition+of+proline-specific+dipeptidyl+peptidases+II%2C+IV+and+VII"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeiting%26aufirst%3DB.%26aulast%3DPryor%26aufirst%3DK.%2BD.%26aulast%3DWu%26aufirst%3DJ.%2BK.%26aulast%3DMarsilio%26aufirst%3DF.%26aulast%3DPatel%26aufirst%3DR.%2BA.%26aulast%3DCraik%26aufirst%3DC.%2BS.%26aulast%3DEllman%26aufirst%3DJ.%2BA.%26aulast%3DCummings%26aufirst%3DR.%2BT.%26aulast%3DThornberry%26aufirst%3DN.%2BA.%26atitle%3DCatalytic%2520properties%2520and%2520inhibition%2520of%2520proline-specific%2520dipeptidyl%2520peptidases%2520II%252C%2520IV%2520and%2520VII%26jtitle%3DBiochem.%2520J.%26date%3D2003%26volume%3D371%26spage%3D525%26epage%3D532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Chiravuri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmitz, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yardley, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Underwood, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dayal, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, B. T.</span><span> </span><span class="NLM_article-title">A novel apoptotic pathway in quiescent lymphocytes identified by inhibition of post-proline cleaving aminopeptidase: A candidate target protease, quiescent cell proline dipeptidase</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">163</span><span class="NLM_x">, </span> <span class="NLM_fpage">3092</span><span class="NLM_x">–</span> <span class="NLM_lpage">3099</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=163&publication_year=1999&pages=3092-3099&author=M.+Chiravuriauthor=T.+Schmitzauthor=K.+Yardleyauthor=R.+Underwoodauthor=Y.+Dayalauthor=B.+T.+Huber&title=A+novel+apoptotic+pathway+in+quiescent+lymphocytes+identified+by+inhibition+of+post-proline+cleaving+aminopeptidase%3A+A+candidate+target+protease%2C+quiescent+cell+proline+dipeptidase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChiravuri%26aufirst%3DM.%26aulast%3DSchmitz%26aufirst%3DT.%26aulast%3DYardley%26aufirst%3DK.%26aulast%3DUnderwood%26aufirst%3DR.%26aulast%3DDayal%26aufirst%3DY.%26aulast%3DHuber%26aufirst%3DB.%2BT.%26atitle%3DA%2520novel%2520apoptotic%2520pathway%2520in%2520quiescent%2520lymphocytes%2520identified%2520by%2520inhibition%2520of%2520post-proline%2520cleaving%2520aminopeptidase%253A%2520A%2520candidate%2520target%2520protease%252C%2520quiescent%2520cell%2520proline%2520dipeptidase%26jtitle%3DJ.%2520Immunol.%26date%3D1999%26volume%3D163%26spage%3D3092%26epage%3D3099" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Lankas, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leiting, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinha, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eiermann, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beconi, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biftu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edmonson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freeney, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ippolito, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyons, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ok, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrov, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pryor, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reigle, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woods, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaller, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thornberry, N. A.</span><span> </span><span class="NLM_article-title">Dipeptidyl peptidase IV inhibition for the treatment of type 2 diabetes: Potential importance of selectivity over dipeptidyl peptidase 8 and 9</span> <span class="citation_source-journal">Diabetes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">2988</span><span class="NLM_x">–</span> <span class="NLM_lpage">2994</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2005&pages=2988-2994&author=G.+Lankasauthor=B.+Leitingauthor=R.+R.+Sinhaauthor=G.+Eiermannauthor=M.+G.+Beconiauthor=T.+Biftuauthor=C.+C.+Chanauthor=S.+Edmonsonauthor=W.+P.+Freeneyauthor=H.+Heauthor=D.+E.+Ippolitoauthor=D.+Kimauthor=K.+A.+Lyonsauthor=H.+Okauthor=R.+A.+Patelauthor=A.+N.+Petrovauthor=K.+A.+Pryorauthor=X.+Qianauthor=L.+Reigleauthor=A.+Woodsauthor=J.+K.+Wuauthor=D.+Zallerauthor=X.+Zhangauthor=L.+Zhuauthor=A.+E.+Weberauthor=N.+A.+Thornberry&title=Dipeptidyl+peptidase+IV+inhibition+for+the+treatment+of+type+2+diabetes%3A+Potential+importance+of+selectivity+over+dipeptidyl+peptidase+8+and+9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLankas%26aufirst%3DG.%26aulast%3DLeiting%26aufirst%3DB.%26aulast%3DSinha%26aufirst%3DR.%2BR.%26aulast%3DEiermann%26aufirst%3DG.%26aulast%3DBeconi%26aufirst%3DM.%2BG.%26aulast%3DBiftu%26aufirst%3DT.%26aulast%3DChan%26aufirst%3DC.%2BC.%26aulast%3DEdmonson%26aufirst%3DS.%26aulast%3DFreeney%26aufirst%3DW.%2BP.%26aulast%3DHe%26aufirst%3DH.%26aulast%3DIppolito%26aufirst%3DD.%2BE.%26aulast%3DKim%26aufirst%3DD.%26aulast%3DLyons%26aufirst%3DK.%2BA.%26aulast%3DOk%26aufirst%3DH.%26aulast%3DPatel%26aufirst%3DR.%2BA.%26aulast%3DPetrov%26aufirst%3DA.%2BN.%26aulast%3DPryor%26aufirst%3DK.%2BA.%26aulast%3DQian%26aufirst%3DX.%26aulast%3DReigle%26aufirst%3DL.%26aulast%3DWoods%26aufirst%3DA.%26aulast%3DWu%26aufirst%3DJ.%2BK.%26aulast%3DZaller%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DWeber%26aufirst%3DA.%2BE.%26aulast%3DThornberry%26aufirst%3DN.%2BA.%26atitle%3DDipeptidyl%2520peptidase%2520IV%2520inhibition%2520for%2520the%2520treatment%2520of%2520type%25202%2520diabetes%253A%2520Potential%2520importance%2520of%2520selectivity%2520over%2520dipeptidyl%2520peptidase%25208%2520and%25209%26jtitle%3DDiabetes%26date%3D2005%26volume%3D54%26spage%3D2988%26epage%3D2994" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Aertgeerts, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tennant, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraus, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sang, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skene, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prasad, G. S.</span><span> </span><span class="NLM_article-title">Crystal structure of human dipeptidyl peptidase IV in complex with a decapeptide reveals details on substrate specificity and tetrahedral intermediate formation</span> <span class="citation_source-journal">Protein Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">412</span><span class="NLM_x">–</span> <span class="NLM_lpage">421</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm101236h&amp;key=10.1110%2Fps.03460604" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm101236h&amp;key=14718659" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm101236h&amp;key=1%3ACAS%3A528%3ADC%252BD2cXotFOlsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2004&pages=412-421&author=K.+Aertgeertsauthor=S.+Yeauthor=M.+G.+Tennantauthor=M.+L.+Krausauthor=J.+Rogersauthor=B.+C.+Sangauthor=R.+J.+Skeneauthor=D.+R.+Webbauthor=G.+S.+Prasad&title=Crystal+structure+of+human+dipeptidyl+peptidase+IV+in+complex+with+a+decapeptide+reveals+details+on+substrate+specificity+and+tetrahedral+intermediate+formation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of human dipeptidyl peptidase IV in complex with a decapeptide reveals details on substrate specificity and tetrahedral intermediate formation</span></div><div class="casAuthors">Aertgeerts, Kathleen; Ye, Sheng; Tennant, Mike G.; Kraus, Michelle L.; Rogers, Joe; Sang, Bi-Ching; Skene, Robert J.; Webb, David R.; Prasad, G. Sridhar</div><div class="citationInfo"><span class="NLM_cas:title">Protein Science</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">412-421</span>CODEN:
                <span class="NLM_cas:coden">PRCIEI</span>;
        ISSN:<span class="NLM_cas:issn">0961-8368</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">Dipeptidyl peptidase IV (DPPIV) is a member of the prolyl oligopeptidase family of serine proteases.  DPPIV removes dipeptides from the N terminus of substrates, including many chemokines, neuropeptides, and peptide hormones.  Specific inhibition of DPPIV is being investigated in human trials for the treatment of type II diabetes.  To understand better the mol. determinants that underlie enzyme catalysis and substrate specificity, we report the crystal structures of DPPIV in the free form and in complex with the first 10 residues of the physiol. substrate, Neuropeptide Y (residues 1-10; tNPY).  The crystal structure of the free form of the enzyme reveals two potential channels through which substrates could access the active site-a so-called propeller opening, and side opening.  The crystal structure of the DPPIV/tNPY complex suggests that bioactive peptides utilize the side opening unique to DPPIV to access the active site.  Other structural features in the active site such as the presence of a Glu motif, a well-defined hydrophobic S1 subsite, and minimal long-range interactions explain the substrate recognition and binding properties of DPPIV.  Moreover, in the DPPIV/tNPY complex structure, the peptide is not cleaved but trapped in a tetrahedral intermediate that occurs during catalysis.  Conformational changes of S630 and H740 between DPPIV in its free form and in complex with tNPY were obsd. and contribute to the stabilization of the tetrahedral intermediate.  Our results facilitate the design of potent, selective small mol. inhibitors of DPPIV that may yield compds. for the development of novel drugs to treat type II diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBugA5cQcmbrVg90H21EOLACvtfcHk0ljxBRsZYtwckg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXotFOlsg%253D%253D&md5=bba77030cb978a9cc84fef52e6d5e1d1</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1110%2Fps.03460604&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1110%252Fps.03460604%26sid%3Dliteratum%253Aachs%26aulast%3DAertgeerts%26aufirst%3DK.%26aulast%3DYe%26aufirst%3DS.%26aulast%3DTennant%26aufirst%3DM.%2BG.%26aulast%3DKraus%26aufirst%3DM.%2BL.%26aulast%3DRogers%26aufirst%3DJ.%26aulast%3DSang%26aufirst%3DB.%2BC.%26aulast%3DSkene%26aufirst%3DR.%2BJ.%26aulast%3DWebb%26aufirst%3DD.%2BR.%26aulast%3DPrasad%26aufirst%3DG.%2BS.%26atitle%3DCrystal%2520structure%2520of%2520human%2520dipeptidyl%2520peptidase%2520IV%2520in%2520complex%2520with%2520a%2520decapeptide%2520reveals%2520details%2520on%2520substrate%2520specificity%2520and%2520tetrahedral%2520intermediate%2520formation%26jtitle%3DProtein%2520Sci.%26date%3D2004%26volume%3D13%26spage%3D412%26epage%3D421" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Otwinowski, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minor, W.</span><span> </span><span class="NLM_article-title">Processing of X-ray diffraction data collected in oscillation mode</span> <span class="citation_source-journal">Methods Enzymol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">307</span><span class="NLM_x">–</span> <span class="NLM_lpage">326</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm101236h&amp;key=10.1016%2FS0076-6879%2897%2976066-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm101236h&amp;key=27754618" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm101236h&amp;key=1%3ACAS%3A528%3ADyaK2sXivFehsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=1997&pages=307-326&author=Z.+Otwinowskiauthor=W.+Minor&title=Processing+of+X-ray+diffraction+data+collected+in+oscillation+mode"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Processing of x-ray diffraction data collected in oscillation mode</span></div><div class="casAuthors">Otwinowski, Zbyszek; Minor, Wladek</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Enzymology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">Macromolecular Crystallography, Part A</span>),
    <span class="NLM_cas:pages">307-326</span>CODEN:
                <span class="NLM_cas:coden">MENZAU</span>;
        ISSN:<span class="NLM_cas:issn">0076-6879</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">Macromol. crystallog. is an iterative process.  Rarely do the first crystals provide all the necessary data to solve the biol. problem being studied.  Each step benefits from experience learned in previous steps.  To monitor the progress, the HKL package provides 2 tools: (1) statistics, both weighted (χ2) and unweighted (R-merge), are provided, and the Bayesian reasoning and multicomponent error model facilitates obtaining the proper error ests. and (2) visualization of the process plays a double role by helping the operator to confirm that the process of data redn., including the resulting statistics, is correct, and allowing one to evaluate problems for which there are no good statistical criteria.  Visualization also provides confidence that the point of diminishing returns in data collection and redn. has been reached.  At that point, the effort should be directed to solving the structure.  The methods presented here have been applied to solve a large variety of problems, from inorg. mols. with 5 Å unit cell to rotavirus of 700 Å diam. crystd. in 700 × 1000 × 1400 Å cell.  Overall quality of the method was tested by many researchers by successful application of the programs to MAD structure detns.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrA3fvBOHqhhrVg90H21EOLACvtfcHk0ljxBRsZYtwckg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXivFehsbw%253D&md5=c9536971d4e32cc35352c40fb9368131</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2FS0076-6879%2897%2976066-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0076-6879%252897%252976066-X%26sid%3Dliteratum%253Aachs%26aulast%3DOtwinowski%26aufirst%3DZ.%26aulast%3DMinor%26aufirst%3DW.%26atitle%3DProcessing%2520of%2520X-ray%2520diffraction%2520data%2520collected%2520in%2520oscillation%2520mode%26jtitle%3DMethods%2520Enzymol.%26date%3D1997%26volume%3D276%26spage%3D307%26epage%3D326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span>Collaborative Computational Project, Number 4. <span> </span><span class="NLM_article-title">The CCP4 suite: programs for protein crystallography</span>.  <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">760</span>− <span class="NLM_lpage">763</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm101236h&amp;key=10.1107%2FS0907444994003112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm101236h&amp;key=15299374" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm101236h&amp;key=1%3ACAS%3A280%3ADC%252BD2czpsV2gug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Collaborative+Computational+Project%2C+Number+4.+The+CCP4+suite%3A+programs+for+protein+crystallography.+Acta+Crystallogr.%2C+Sect.+D%3A+Biol.+Crystallogr.+1994%2C+50%2C+760%E2%88%92763."target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">The CCP4 suite: programs for protein crystallography</span></div><div class="casAuthors">Anonymous</div><div class="citationInfo"><span class="NLM_cas:title">Acta crystallographica. Section D, Biological crystallography</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">Pt 5</span>),
    <span class="NLM_cas:pages">760-3</span>
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    </div><div class="casAbstract">The CCP4 (Collaborative Computational Project, number 4) program suite is a collection of programs and associated data and subroutine libraries which can be used for macromolecular structure determination by X-ray crystallography.  The suite is designed to be flexible, allowing users a number of methods of achieving their aims and so there may be more than one program to cover each function.  The programs are written mainly in standard Fortran77.  They are from a wide variety of sources but are connected by standard data file formats.  The package has been ported to all the major platforms under both Unix and VMS.  The suite is distributed by anonymous ftp from Daresbury Laboratory and is widely used throughout the world.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ1Q-skJYIZ2IYPsCkJIw00fW6udTcc2ebeBJObLD07v7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2czpsV2gug%253D%253D&md5=92b759927d6071ea3f20c08b78ad1eb2</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1107%2FS0907444994003112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444994003112%26sid%3Dliteratum%253Aachs%26atitle%3DThe%2520CCP4%2520suite%253A%2520programs%2520for%2520protein%2520crystallography%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D1994%26volume%3D50%26spage%3D760%26epage%3D763" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">McRee, D. E.</span><span> </span><span class="NLM_article-title">XtalView/Xfit—A versatile program for manipulating atomic coordinates and electron density</span> <span class="citation_source-journal">J. Struct. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">125</span><span class="NLM_x">, </span> <span class="NLM_fpage">156</span><span class="NLM_x">–</span> <span class="NLM_lpage">165</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=1999&pages=156-165&author=D.+E.+McRee&title=XtalView%2FXfit%E2%80%94A+versatile+program+for+manipulating+atomic+coordinates+and+electron+density"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcRee%26aufirst%3DD.%2BE.%26atitle%3DXtalView%252FXfit%25E2%2580%2594A%2520versatile%2520program%2520for%2520manipulating%2520atomic%2520coordinates%2520and%2520electron%2520density%26jtitle%3DJ.%2520Struct.%2520Biol.%26date%3D1999%26volume%3D125%26spage%3D156%26epage%3D165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><i>GOLD (version 3.0)</i>; <span class="NLM_publisher-name">The Cambridge Crystallographic Data Centre (CCDC)</span>: <span class="NLM_publisher-loc">12 Union Road, Cambridge, CB2 1EZ2, U.K.</span>,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=GOLD+%28version+3.0%29%3B+The+Cambridge+Crystallographic+Data+Centre+%28CCDC%29%3A+12+Union+Road%2C+Cambridge%2C+CB2+1EZ2%2C+U.K.%2C+2005."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26pub%3DThe%2520Cambridge%2520Crystallographic%2520Data%2520Centre%2520%2528CCDC%2529%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><i>MOE (version 2005.06)</i>; <span class="NLM_publisher-name">Chemical Computing Group Inc. (CCG)</span>: <span class="NLM_publisher-loc">1010 Sherbrooke St. W, Suite 910 Montreal, Quebec, Canada</span>,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=MOE+%28version+2005.06%29%3B+Chemical+Computing+Group+Inc.+%28CCG%29%3A+1010+Sherbrooke+St.+W%2C+Suite+910+Montreal%2C+Quebec%2C+Canada%2C+2005."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26pub%3DChemical%2520Computing%2520Group%2520Inc.%2520%2528CCG%2529%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Mantle, D.</span><span> </span><span class="NLM_article-title">Characterization of dipeptidyl and tripeptidyl aminopeptidases in human kidney soluble fraction</span> <span class="citation_source-journal">Clin. Chim. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">196</span><span class="NLM_x">, </span> <span class="NLM_fpage">135</span><span class="NLM_x">–</span> <span class="NLM_lpage">142</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm101236h&amp;key=10.1016%2F0009-8981%2891%2990066-L" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm101236h&amp;key=1674238" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm101236h&amp;key=1%3ACAS%3A528%3ADyaK3MXhsVSgsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=196&publication_year=1991&pages=135-142&author=D.+Mantle&title=Characterization+of+dipeptidyl+and+tripeptidyl+aminopeptidases+in+human+kidney+soluble+fraction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of dipeptidyl and tripeptidyl aminopeptidases in human kidney soluble fraction</span></div><div class="casAuthors">Mantle, David</div><div class="citationInfo"><span class="NLM_cas:title">Clinica Chimica Acta</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">196</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">135-42</span>CODEN:
                <span class="NLM_cas:coden">CCATAR</span>;
        ISSN:<span class="NLM_cas:issn">0009-8981</span>.
    </div><div class="casAbstract">To identify improved biochem. markers for the diagnosis of early kidney damage via urinary anal. of kidney derived enzymes, systematic identification, quantification, and characterization (following purifn. via anion exchange and gel filtration chromatog., and preparative electrophoresis) was undertaken of the dipeptidyl and tripeptidyl aminopeptidases in normal human kidney sol. ext. (with which the majority of the cellular activity of these enzymes is assocd.).  Four chromatog. separable enzyme types were identified as follows (% relative activity in parentheses): dipeptidyl aminopeptidase I (EC 3.4.14.1; 24%); dipeptidyl aminopeptidase II (EC 3.4.14.2; 8%); dipeptidyl aminopeptidase IV (EC 3.4.14.5; 61%); tripeptidyl aminopeptidase (unclassified; 7%).  Comparison of the levels of activity for the above enzyme types in normal and pathol. urine may lead to an improvement upon existing procedures for the early detection of renal damage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1rWf7QqQ7BLVg90H21EOLACvtfcHk0lh6ROo5aoYKag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXhsVSgsb0%253D&md5=c13a0cb8a94f066ebb7725ea38742db4</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2F0009-8981%2891%2990066-L&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0009-8981%252891%252990066-L%26sid%3Dliteratum%253Aachs%26aulast%3DMantle%26aufirst%3DD.%26atitle%3DCharacterization%2520of%2520dipeptidyl%2520and%2520tripeptidyl%2520aminopeptidases%2520in%2520human%2520kidney%2520soluble%2520fraction%26jtitle%3DClin.%2520Chim.%2520Acta%26date%3D1991%26volume%3D196%26spage%3D135%26epage%3D142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1a','cit1b'],'ref2':['cit2a','cit2b'],'ref3':['cit3a','cit3b','cit3c','cit3d','cit3e'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6a','cit6b','cit6c','cit6d','cit6e'],'ref7':['cit7a','cit7b'],'ref8':['cit8a','cit8b'],'ref9':['cit9'],'ref10':['cit10a','cit10b','cit10c'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13a','cit13b'],'ref14':[],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 45 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Kentaro Futatsugi, Aaron C. Smith, Meihua Tu, Brian Raymer, Kay Ahn, Steven B. Coffey, Matthew S. Dowling, Dilinie P. Fernando, Jemy A. Gutierrez, Kim Huard, Jayasankar Jasti, Amit S. Kalgutkar, John D. Knafels, Jayvardhan Pandit, Kevin D. Parris, Sylvie Perez, Jeffrey A. Pfefferkorn, David A. Price, Tim Ryder, Andre Shavnya, Ingrid A. Stock, Andy S. Tsai, Gregory J. Tesz, Benjamin A. Thuma, Yan Weng, Hanna M. Wisniewska, Gang Xing, Jun Zhou, <span class="NLM_string-name hlFld-ContribAuthor">Thomas V. Magee</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of PF-06835919: A Potent Inhibitor of Ketohexokinase (KHK) for the Treatment of Metabolic Disorders Driven by the Overconsumption of Fructose. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (22)
                                     , 13546-13560. <a href="https://doi.org/10.1021/acs.jmedchem.0c00944" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00944</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00944&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00944%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BPF-06835919%25253A%252BA%252BPotent%252BInhibitor%252Bof%252BKetohexokinase%252B%252528KHK%252529%252Bfor%252Bthe%252BTreatment%252Bof%252BMetabolic%252BDisorders%252BDriven%252Bby%252Bthe%252BOverconsumption%252Bof%252BFructose%26aulast%3DFutatsugi%26aufirst%3DKentaro%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D02062020%26date%3D27092020%26date%3D10092020%26volume%3D63%26issue%3D22%26spage%3D13546%26epage%3D13560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Zhenghui Kang, Yongheng Wang, Dan Zhang, Ruibo Wu, Xinfang Xu, <span class="NLM_string-name hlFld-ContribAuthor">Wenhao Hu</span>. </span><span class="cited-content_cbyCitation_article-title">Asymmetric Counter-Anion-Directed Aminomethylation: Synthesis of Chiral β-Amino Acids via Trapping of an Enol Intermediate. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2019,</strong> <em>141 </em>
                                    (4)
                                     , 1473-1478. <a href="https://doi.org/10.1021/jacs.8b12832" title="DOI URL">https://doi.org/10.1021/jacs.8b12832</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jacs.8b12832&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjacs.8b12832%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DAsymmetric%252BCounter-Anion-Directed%252BAminomethylation%25253A%252BSynthesis%252Bof%252BChiral%252B%2525CE%2525B2-Amino%252BAcids%252Bvia%252BTrapping%252Bof%252Ban%252BEnol%252BIntermediate%26aulast%3DKang%26aufirst%3DZhenghui%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D05122018%26date%3D14012019%26date%3D09012019%26volume%3D141%26issue%3D4%26spage%3D1473%26epage%3D1478" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Meina  Li</span>, <span class="hlFld-ContribAuthor ">Duanyang  Kong</span>, <span class="hlFld-ContribAuthor ">Guofu  Zi</span>, and <span class="hlFld-ContribAuthor ">Guohua  Hou</span>  . </span><span class="cited-content_cbyCitation_article-title">Rh-Catalyzed Asymmetric Hydrogenation of 1,2-Dicyanoalkenes. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2017,</strong> <em>82 </em>
                                    (1)
                                     , 680-687. <a href="https://doi.org/10.1021/acs.joc.6b02678" title="DOI URL">https://doi.org/10.1021/acs.joc.6b02678</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.6b02678&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.6b02678%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DRh-Catalyzed%252BAsymmetric%252BHydrogenation%252Bof%252B1%25252C2-Dicyanoalkenes%26aulast%3DLi%26aufirst%3DMeina%26date%3D2017%26date%3D2016%26date%3D2016%26date%3D05112016%26date%3D21122016%26date%3D06012017%26date%3D13122016%26volume%3D82%26issue%3D1%26spage%3D680%26epage%3D687" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hang  Shen</span>, <span class="hlFld-ContribAuthor ">Jiaqiang  Li</span>, <span class="hlFld-ContribAuthor ">Qing  Liu</span>, <span class="hlFld-ContribAuthor ">Jing  Pan</span>, <span class="hlFld-ContribAuthor ">Ruofeng  Huang</span>, and <span class="hlFld-ContribAuthor ">Yan  Xiong</span>  . </span><span class="cited-content_cbyCitation_article-title">Umpolung Strategy for Synthesis of β-Ketonitriles through Hypervalent Iodine-Promoted Cyanation of Silyl Enol Ethers. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2015,</strong> <em>80 </em>
                                    (14)
                                     , 7212-7218. <a href="https://doi.org/10.1021/acs.joc.5b01102" title="DOI URL">https://doi.org/10.1021/acs.joc.5b01102</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.5b01102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.5b01102%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DUmpolung%252BStrategy%252Bfor%252BSynthesis%252Bof%252B%2525CE%2525B2-Ketonitriles%252Bthrough%252BHypervalent%252BIodine-Promoted%252BCyanation%252Bof%252BSilyl%252BEnol%252BEthers%26aulast%3DShen%26aufirst%3DHang%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D17052015%26date%3D25062015%26date%3D17072015%26date%3D11062015%26volume%3D80%26issue%3D14%26spage%3D7212%26epage%3D7218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yan  He</span>, <span class="hlFld-ContribAuthor ">Shenghai  Guo</span>, <span class="hlFld-ContribAuthor ">Xinying  Zhang</span>, and <span class="hlFld-ContribAuthor ">Xuesen  Fan</span>  . </span><span class="cited-content_cbyCitation_article-title">Zinc-Mediated One-Pot Tandem Reaction of Nitriles with Propargyl Bromides: An Access to 3-Alkynylpyridines. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2014,</strong> <em>79 </em>
                                    (21)
                                     , 10611-10618. <a href="https://doi.org/10.1021/jo501869d" title="DOI URL">https://doi.org/10.1021/jo501869d</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jo501869d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjo501869d%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DZinc-Mediated%252BOne-Pot%252BTandem%252BReaction%252Bof%252BNitriles%252Bwith%252BPropargyl%252BBromides%25253A%252BAn%252BAccess%252Bto%252B3-Alkynylpyridines%26aulast%3DHe%26aufirst%3DYan%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D13082014%26date%3D10102014%26date%3D07112014%26date%3D01102014%26volume%3D79%26issue%3D21%26spage%3D10611%26epage%3D10618" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lucienne  Juillerat-Jeanneret</span>  . </span><span class="cited-content_cbyCitation_article-title">Dipeptidyl Peptidase IV and Its Inhibitors: Therapeutics for Type 2 Diabetes and What Else?. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (6)
                                     , 2197-2212. <a href="https://doi.org/10.1021/jm400658e" title="DOI URL">https://doi.org/10.1021/jm400658e</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm400658e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm400658e%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDipeptidyl%252BPeptidase%252BIV%252Band%252BIts%252BInhibitors%25253A%252BTherapeutics%252Bfor%252BType%252B2%252BDiabetes%252Band%252BWhat%252BElse%25253F%26aulast%3DJuillerat-Jeanneret%26aufirst%3DLucienne%26date%3D2014%26date%3D2013%26date%3D2013%26date%3D03052013%26date%3D24102013%26date%3D27032014%26date%3D07102013%26volume%3D57%26issue%3D6%26spage%3D2197%26epage%3D2212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Norio  Murai</span>, <span class="hlFld-ContribAuthor ">Masayuki  Miyano</span>, <span class="hlFld-ContribAuthor ">Masahiro  Yonaga</span>, and <span class="hlFld-ContribAuthor ">Keigo  Tanaka</span>  . </span><span class="cited-content_cbyCitation_article-title">One-Pot Primary Aminomethylation of Aryl and Heteroaryl Halides with Sodium Phthalimidomethyltrifluoroborate. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2012,</strong> <em>14 </em>
                                    (11)
                                     , 2818-2821. <a href="https://doi.org/10.1021/ol301037s" title="DOI URL">https://doi.org/10.1021/ol301037s</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ol301037s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fol301037s%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DOne-Pot%252BPrimary%252BAminomethylation%252Bof%252BAryl%252Band%252BHeteroaryl%252BHalides%252Bwith%252BSodium%252BPhthalimidomethyltrifluoroborate%26aulast%3DMurai%26aufirst%3DNorio%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D20042012%26date%3D16052012%26date%3D01062012%26volume%3D14%26issue%3D11%26spage%3D2818%26epage%3D2821" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pramod C.  Nair</span>, <span class="hlFld-ContribAuthor ">Nuy  Chau</span>, <span class="hlFld-ContribAuthor ">Ross A.  McKinnon</span>, <span class="hlFld-ContribAuthor ">John O.  Miners</span>. </span><span class="cited-content_cbyCitation_article-title">Arginine-259 of UGT2B7 Confers UDP-Sugar Selectivity. </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmacology</span><span> <strong>2020,</strong> <em>98 </em>
                                    (6)
                                     , 710-718. <a href="https://doi.org/10.1124/molpharm.120.000104" title="DOI URL">https://doi.org/10.1124/molpharm.120.000104</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/molpharm.120.000104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fmolpharm.120.000104%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmacology%26atitle%3DArginine-259%252Bof%252BUGT2B7%252BConfers%252BUDP-Sugar%252BSelectivity%26aulast%3DNair%26aufirst%3DPramod%2BC.%26date%3D2020%26date%3D2020%26volume%3D98%26issue%3D6%26spage%3D710%26epage%3D718" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Leila  Emami</span>, <span class="hlFld-ContribAuthor ">Zahra  Faghih</span>, <span class="hlFld-ContribAuthor ">Amirhossein  Sakhteman</span>, <span class="hlFld-ContribAuthor ">Zahra  Rezaei</span>, <span class="hlFld-ContribAuthor ">Zeinab  Faghih</span>, <span class="hlFld-ContribAuthor ">Farnaz  Salehi</span>, <span class="hlFld-ContribAuthor ">Soghra  Khabnadideh</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, molecular simulation, and biological activities of novel quinazolinone-pyrimidine hybrid derivatives as dipeptidyl peptidase-4 inhibitors and anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">New Journal of Chemistry</span><span> <strong>2020,</strong> <em>44 </em>
                                    (45)
                                     , 19515-19531. <a href="https://doi.org/10.1039/D0NJ03774E" title="DOI URL">https://doi.org/10.1039/D0NJ03774E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0NJ03774E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0NJ03774E%26sid%3Dliteratum%253Aachs%26jtitle%3DNew%2520Journal%2520of%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Bmolecular%252Bsimulation%25252C%252Band%252Bbiological%252Bactivities%252Bof%252Bnovel%252Bquinazolinone-pyrimidine%252Bhybrid%252Bderivatives%252Bas%252Bdipeptidyl%252Bpeptidase-4%252Binhibitors%252Band%252Banticancer%252Bagents%26aulast%3DEmami%26aufirst%3DLeila%26date%3D2020%26date%3D2020%26volume%3D44%26issue%3D45%26spage%3D19515%26epage%3D19531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Simone Queiroz  Pantaleão</span>, <span class="hlFld-ContribAuthor ">Eric Allison  Philot</span>, <span class="hlFld-ContribAuthor ">Michell  de Oliveira Almeida</span>, <span class="hlFld-ContribAuthor ">Angelica Nakagawa  Lima</span>, <span class="hlFld-ContribAuthor ">Mirela Inês  de Sairre</span>, <span class="hlFld-ContribAuthor ">Ana Ligia  Scott</span>, <span class="hlFld-ContribAuthor ">Kathia Maria  Honorio</span>. </span><span class="cited-content_cbyCitation_article-title">Integrated Protocol to Design Potential Inhibitors of Dipeptidyl Peptidase- 4 (DPP-4). </span><span class="cited-content_cbyCitation_journal-name">Current Topics in Medicinal Chemistry</span><span> <strong>2020,</strong> <em>20 </em>
                                    (3)
                                     , 209-226. <a href="https://doi.org/10.2174/1568026620666191226101543" title="DOI URL">https://doi.org/10.2174/1568026620666191226101543</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1568026620666191226101543&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1568026620666191226101543%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Topics%2520in%2520Medicinal%2520Chemistry%26atitle%3DIntegrated%252BProtocol%252Bto%252BDesign%252BPotential%252BInhibitors%252Bof%252BDipeptidyl%252BPeptidase-%252B4%252B%252528DPP-4%252529%26aulast%3DPantale%25C3%25A3o%26aufirst%3DSimone%2BQueiroz%26date%3D2020%26volume%3D20%26issue%3D3%26spage%3D209%26epage%3D226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel P  Pienaar</span>, <span class="hlFld-ContribAuthor ">Kamogelo R  Butsi</span>, <span class="hlFld-ContribAuthor ">Amanda L  Rousseau</span>, <span class="hlFld-ContribAuthor ">Dean  Brady</span>. </span><span class="cited-content_cbyCitation_article-title">A green, economical synthesis of β-ketonitriles and trifunctionalized building blocks from esters and lactones. </span><span class="cited-content_cbyCitation_journal-name">Beilstein Journal of Organic Chemistry</span><span> <strong>2019,</strong> <em>15 </em>, 2930-2935. <a href="https://doi.org/10.3762/bjoc.15.287" title="DOI URL">https://doi.org/10.3762/bjoc.15.287</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3762/bjoc.15.287&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3762%2Fbjoc.15.287%26sid%3Dliteratum%253Aachs%26jtitle%3DBeilstein%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DA%252Bgreen%25252C%252Beconomical%252Bsynthesis%252Bof%252B%2525CE%2525B2-ketonitriles%252Band%252Btrifunctionalized%252Bbuilding%252Bblocks%252Bfrom%252Besters%252Band%252Blactones%26aulast%3DPienaar%26aufirst%3DDaniel%2BP%26date%3D2019%26date%3D2019%26volume%3D15%26spage%3D2930%26epage%3D2935" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sourav  De</span>, <span class="hlFld-ContribAuthor ">Subhasis  Banerjee</span>, <span class="hlFld-ContribAuthor ">S.K. Ashok  Kumar</span>, <span class="hlFld-ContribAuthor ">Priyankar  Paira</span>. </span><span class="cited-content_cbyCitation_article-title">Critical Role of Dipeptidyl Peptidase IV: A Therapeutic Target for Diabetes and Cancer. </span><span class="cited-content_cbyCitation_journal-name">Mini-Reviews in Medicinal Chemistry</span><span> <strong>2018,</strong> <em>19 </em>
                                    (2)
                                     , 88-97. <a href="https://doi.org/10.2174/1389557518666180423112154" title="DOI URL">https://doi.org/10.2174/1389557518666180423112154</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1389557518666180423112154&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1389557518666180423112154%26sid%3Dliteratum%253Aachs%26jtitle%3DMini-Reviews%2520in%2520Medicinal%2520Chemistry%26atitle%3DCritical%252BRole%252Bof%252BDipeptidyl%252BPeptidase%252BIV%25253A%252BA%252BTherapeutic%252BTarget%252Bfor%252BDiabetes%252Band%252BCancer%26aulast%3DDe%26aufirst%3DSourav%26date%3D2018%26volume%3D19%26issue%3D2%26spage%3D88%26epage%3D97" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">María José  Ojeda-Montes</span>, <span class="hlFld-ContribAuthor ">Aleix  Gimeno</span>, <span class="hlFld-ContribAuthor ">Sarah  Tomas-Hernández</span>, <span class="hlFld-ContribAuthor ">Adrià  Cereto-Massagué</span>, <span class="hlFld-ContribAuthor ">Raúl  Beltrán-Debón</span>, <span class="hlFld-ContribAuthor ">Cristina  Valls</span>, <span class="hlFld-ContribAuthor ">Miquel  Mulero</span>, <span class="hlFld-ContribAuthor ">Gerard  Pujadas</span>, <span class="hlFld-ContribAuthor ">Santiago  Garcia-Vallvé</span>. </span><span class="cited-content_cbyCitation_article-title">Activity and selectivity cliffs for DPP-IV inhibitors: Lessons we can learn from SAR studies and their application to virtual screening. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2018,</strong> <em>38 </em>
                                    (6)
                                     , 1874-1915. <a href="https://doi.org/10.1002/med.21499" title="DOI URL">https://doi.org/10.1002/med.21499</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21499&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21499%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DActivity%252Band%252Bselectivity%252Bcliffs%252Bfor%252BDPP-IV%252Binhibitors%25253A%252BLessons%252Bwe%252Bcan%252Blearn%252Bfrom%252BSAR%252Bstudies%252Band%252Btheir%252Bapplication%252Bto%252Bvirtual%252Bscreening%26aulast%3DOjeda-Montes%26aufirst%3DMar%25C3%25ADa%2BJos%25C3%25A9%26date%3D2018%26date%3D2018%26volume%3D38%26issue%3D6%26spage%3D1874%26epage%3D1915" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ankit  Rohilla</span>, <span class="hlFld-ContribAuthor ">Tanya  Gupta</span>, <span class="hlFld-ContribAuthor ">Ankita  Pathak</span>, <span class="hlFld-ContribAuthor ">Md J.  Akhtar</span>, <span class="hlFld-ContribAuthor ">Md R.  Haider</span>, <span class="hlFld-ContribAuthor ">Kashif  Haider</span>, <span class="hlFld-ContribAuthor ">Mohammad  Shahar Yar</span>. </span><span class="cited-content_cbyCitation_article-title">Emergence of promising novel DPP-4 inhibitory heterocycles as anti-diabetic agents: A review. </span><span class="cited-content_cbyCitation_journal-name">Archiv der Pharmazie</span><span> <strong>2018,</strong> <em>351 </em>
                                    (8)
                                     , 1800127. <a href="https://doi.org/10.1002/ardp.201800127" title="DOI URL">https://doi.org/10.1002/ardp.201800127</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ardp.201800127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fardp.201800127%26sid%3Dliteratum%253Aachs%26jtitle%3DArchiv%2520der%2520Pharmazie%26atitle%3DEmergence%252Bof%252Bpromising%252Bnovel%252BDPP-4%252Binhibitory%252Bheterocycles%252Bas%252Banti-diabetic%252Bagents%25253A%252BA%252Breview%26aulast%3DRohilla%26aufirst%3DAnkit%26date%3D2018%26date%3D2018%26volume%3D351%26issue%3D8%26spage%3D1800127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zijun  Huang</span>, <span class="hlFld-ContribAuthor ">Yazhe  Cheng</span>, <span class="hlFld-ContribAuthor ">Xipeng  Chen</span>, <span class="hlFld-ContribAuthor ">Hui-Fang  Wang</span>, <span class="hlFld-ContribAuthor ">Chen-Xia  Du</span>, <span class="hlFld-ContribAuthor ">Yuehui  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Regioselectivity inversion tuned by iron(
              iii
              ) salts in palladium-catalyzed carbonylations. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2018,</strong> <em>54 </em>
                                    (32)
                                     , 3967-3970. <a href="https://doi.org/10.1039/C8CC01190G" title="DOI URL">https://doi.org/10.1039/C8CC01190G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8CC01190G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8CC01190G%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DRegioselectivity%252Binversion%252Btuned%252Bby%252Biron%252528%252Biii%252B%252529%252Bsalts%252Bin%252Bpalladium-catalyzed%252Bcarbonylations%26aulast%3DHuang%26aufirst%3DZijun%26date%3D2018%26date%3D2018%26volume%3D54%26issue%3D32%26spage%3D3967%26epage%3D3970" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaoyan  Deng</span>, <span class="hlFld-ContribAuthor ">Li  Han</span>, <span class="hlFld-ContribAuthor ">Jinpei  Zhou</span>, <span class="hlFld-ContribAuthor ">Huibin  Zhang</span>, <span class="hlFld-ContribAuthor ">Qing  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of triazole-based uracil derivatives bearing amide moieties as novel dipeptidyl peptidase-IV inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2017,</strong> <em>75 </em>, 357-367. <a href="https://doi.org/10.1016/j.bioorg.2017.10.010" title="DOI URL">https://doi.org/10.1016/j.bioorg.2017.10.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2017.10.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2017.10.010%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDiscovery%252Bof%252Btriazole-based%252Buracil%252Bderivatives%252Bbearing%252Bamide%252Bmoieties%252Bas%252Bnovel%252Bdipeptidyl%252Bpeptidase-IV%252Binhibitors%26aulast%3DDeng%26aufirst%3DXiaoyan%26date%3D2017%26volume%3D75%26spage%3D357%26epage%3D367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Romain  Duroux</span>, <span class="hlFld-ContribAuthor ">Marouan  Rami</span>, <span class="hlFld-ContribAuthor ">Elodie  Landagaray</span>, <span class="hlFld-ContribAuthor ">Mohamed  Ettaoussi</span>, <span class="hlFld-ContribAuthor ">Daniel-Henri  Caignard</span>, <span class="hlFld-ContribAuthor ">Philippe  Delagrange</span>, <span class="hlFld-ContribAuthor ">Patricia  Melnyk</span>, <span class="hlFld-ContribAuthor ">Saïd  Yous</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of new naphtho- and quinolinocyclopentane derivatives as potent melatoninergic (MT 1 /MT 2 ) and serotoninergic (5-HT 2C ) dual ligands. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>141 </em>, 552-566. <a href="https://doi.org/10.1016/j.ejmech.2017.10.025" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.10.025</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.10.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.10.025%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnew%252Bnaphtho-%252Band%252Bquinolinocyclopentane%252Bderivatives%252Bas%252Bpotent%252Bmelatoninergic%252B%252528MT%252B1%252B%25252FMT%252B2%252B%252529%252Band%252Bserotoninergic%252B%2525285-HT%252B2C%252B%252529%252Bdual%252Bligands%26aulast%3DDuroux%26aufirst%3DRomain%26date%3D2017%26volume%3D141%26spage%3D552%26epage%3D566" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sharat  Chandra</span>, <span class="hlFld-ContribAuthor ">Jyotsana  Pandey</span>, <span class="hlFld-ContribAuthor ">Akhilesh K.  Tamrakar</span>, <span class="hlFld-ContribAuthor ">Mohammad Imran  Siddiqi</span>. </span><span class="cited-content_cbyCitation_article-title">SVMDLF: A novel R-based Web application for prediction of dipeptidyl peptidase 4 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2017,</strong> <em>90 </em>
                                    (6)
                                     , 1173-1183. <a href="https://doi.org/10.1111/cbdd.13037" title="DOI URL">https://doi.org/10.1111/cbdd.13037</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.13037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.13037%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DSVMDLF%25253A%252BA%252Bnovel%252BR-based%252BWeb%252Bapplication%252Bfor%252Bprediction%252Bof%252Bdipeptidyl%252Bpeptidase%252B4%252Binhibitors%26aulast%3DChandra%26aufirst%3DSharat%26date%3D2017%26date%3D2017%26volume%3D90%26issue%3D6%26spage%3D1173%26epage%3D1183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hironobu  Maezaki</span>, <span class="hlFld-ContribAuthor ">Michiko  Tawada</span>, <span class="hlFld-ContribAuthor ">Tohru  Yamashita</span>, <span class="hlFld-ContribAuthor ">Yoshihiro  Banno</span>, <span class="hlFld-ContribAuthor ">Yasufumi  Miyamoto</span>, <span class="hlFld-ContribAuthor ">Yoshio  Yamamoto</span>, <span class="hlFld-ContribAuthor ">Koji  Ikedo</span>, <span class="hlFld-ContribAuthor ">Takuo  Kosaka</span>, <span class="hlFld-ContribAuthor ">Shigetoshi  Tsubotani</span>, <span class="hlFld-ContribAuthor ">Akiyoshi  Tani</span>, <span class="hlFld-ContribAuthor ">Tomoko  Asakawa</span>, <span class="hlFld-ContribAuthor ">Nobuhiro  Suzuki</span>, <span class="hlFld-ContribAuthor ">Satoru  Oi</span>. </span><span class="cited-content_cbyCitation_article-title">Design of potent dipeptidyl peptidase IV (DPP-4) inhibitors by employing a strategy to form a salt bridge with Lys554. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (15)
                                     , 3565-3571. <a href="https://doi.org/10.1016/j.bmcl.2017.05.048" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.05.048</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.05.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.05.048%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%252Bof%252Bpotent%252Bdipeptidyl%252Bpeptidase%252BIV%252B%252528DPP-4%252529%252Binhibitors%252Bby%252Bemploying%252Ba%252Bstrategy%252Bto%252Bform%252Ba%252Bsalt%252Bbridge%252Bwith%252BLys554%26aulast%3DMaezaki%26aufirst%3DHironobu%26date%3D2017%26volume%3D27%26issue%3D15%26spage%3D3565%26epage%3D3571" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yan  Zhu</span>, <span class="hlFld-ContribAuthor ">Xiangguo  Meng</span>, <span class="hlFld-ContribAuthor ">Zhengyan  Cai</span>, <span class="hlFld-ContribAuthor ">Qun  Hao</span>, <span class="hlFld-ContribAuthor ">Weicheng  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of phenylpyridine derivatives and their biological evaluation toward dipeptidyl peptidase-4. </span><span class="cited-content_cbyCitation_journal-name">Chemistry of Heterocyclic Compounds</span><span> <strong>2017,</strong> <em>53 </em>
                                    (3)
                                     , 350-356. <a href="https://doi.org/10.1007/s10593-017-2062-4" title="DOI URL">https://doi.org/10.1007/s10593-017-2062-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10593-017-2062-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10593-017-2062-4%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520of%2520Heterocyclic%2520Compounds%26atitle%3DSynthesis%252Bof%252Bphenylpyridine%252Bderivatives%252Band%252Btheir%252Bbiological%252Bevaluation%252Btoward%252Bdipeptidyl%252Bpeptidase-4%26aulast%3DZhu%26aufirst%3DYan%26date%3D2017%26date%3D2017%26volume%3D53%26issue%3D3%26spage%3D350%26epage%3D356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">T.  Biftu</span>, <span class="hlFld-ContribAuthor ">R.  SinhaRoy</span>. </span><span class="cited-content_cbyCitation_article-title">DPP-4 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 512-555. <a href="https://doi.org/10.1016/B978-0-12-409547-2.12443-6" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.12443-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.12443-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.12443-6%26sid%3Dliteratum%253Aachs%26atitle%3DDPP-4%252BInhibitors%26aulast%3DBiftu%26aufirst%3DT.%26date%3D2017%26spage%3D512%26epage%3D555%26pub%3DElsevier%26atitle%3DComprehensive%252BMedicinal%252BChemistry%252BIII%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gaurav  Taneja</span>, <span class="hlFld-ContribAuthor ">Chandra Prakash  Gupta</span>, <span class="hlFld-ContribAuthor ">Shachi  Mishra</span>, <span class="hlFld-ContribAuthor ">Rohit  Srivastava</span>, <span class="hlFld-ContribAuthor ">Neha  Rahuja</span>, <span class="hlFld-ContribAuthor ">Arun Kumar  Rawat</span>, <span class="hlFld-ContribAuthor ">Jyotsana  Pandey</span>, <span class="hlFld-ContribAuthor ">Anand P.  Gupta</span>, <span class="hlFld-ContribAuthor ">Natasha  Jaiswal</span>, <span class="hlFld-ContribAuthor ">Jiaur R.  Gayen</span>, <span class="hlFld-ContribAuthor ">Akhilesh K.  Tamrakar</span>, <span class="hlFld-ContribAuthor ">Arvind Kumar  Srivastava</span>, <span class="hlFld-ContribAuthor ">Atul  Goel</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of substituted 2H-benzo[e]indazole-9-carboxylate as a potent antihyperglycemic agent that may act through IRS-1, Akt and GSK-3β pathways. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2017,</strong> <em>8 </em>
                                    (2)
                                     , 329-337. <a href="https://doi.org/10.1039/C6MD00467A" title="DOI URL">https://doi.org/10.1039/C6MD00467A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6MD00467A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6MD00467A%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DSynthesis%252Bof%252Bsubstituted%252B2H-benzo%25255Be%25255Dindazole-9-carboxylate%252Bas%252Ba%252Bpotent%252Bantihyperglycemic%252Bagent%252Bthat%252Bmay%252Bact%252Bthrough%252BIRS-1%25252C%252BAkt%252Band%252BGSK-3%2525CE%2525B2%252Bpathways%26aulast%3DTaneja%26aufirst%3DGaurav%26date%3D2017%26date%3D2017%26volume%3D8%26issue%3D2%26spage%3D329%26epage%3D337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sho  Hirai</span>, <span class="hlFld-ContribAuthor ">Yurie  Horikawa</span>, <span class="hlFld-ContribAuthor ">Haruyasu  Asahara</span>, <span class="hlFld-ContribAuthor ">Nagatoshi  Nishiwaki</span>. </span><span class="cited-content_cbyCitation_article-title">Tailor-made synthesis of fully alkylated/arylated nicotinates by FeCl
              3
              -mediated condensation of enamino esters with enones. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2017,</strong> <em>53 </em>
                                    (15)
                                     , 2390-2393. <a href="https://doi.org/10.1039/C7CC00051K" title="DOI URL">https://doi.org/10.1039/C7CC00051K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7CC00051K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7CC00051K%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DTailor-made%252Bsynthesis%252Bof%252Bfully%252Balkylated%25252Farylated%252Bnicotinates%252Bby%252BFeCl%252B3%252B-mediated%252Bcondensation%252Bof%252Benamino%252Besters%252Bwith%252Benones%26aulast%3DHirai%26aufirst%3DSho%26date%3D2017%26date%3D2017%26volume%3D53%26issue%3D15%26spage%3D2390%26epage%3D2393" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Renato  Ferreira de Freitas</span>, <span class="hlFld-ContribAuthor ">Matthieu  Schapira</span>. </span><span class="cited-content_cbyCitation_article-title">A systematic analysis of atomic protein–ligand interactions in the PDB. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2017,</strong> <em>8 </em>
                                    (10)
                                     , 1970-1981. <a href="https://doi.org/10.1039/C7MD00381A" title="DOI URL">https://doi.org/10.1039/C7MD00381A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7MD00381A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7MD00381A%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DA%252Bsystematic%252Banalysis%252Bof%252Batomic%252Bprotein%2525E2%252580%252593ligand%252Binteractions%252Bin%252Bthe%252BPDB%26aulast%3DFerreira%2Bde%2BFreitas%26aufirst%3DRenato%26date%3D2017%26date%3D2017%26volume%3D8%26issue%3D10%26spage%3D1970%26epage%3D1981" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hiroyuki  Nojima</span>, <span class="hlFld-ContribAuthor ">Kazuhiko  Kanou</span>, <span class="hlFld-ContribAuthor ">Genki  Terashi</span>, <span class="hlFld-ContribAuthor ">Mayuko  Takeda-Shitaka</span>, <span class="hlFld-ContribAuthor ">Gaku  Inoue</span>, <span class="hlFld-ContribAuthor ">Koichiro  Atsuda</span>, <span class="hlFld-ContribAuthor ">Chihiro  Itoh</span>, <span class="hlFld-ContribAuthor ">Chie  Iguchi</span>, <span class="hlFld-ContribAuthor ">Hajime  Matsubara</span>. </span><span class="cited-content_cbyCitation_article-title">Comprehensive analysis of the Co-structures of dipeptidyl peptidase IV and its inhibitor. </span><span class="cited-content_cbyCitation_journal-name">BMC Structural Biology</span><span> <strong>2016,</strong> <em>16 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s12900-016-0062-8" title="DOI URL">https://doi.org/10.1186/s12900-016-0062-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s12900-016-0062-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs12900-016-0062-8%26sid%3Dliteratum%253Aachs%26jtitle%3DBMC%2520Structural%2520Biology%26atitle%3DComprehensive%252Banalysis%252Bof%252Bthe%252BCo-structures%252Bof%252Bdipeptidyl%252Bpeptidase%252BIV%252Band%252Bits%252Binhibitor%26aulast%3DNojima%26aufirst%3DHiroyuki%26date%3D2016%26date%3D2016%26volume%3D16%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yan  Zhu</span>, <span class="hlFld-ContribAuthor ">Zhengyan  Cai</span>, <span class="hlFld-ContribAuthor ">Qun  Hao</span>, <span class="hlFld-ContribAuthor ">Weicheng  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Alkylation of 2-(2,4-dichlorophenyl)-3-cyano-6-methyl-4-(1H-1,2,4-triazol-1-yl)methylpyridine at the methylene group. </span><span class="cited-content_cbyCitation_journal-name">Chemistry of Heterocyclic Compounds</span><span> <strong>2016,</strong> <em>52 </em>
                                    (8)
                                     , 564-569. <a href="https://doi.org/10.1007/s10593-016-1932-5" title="DOI URL">https://doi.org/10.1007/s10593-016-1932-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10593-016-1932-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10593-016-1932-5%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520of%2520Heterocyclic%2520Compounds%26atitle%3DAlkylation%252Bof%252B2-%2525282%25252C4-dichlorophenyl%252529-3-cyano-6-methyl-4-%2525281H-1%25252C2%25252C4-triazol-1-yl%252529methylpyridine%252Bat%252Bthe%252Bmethylene%252Bgroup%26aulast%3DZhu%26aufirst%3DYan%26date%3D2016%26date%3D2016%26volume%3D52%26issue%3D8%26spage%3D564%26epage%3D569" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrei V.  Bogdanov</span>, <span class="hlFld-ContribAuthor ">Vladimir F.  Mironov</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of isatoic anhydride derivatives (microreview). </span><span class="cited-content_cbyCitation_journal-name">Chemistry of Heterocyclic Compounds</span><span> <strong>2016,</strong> <em>52 </em>
                                    (2)
                                     , 90-92. <a href="https://doi.org/10.1007/s10593-016-1837-3" title="DOI URL">https://doi.org/10.1007/s10593-016-1837-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10593-016-1837-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10593-016-1837-3%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520of%2520Heterocyclic%2520Compounds%26atitle%3DSynthesis%252Bof%252Bisatoic%252Banhydride%252Bderivatives%252B%252528microreview%252529%26aulast%3DBogdanov%26aufirst%3DAndrei%2BV.%26date%3D2016%26date%3D2016%26volume%3D52%26issue%3D2%26spage%3D90%26epage%3D92" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qing  Li</span>, <span class="hlFld-ContribAuthor ">Li  Han</span>, <span class="hlFld-ContribAuthor ">Bin  Zhang</span>, <span class="hlFld-ContribAuthor ">Jinpei  Zhou</span>, <span class="hlFld-ContribAuthor ">Huibin  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of triazole based uracil derivatives as novel DPP-4 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2016,</strong> <em>14 </em>
                                    (40)
                                     , 9598-9611. <a href="https://doi.org/10.1039/C6OB01818A" title="DOI URL">https://doi.org/10.1039/C6OB01818A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6OB01818A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6OB01818A%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Btriazole%252Bbased%252Buracil%252Bderivatives%252Bas%252Bnovel%252BDPP-4%252Binhibitors%26aulast%3DLi%26aufirst%3DQing%26date%3D2016%26date%3D2016%26volume%3D14%26issue%3D40%26spage%3D9598%26epage%3D9611" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A. V.  Bogdanov</span>, <span class="hlFld-ContribAuthor ">T. I.  Sadykov</span>, <span class="hlFld-ContribAuthor ">L. I.  Musin</span>, <span class="hlFld-ContribAuthor ">A. R.  Khamatgalimov</span>, <span class="hlFld-ContribAuthor ">D. B.  Krivolapov</span>, <span class="hlFld-ContribAuthor ">A. B.  Dobrynin</span>, <span class="hlFld-ContribAuthor ">V. F.  Mironov</span>. </span><span class="cited-content_cbyCitation_article-title">Chemoselective oxidation of 1-alkenylisatins with m-chloroperbenzoic acid. Synthesis of new derivatives of isatoic anhydride. </span><span class="cited-content_cbyCitation_journal-name">Russian Journal of General Chemistry</span><span> <strong>2015,</strong> <em>85 </em>
                                    (9)
                                     , 2030-2036. <a href="https://doi.org/10.1134/S1070363215090030" title="DOI URL">https://doi.org/10.1134/S1070363215090030</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1134/S1070363215090030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1134%2FS1070363215090030%26sid%3Dliteratum%253Aachs%26jtitle%3DRussian%2520Journal%2520of%2520General%2520Chemistry%26atitle%3DChemoselective%252Boxidation%252Bof%252B1-alkenylisatins%252Bwith%252Bm-chloroperbenzoic%252Bacid.%252BSynthesis%252Bof%252Bnew%252Bderivatives%252Bof%252Bisatoic%252Banhydride%26aulast%3DBogdanov%26aufirst%3DA.%2BV.%26date%3D2015%26date%3D2015%26volume%3D85%26issue%3D9%26spage%3D2030%26epage%3D2036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">R.  Abu Khalaf</span>, <span class="hlFld-ContribAuthor ">Z.  Jarekji</span>, <span class="hlFld-ContribAuthor ">T.  Al-Qirim</span>, <span class="hlFld-ContribAuthor ">D.  Sabbah</span>, <span class="hlFld-ContribAuthor ">G.  Shattat</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacophore modeling and molecular docking studies of acridines as potential DPP-IV inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Canadian Journal of Chemistry</span><span> <strong>2015,</strong> <em>93 </em>
                                    (7)
                                     , 721-729. <a href="https://doi.org/10.1139/cjc-2015-0039" title="DOI URL">https://doi.org/10.1139/cjc-2015-0039</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1139/cjc-2015-0039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1139%2Fcjc-2015-0039%26sid%3Dliteratum%253Aachs%26jtitle%3DCanadian%2520Journal%2520of%2520Chemistry%26atitle%3DPharmacophore%252Bmodeling%252Band%252Bmolecular%252Bdocking%252Bstudies%252Bof%252Bacridines%252Bas%252Bpotential%252BDPP-IV%252Binhibitors%26aulast%3DAbu%2BKhalaf%26aufirst%3DR.%26date%3D2015%26volume%3D93%26issue%3D7%26spage%3D721%26epage%3D729" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vânia M.T.  Carneiro</span>, <span class="hlFld-ContribAuthor ">Daniela B.B.  Trivella</span>, <span class="hlFld-ContribAuthor ">Valéria  Scorsato</span>, <span class="hlFld-ContribAuthor ">Viviane L.  Beraldo</span>, <span class="hlFld-ContribAuthor ">Mariana P.  Dias</span>, <span class="hlFld-ContribAuthor ">Tiago J.P.  Sobreira</span>, <span class="hlFld-ContribAuthor ">Ricardo  Aparicio</span>, <span class="hlFld-ContribAuthor ">Ronaldo A.  Pilli</span>. </span><span class="cited-content_cbyCitation_article-title">Is RK-682 a promiscuous enzyme inhibitor? Synthesis and in vitro evaluation of protein tyrosine phosphatase inhibition of racemic RK-682 and analogues. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>97 </em>, 42-54. <a href="https://doi.org/10.1016/j.ejmech.2015.04.036" title="DOI URL">https://doi.org/10.1016/j.ejmech.2015.04.036</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2015.04.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2015.04.036%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIs%252BRK-682%252Ba%252Bpromiscuous%252Benzyme%252Binhibitor%25253F%252BSynthesis%252Band%252Bin%2525C2%2525A0vitro%252Bevaluation%252Bof%252Bprotein%252Btyrosine%252Bphosphatase%252Binhibition%252Bof%252Bracemic%252BRK-682%252Band%252Banalogues%26aulast%3DCarneiro%26aufirst%3DV%25C3%25A2nia%2BM.T.%26date%3D2015%26volume%3D97%26spage%3D42%26epage%3D54" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Di-Wei  Mo</span>, <span class="hlFld-ContribAuthor ">Shuai  Dong</span>, <span class="hlFld-ContribAuthor ">Haiyan  Sun</span>, <span class="hlFld-ContribAuthor ">Jia-Sheng  Chen</span>, <span class="hlFld-ContribAuthor ">Jian-Xin  Pang</span>, <span class="hlFld-ContribAuthor ">Bao-Min  Xi</span>, <span class="hlFld-ContribAuthor ">Wen-Hua  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and potent inhibitory activities of carboxybenzyl-substituted 8-(3-(R)-aminopiperidin-1-yl)-7-(2-chloro/cyanobenzyl)-3-methyl-3,7-dihydro-purine-2,6-diones as dipeptidyl peptidase IV (DPP-IV) inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (9)
                                     , 1872-1875. <a href="https://doi.org/10.1016/j.bmcl.2015.03.048" title="DOI URL">https://doi.org/10.1016/j.bmcl.2015.03.048</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2015.03.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2015.03.048%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252Bpotent%252Binhibitory%252Bactivities%252Bof%252Bcarboxybenzyl-substituted%252B8-%2525283-%252528R%252529-aminopiperidin-1-yl%252529-7-%2525282-chloro%25252Fcyanobenzyl%252529-3-methyl-3%25252C7-dihydro-purine-2%25252C6-diones%252Bas%252Bdipeptidyl%252Bpeptidase%252BIV%252B%252528DPP-IV%252529%252Binhibitors%26aulast%3DMo%26aufirst%3DDi-Wei%26date%3D2015%26volume%3D25%26issue%3D9%26spage%3D1872%26epage%3D1875" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Weijian  Ye</span>, <span class="hlFld-ContribAuthor ">Yan  Li</span>, <span class="hlFld-ContribAuthor ">Lanxiang  Zhou</span>, <span class="hlFld-ContribAuthor ">Juanjuan  Liu</span>, <span class="hlFld-ContribAuthor ">Cunde  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Three-component reaction between substituted β-nitrostyrenes, β-dicarbonyl compounds and amines: diversity-oriented synthesis of novel β-enaminones. </span><span class="cited-content_cbyCitation_journal-name">Green Chemistry</span><span> <strong>2015,</strong> <em>17 </em>
                                    (1)
                                     , 188-192. <a href="https://doi.org/10.1039/C4GC01234H" title="DOI URL">https://doi.org/10.1039/C4GC01234H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C4GC01234H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC4GC01234H%26sid%3Dliteratum%253Aachs%26jtitle%3DGreen%2520Chemistry%26atitle%3DThree-component%252Breaction%252Bbetween%252Bsubstituted%252B%2525CE%2525B2-nitrostyrenes%25252C%252B%2525CE%2525B2-dicarbonyl%252Bcompounds%252Band%252Bamines%25253A%252Bdiversity-oriented%252Bsynthesis%252Bof%252Bnovel%252B%2525CE%2525B2-enaminones%26aulast%3DYe%26aufirst%3DWeijian%26date%3D2015%26date%3D2015%26volume%3D17%26issue%3D1%26spage%3D188%26epage%3D192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Simone Queiroz  Pantaleão</span>, <span class="hlFld-ContribAuthor ">Vinicius Gonçalves  Maltarollo</span>, <span class="hlFld-ContribAuthor ">Sheila Cruz  Araujo</span>, <span class="hlFld-ContribAuthor ">Jadson Castro  Gertrudes</span>, <span class="hlFld-ContribAuthor ">Kathia Maria  Honorio</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular docking studies and 2D analyses of DPP-4 inhibitors as candidates in the treatment of diabetes. </span><span class="cited-content_cbyCitation_journal-name">Molecular BioSystems</span><span> <strong>2015,</strong> <em>11 </em>
                                    (11)
                                     , 3188-3193. <a href="https://doi.org/10.1039/C5MB00493D" title="DOI URL">https://doi.org/10.1039/C5MB00493D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5MB00493D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5MB00493D%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520BioSystems%26atitle%3DMolecular%252Bdocking%252Bstudies%252Band%252B2D%252Banalyses%252Bof%252BDPP-4%252Binhibitors%252Bas%252Bcandidates%252Bin%252Bthe%252Btreatment%252Bof%252Bdiabetes%26aulast%3DPantale%25C3%25A3o%26aufirst%3DSimone%2BQueiroz%26date%3D2015%26date%3D2015%26volume%3D11%26issue%3D11%26spage%3D3188%26epage%3D3193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xun  Ji</span>, <span class="hlFld-ContribAuthor ">Chunmei  Xia</span>, <span class="hlFld-ContribAuthor ">Jiang  Wang</span>, <span class="hlFld-ContribAuthor ">Mingbo  Su</span>, <span class="hlFld-ContribAuthor ">Lei  Zhang</span>, <span class="hlFld-ContribAuthor ">Tiancheng  Dong</span>, <span class="hlFld-ContribAuthor ">Zeng  Li</span>, <span class="hlFld-ContribAuthor ">Xia  Wan</span>, <span class="hlFld-ContribAuthor ">Jingya  Li</span>, <span class="hlFld-ContribAuthor ">Jia  Li</span>, <span class="hlFld-ContribAuthor ">Linxiang  Zhao</span>, <span class="hlFld-ContribAuthor ">Zhaobing  Gao</span>, <span class="hlFld-ContribAuthor ">Hualiang  Jiang</span>, <span class="hlFld-ContribAuthor ">Hong  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of 4-fluoropyrrolidine-2-carbonitrile and octahydrocyclopenta[b]pyrrole-2-carbonitrile derivatives as dipeptidyl peptidase IV inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>86 </em>, 242-256. <a href="https://doi.org/10.1016/j.ejmech.2014.08.059" title="DOI URL">https://doi.org/10.1016/j.ejmech.2014.08.059</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2014.08.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2014.08.059%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252B4-fluoropyrrolidine-2-carbonitrile%252Band%252Boctahydrocyclopenta%25255Bb%25255Dpyrrole-2-carbonitrile%252Bderivatives%252Bas%252Bdipeptidyl%252Bpeptidase%252BIV%252Binhibitors%26aulast%3DJi%26aufirst%3DXun%26date%3D2014%26volume%3D86%26spage%3D242%26epage%3D256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Junhao  Xing</span>, <span class="hlFld-ContribAuthor ">Qing  Li</span>, <span class="hlFld-ContribAuthor ">Shengping  Zhang</span>, <span class="hlFld-ContribAuthor ">Haomiao  Liu</span>, <span class="hlFld-ContribAuthor ">Leilei  Zhao</span>, <span class="hlFld-ContribAuthor ">Haibo  Cheng</span>, <span class="hlFld-ContribAuthor ">Yuan  Zhang</span>, <span class="hlFld-ContribAuthor ">Jinpei  Zhou</span>, <span class="hlFld-ContribAuthor ">Huibin  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of Dipeptidyl Peptidase
              IV
              Inhibitors: Virtual Screening, Synthesis and Biological Evaluation. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2014,</strong> <em>84 </em>
                                    (3)
                                     , 364-377. <a href="https://doi.org/10.1111/cbdd.12327" title="DOI URL">https://doi.org/10.1111/cbdd.12327</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.12327&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.12327%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DIdentification%252Bof%252BDipeptidyl%252BPeptidase%252BIV%252BInhibitors%25253A%252BVirtual%252BScreening%25252C%252BSynthesis%252Band%252BBiological%252BEvaluation%26aulast%3DXing%26aufirst%3DJunhao%26date%3D2014%26date%3D2014%26volume%3D84%26issue%3D3%26spage%3D364%26epage%3D377" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Atul  Goel</span>, <span class="hlFld-ContribAuthor ">Pankaj  Nag</span>, <span class="hlFld-ContribAuthor ">Neha  Rahuja</span>, <span class="hlFld-ContribAuthor ">Rohit  Srivastava</span>, <span class="hlFld-ContribAuthor ">Sumit  Chaurasia</span>, <span class="hlFld-ContribAuthor ">Sudeep  Gautam</span>, <span class="hlFld-ContribAuthor ">Sharat  Chandra</span>, <span class="hlFld-ContribAuthor ">Mohammad Imran  Siddiqi</span>, <span class="hlFld-ContribAuthor ">Arvind K.  Srivastava</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of biaryl-4-carbonitriles as antihyperglycemic agents that may act through AMPK-p38 MAPK pathway. </span><span class="cited-content_cbyCitation_journal-name">Molecular and Cellular Endocrinology</span><span> <strong>2014,</strong> <em>394 </em>
                                    (1-2)
                                     , 1-12. <a href="https://doi.org/10.1016/j.mce.2014.06.007" title="DOI URL">https://doi.org/10.1016/j.mce.2014.06.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.mce.2014.06.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.mce.2014.06.007%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520and%2520Cellular%2520Endocrinology%26atitle%3DDiscovery%252Bof%252Bbiaryl-4-carbonitriles%252Bas%252Bantihyperglycemic%252Bagents%252Bthat%252Bmay%252Bact%252Bthrough%252BAMPK-p38%252BMAPK%252Bpathway%26aulast%3DGoel%26aufirst%3DAtul%26date%3D2014%26volume%3D394%26issue%3D1-2%26spage%3D1%26epage%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bhumika D.  Patel</span>, <span class="hlFld-ContribAuthor ">Manjunath D.  Ghate</span>. </span><span class="cited-content_cbyCitation_article-title">Recent approaches to medicinal chemistry and therapeutic potential of dipeptidyl peptidase-4 (DPP-4) inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>74 </em>, 574-605. <a href="https://doi.org/10.1016/j.ejmech.2013.12.038" title="DOI URL">https://doi.org/10.1016/j.ejmech.2013.12.038</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2013.12.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2013.12.038%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRecent%252Bapproaches%252Bto%252Bmedicinal%252Bchemistry%252Band%252Btherapeutic%252Bpotential%252Bof%252Bdipeptidyl%252Bpeptidase-4%252B%252528DPP-4%252529%252Binhibitors%26aulast%3DPatel%26aufirst%3DBhumika%2BD.%26date%3D2014%26volume%3D74%26spage%3D574%26epage%3D605" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xun  Ji</span>, <span class="hlFld-ContribAuthor ">Mingbo  Su</span>, <span class="hlFld-ContribAuthor ">Jiang  Wang</span>, <span class="hlFld-ContribAuthor ">Guanghui  Deng</span>, <span class="hlFld-ContribAuthor ">Sisi  Deng</span>, <span class="hlFld-ContribAuthor ">Zeng  Li</span>, <span class="hlFld-ContribAuthor ">Chunlan  Tang</span>, <span class="hlFld-ContribAuthor ">Jingya  Li</span>, <span class="hlFld-ContribAuthor ">Jia  Li</span>, <span class="hlFld-ContribAuthor ">Linxiang  Zhao</span>, <span class="hlFld-ContribAuthor ">Hualiang  Jiang</span>, <span class="hlFld-ContribAuthor ">Hong  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of hetero-aromatic moieties substituted pyrrole-2-carbonitrile derivatives as dipeptidyl peptidase IV inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>75 </em>, 111-122. <a href="https://doi.org/10.1016/j.ejmech.2014.01.021" title="DOI URL">https://doi.org/10.1016/j.ejmech.2014.01.021</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2014.01.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2014.01.021%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bhetero-aromatic%252Bmoieties%252Bsubstituted%252Bpyrrole-2-carbonitrile%252Bderivatives%252Bas%252Bdipeptidyl%252Bpeptidase%252BIV%252Binhibitors%26aulast%3DJi%26aufirst%3DXun%26date%3D2014%26volume%3D75%26spage%3D111%26epage%3D122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiang  Wang</span>, <span class="hlFld-ContribAuthor ">Ying  Feng</span>, <span class="hlFld-ContribAuthor ">Xun  Ji</span>, <span class="hlFld-ContribAuthor ">Guanghui  Deng</span>, <span class="hlFld-ContribAuthor ">Ying  Leng</span>, <span class="hlFld-ContribAuthor ">Hong  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of pyrrolidine-2-carbonitrile and 4-fluoropyrrolidine-2-carbonitrile derivatives as dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2013,</strong> <em>21 </em>
                                    (23)
                                     , 7418-7429. <a href="https://doi.org/10.1016/j.bmc.2013.09.048" title="DOI URL">https://doi.org/10.1016/j.bmc.2013.09.048</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2013.09.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2013.09.048%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bpyrrolidine-2-carbonitrile%252Band%252B4-fluoropyrrolidine-2-carbonitrile%252Bderivatives%252Bas%252Bdipeptidyl%252Bpeptidase-4%252Binhibitors%252Bfor%252Bthe%252Btreatment%252Bof%252Btype%252B2%252Bdiabetes%26aulast%3DWang%26aufirst%3DJiang%26date%3D2013%26volume%3D21%26issue%3D23%26spage%3D7418%26epage%3D7429" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jun  Chen</span>, <span class="hlFld-ContribAuthor ">Hangcheng  Ni</span>, <span class="hlFld-ContribAuthor ">Wenteng  Chen</span>, <span class="hlFld-ContribAuthor ">Guolin  Zhang</span>, <span class="hlFld-ContribAuthor ">Yongping  Yu</span>. </span><span class="cited-content_cbyCitation_article-title">A new strategy for facile synthesis of tetrasubstituted pyridine derivatives. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2013,</strong> <em>69 </em>
                                    (37)
                                     , 8069-8073. <a href="https://doi.org/10.1016/j.tet.2013.06.082" title="DOI URL">https://doi.org/10.1016/j.tet.2013.06.082</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2013.06.082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2013.06.082%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DA%252Bnew%252Bstrategy%252Bfor%252Bfacile%252Bsynthesis%252Bof%252Btetrasubstituted%252Bpyridine%252Bderivatives%26aulast%3DChen%26aufirst%3DJun%26date%3D2013%26volume%3D69%26issue%3D37%26spage%3D8069%26epage%3D8073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Betty  Lam</span>, <span class="hlFld-ContribAuthor ">Zhiyuan  Zhang</span>, <span class="hlFld-ContribAuthor ">Jeffery A.  Stafford</span>, <span class="hlFld-ContribAuthor ">Robert J.  Skene</span>, <span class="hlFld-ContribAuthor ">Lihong  Shi</span>, <span class="hlFld-ContribAuthor ">Stephen L.  Gwaltney</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-based design of pyridopyrimidinediones as dipeptidyl peptidase IV inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2012,</strong> <em>22 </em>
                                    (21)
                                     , 6628-6631. <a href="https://doi.org/10.1016/j.bmcl.2012.08.110" title="DOI URL">https://doi.org/10.1016/j.bmcl.2012.08.110</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2012.08.110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2012.08.110%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DStructure-based%252Bdesign%252Bof%252Bpyridopyrimidinediones%252Bas%252Bdipeptidyl%252Bpeptidase%252BIV%252Binhibitors%26aulast%3DLam%26aufirst%3DBetty%26date%3D2012%26volume%3D22%26issue%3D21%26spage%3D6628%26epage%3D6631" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yohei  Ikuma</span>, <span class="hlFld-ContribAuthor ">Hitoshi  Hochigai</span>, <span class="hlFld-ContribAuthor ">Hidenori  Kimura</span>, <span class="hlFld-ContribAuthor ">Noriko  Nunami</span>, <span class="hlFld-ContribAuthor ">Tomonori  Kobayashi</span>, <span class="hlFld-ContribAuthor ">Katsuya  Uchiyama</span>, <span class="hlFld-ContribAuthor ">Yudai  Furuta</span>, <span class="hlFld-ContribAuthor ">Mutsuko  Sakai</span>, <span class="hlFld-ContribAuthor ">Masakuni  Horiguchi</span>, <span class="hlFld-ContribAuthor ">Yumi  Masui</span>, <span class="hlFld-ContribAuthor ">Kazuhiko  Okazaki</span>, <span class="hlFld-ContribAuthor ">Yasuhiro  Sato</span>, <span class="hlFld-ContribAuthor ">Hiroyuki  Nakahira</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 3H-imidazo[4,5-c]quinolin-4(5H)-ones as potent and selective dipeptidyl peptidase IV (DPP-4) inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2012,</strong> <em>20 </em>
                                    (19)
                                     , 5864-5883. <a href="https://doi.org/10.1016/j.bmc.2012.07.046" title="DOI URL">https://doi.org/10.1016/j.bmc.2012.07.046</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2012.07.046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2012.07.046%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B3H-imidazo%25255B4%25252C5-c%25255Dquinolin-4%2525285H%252529-ones%252Bas%252Bpotent%252Band%252Bselective%252Bdipeptidyl%252Bpeptidase%252BIV%252B%252528DPP-4%252529%252Binhibitors%26aulast%3DIkuma%26aufirst%3DYohei%26date%3D2012%26volume%3D20%26issue%3D19%26spage%3D5864%26epage%3D5883" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiaan  Shao</span>, <span class="hlFld-ContribAuthor ">Wanwan  Yu</span>, <span class="hlFld-ContribAuthor ">Zhanying  Shao</span>, <span class="hlFld-ContribAuthor ">Yongping  Yu</span>. </span><span class="cited-content_cbyCitation_article-title">A “one-pot” multicomponent approach to polysubstituted 4-aminopyridines. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2012,</strong> <em>48 </em>
                                    (22)
                                     , 2785. <a href="https://doi.org/10.1039/c2cc17850h" title="DOI URL">https://doi.org/10.1039/c2cc17850h</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/c2cc17850h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2Fc2cc17850h%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DA%252B%2525E2%252580%25259Cone-pot%2525E2%252580%25259D%252Bmulticomponent%252Bapproach%252Bto%252Bpolysubstituted%252B4-aminopyridines%26aulast%3DShao%26aufirst%3DJiaan%26date%3D2012%26volume%3D48%26issue%3D22%26spage%3D2785" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Noriyasu  Kato</span>, <span class="hlFld-ContribAuthor ">Mitsuru  Oka</span>, <span class="hlFld-ContribAuthor ">Takayo  Murase</span>, <span class="hlFld-ContribAuthor ">Masahiro  Yoshida</span>, <span class="hlFld-ContribAuthor ">Masao  Sakairi</span>, <span class="hlFld-ContribAuthor ">Satoko  Yamashita</span>, <span class="hlFld-ContribAuthor ">Yoshika  Yasuda</span>, <span class="hlFld-ContribAuthor ">Aya  Yoshikawa</span>, <span class="hlFld-ContribAuthor ">Yuuji  Hayashi</span>, <span class="hlFld-ContribAuthor ">Mitsuhiro  Makino</span>, <span class="hlFld-ContribAuthor ">Motohiro  Takeda</span>, <span class="hlFld-ContribAuthor ">Yakufu  Mirensha</span>, <span class="hlFld-ContribAuthor ">Takuji  Kakigami</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and pharmacological characterization of N-[2-({2-[(2S)-2-cyanopyrrolidin-1-yl]-2-oxoethyl}amino)-2-methylpropyl]-2-methylpyrazolo[1,5-a]pyrimidine-6-carboxamide hydrochloride (anagliptin hydrochloride salt) as a potent and selective DPP-IV inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2011,</strong> <em>19 </em>
                                    (23)
                                     , 7221-7227. <a href="https://doi.org/10.1016/j.bmc.2011.09.043" title="DOI URL">https://doi.org/10.1016/j.bmc.2011.09.043</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2011.09.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2011.09.043%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252Bpharmacological%252Bcharacterization%252Bof%252BN-%25255B2-%252528%25257B2-%25255B%2525282S%252529-2-cyanopyrrolidin-1-yl%25255D-2-oxoethyl%25257Damino%252529-2-methylpropyl%25255D-2-methylpyrazolo%25255B1%25252C5-a%25255Dpyrimidine-6-carboxamide%252Bhydrochloride%252B%252528anagliptin%252Bhydrochloride%252Bsalt%252529%252Bas%252Ba%252Bpotent%252Band%252Bselective%252BDPP-IV%252Binhibitor%26aulast%3DKato%26aufirst%3DNoriyasu%26date%3D2011%26volume%3D19%26issue%3D23%26spage%3D7221%26epage%3D7227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-3/jm101236h/production/images/medium/jm-2010-01236h_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-3/jm101236h/production/images/large/jm-2010-01236h_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101236h&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-3/jm101236h/production/images/medium/jm-2010-01236h_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-3/jm101236h/production/images/large/jm-2010-01236h_0016.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structure of compound <b>1</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-3/jm101236h/production/images/large/jm-2010-01236h_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101236h&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-3/jm101236h/production/images/medium/jm-2010-01236h_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-3/jm101236h/production/images/large/jm-2010-01236h_0017.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Docking study of DPP-4 protein and compound <b>1</b> (blue carbon). The amino acids (orange carbons, white text) and binding sites (red text) are indicated. The important pharmacophore is indicated by the square of red dotted lines. The hydrogen bonds are shown as yellow dotted lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-3/jm101236h/production/images/large/jm-2010-01236h_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101236h&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-3/jm101236h/production/images/medium/jm-2010-01236h_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-3/jm101236h/production/images/large/jm-2010-01236h_0018.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Design of novel quinoline derivatives possessing a carboxy group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-3/jm101236h/production/images/large/jm-2010-01236h_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101236h&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-3/jm101236h/production/images/medium/jm-2010-01236h_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-3/jm101236h/production/images/large/jm-2010-01236h_0019.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Design for reducing the conjugation of the molecule.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-3/jm101236h/production/images/large/jm-2010-01236h_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101236h&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-3/jm101236h/production/images/medium/jm-2010-01236h_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-3/jm101236h/production/images/large/jm-2010-01236h_0020.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compounds <b>6</b> and <b>9</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-3/jm101236h/production/images/large/jm-2010-01236h_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101236h&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) triphosgene, THF, reflux, 2 h; (b) <i>N</i>,<i>O</i>-dimethyl hydroxylamine hydrochloride, Et<sub>3</sub>N, EtOH, reflux, 2 h; (c) 4-Me-C<sub>6</sub>H<sub>4</sub>−MgBr, THF, Et<sub>2</sub>O, 0 °C, 30 min; (d) <b>11A</b>, MsOH, toluene, reflux, Dean−Stark, 17 h; (e) (1) <i>tert</i>-BuOH, <i>tert</i>-BuONa, racemic BINAP, Pd(OAc)<sub>2</sub>, toluene, 70 °C, 15 h; (2) TFA, THF, rt, 4 h; (f) (1) H<sub>2</sub>, Raney-Ni, 25% NH<sub>3</sub>, MeOH, 70 °C, 8 h; (2) (Boc)<sub>2</sub>O, THF, rt, 3 h; (g) NaH, <i>N</i>-phenyl bis(trifluoromethanesulfonimide), DMF, rt, 30 min; (h) NaH, MeCN, THF, reflux, 15 h.</p></p></figure><figure data-id="sch2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-3/jm101236h/production/images/medium/jm-2010-01236h_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-3/jm101236h/production/images/large/jm-2010-01236h_0001.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compounds <b>17a</b>−<b>d</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-3/jm101236h/production/images/large/jm-2010-01236h_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101236h&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, ethyl acrylate, Et<sub>3</sub>N, DMF, 70 °C, 6 h; (b) acrolein, Pd(OAc)<sub>2</sub>, BnEt<sub>3</sub>NCl, DMF, 70 °C, 20 h; (c) NaBH<sub>4</sub>, THF, MeOH, 0 °C, 10 min; (d) H<sub>2</sub>, Raney-Ni, 25% NH<sub>3</sub>, MeOH, 70 °C, 3 h; (e) (Boc)<sub>2</sub>O, THF, rt, 1−3 h; (f) MsCl, Et<sub>3</sub>N, DMF, 0 °C, 30 min; (g) KCN, DMSO, 60 °C, 1.5 h; (h) NaH, (EtO)<sub>2</sub>P(O)CH<sub>2</sub>COOEt, THF, rt, 10 min; (i) 5-cyano-1-pentyne, PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, Et<sub>3</sub>N, CuI, THF, 80 °C, 10 min; (j) H<sub>2</sub>, Pd/C, EtOH, THF, rt, 2−3.5 h; (k) 1 or 2 M NaOH, THF, rt, 40 min−4 h; (l) 4 M HCl in AcOEt or dioxane, rt, 20 min−4 h; (m) 2 M NaOH, EtOH, reflux, 6−13 h; (n) (1) H<sub>2</sub>, Raney-Ni, 25% NH<sub>3</sub>, DMA, rt, 4 h; (2) H<sub>2</sub>, Raney-Ni, 25% NH<sub>3</sub>, MeOH, rt, 3 h.</p></p></figure><figure data-id="sch3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-3/jm101236h/production/images/medium/jm-2010-01236h_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-3/jm101236h/production/images/large/jm-2010-01236h_0002.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Compounds <b>27a</b>−<b>i</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-3/jm101236h/production/images/large/jm-2010-01236h_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101236h&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NaH, MeCN, THF, reflux, 8−15 h; (b) <i>p</i>-tolualdehyde, piperidine, AcOH, toluene, reflux, Dean−Stark, 5−8 h; (c) 25% NH<sub>3</sub>, MeOH, rt, 15 h; (d) R<sup>2</sup>COCl, CH<sub>2</sub>Cl<sub>2</sub>, rt; (e) (1) <i>tert</i>-BuOH, toluene, reflux, 6 h; (2) 25% NH<sub>3</sub>, MeOH, rt, 12 h; (f) AcOH, 80 °C, 1 h; (g) CAN, H<sub>2</sub>O, acetone, rt, 30 min; (h) H<sub>2</sub>, Raney-Ni, 25% NH<sub>3</sub>, MeOH, 40 °C, 6 h; (i) (Boc)<sub>2</sub>O, THF, rt, 1 h; (j) TFA, rt, 4 h; (k) (1) 1 M NaOH, THF, MeOH, rt, 15−72 h; (2) 4 M HCl in AcOEt or dioxane, 2 h.</p></p></figure><figure data-id="sch4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-3/jm101236h/production/images/medium/jm-2010-01236h_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-3/jm101236h/production/images/large/jm-2010-01236h_0003.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Compounds <b>30a</b>−<b>c</b>, <b>32</b> and <b>33</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-3/jm101236h/production/images/large/jm-2010-01236h_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101236h&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (1) DIBAL-H, toluene, −78 °C, 0.5−2 h; (2) (Boc)<sub>2</sub>O, THF, rt, 1 h; (b) (1) MsCl, Et<sub>3</sub>N, THF, 0 °C, 30 min; (2) TMSCN, TBAF, THF, rt, 1 h; (c) (1) 6 M HCl, reflux, 20−24 h; (2) (Boc)<sub>2</sub>O, AcOEt, 8 M NaOH, rt, 1−17 h; (3) 4 M HCl in dioxane, rt, 2−3 h; (d) (1) 6 M HCl, reflux, 24 h; (2) (Boc)<sub>2</sub>O, AcOEt, 8 M NaOH, rt, 1 h; (3) 6 M HCl, rt, 3 h; (4) 1 M NaOH, 5 °C, 1 h; (e) (1) MnO<sub>2</sub>, THF, rt, 19 h; (2) (EtO)<sub>2</sub>P(O)CH<sub>2</sub>CO<sub>2</sub>Et, NaH, THF, rt, 45 min; (f) 1 M NaOH, THF, 60 °C, 12 h; (g) 4 M HCl, dioxane, rt, 15 min; (h) H<sub>2</sub> (0.5 MPa), Pd/C, EtOH, 1 h.</p></p></figure><figure data-id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-3/jm101236h/production/images/medium/jm-2010-01236h_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-3/jm101236h/production/images/large/jm-2010-01236h_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. A docking study of DPP-4 protein and compound <b>17d</b> (blue carbons). The amino acids (orange carbons, white text) are indicated. The hydrogen bonds are shown as yellow dotted lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-3/jm101236h/production/images/large/jm-2010-01236h_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101236h&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-3/jm101236h/production/images/medium/jm-2010-01236h_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-3/jm101236h/production/images/large/jm-2010-01236h_0008.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. X-ray structure of compound <b>27c</b> (blue carbons) in a complex with human DPP-4. The amino acids (orange carbons, white text) are indicated. The hydrogen bonds are shown as yellow dotted lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-3/jm101236h/production/images/large/jm-2010-01236h_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101236h&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-3/jm101236h/production/images/medium/jm-2010-01236h_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-3/jm101236h/production/images/large/jm-2010-01236h_0012.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. X-ray structure of compound <b>30c</b> (green carbons) in a complex with human DPP-4. The amino acids (orange carbons, white text) are indicated. The hydrogen bonds are shown as yellow dotted lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-3/jm101236h/production/images/large/jm-2010-01236h_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101236h&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-3/jm101236h/production/images/medium/jm-2010-01236h_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-3/jm101236h/production/images/large/jm-2010-01236h_0013.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Ex vivo study of compound <b>30c</b> in dogs. Compound <b>30c</b> was dissolved in a 0.5% suspension of methylcellulose. Five dogs (age, 28−42 months) were orally administered the suspension at the dose of 0.5 mg/kg. Blood samples were collected from the cephalic vein before (0 h) and 0.5, 1, 2, 4, 6, 8, and 24 h after dosing. Plasma sample was prepared from each of the blood samples, and the residual DPP-4 activity was measured by a method similar to that described in the <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-3/jm101236h/production/images/large/jm-2010-01236h_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101236h&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-3/jm101236h/production/images/medium/jm-2010-01236h_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-3/jm101236h/production/images/large/jm-2010-01236h_0014.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Effects of <b>30c</b> on plasma glucose (A), plasma immunoreactive insulin (IRI) (B), baseline (0 min)-adjusted AUC<sub>0−60min</sub> of plasma glucose levels (C), and plasma IRI levels at 10 min after the oral glucose load (D) in glucose tolerance test of female Wistar fatty rats. These studies were conducted using monohydrate of compound <b>30c</b>. Doses are normalized to reflect the amount of free base administered. Values are the mean and SD (<i>n</i> = 6): (*) <i>p</i> ≤ 0.025 vs control by one-tailed Williams test; ($) <i>p</i> ≤ 0.025 vs control by one-tailed Shirley−Williams test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-3/jm101236h/production/images/large/jm-2010-01236h_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101236h&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i106">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27137" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27137" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 24 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Gorrell, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gysbers, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCaughan, G. W.</span><span> </span><span class="NLM_article-title">CD26: A multifunctional integral membrane and secreted protein of activated lymphocytes</span> <span class="citation_source-journal">Scand. J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">249</span><span class="NLM_x">–</span> <span class="NLM_lpage">264</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Fjm101236h&amp;key=10.1046%2Fj.1365-3083.2001.00984.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Fjm101236h&amp;key=11555388" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Fjm101236h&amp;key=1%3ACAS%3A528%3ADC%252BD3MXnt1Sru7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2001&pages=249-264&author=M.+D.+Gorrellauthor=V.+Gysbersauthor=G.+W.+McCaughan&title=CD26%3A+A+multifunctional+integral+membrane+and+secreted+protein+of+activated+lymphocytes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">CD26: a multifunctional integral membrane and secreted protein of activated lymphocytes</span></div><div class="casAuthors">Gorrell, M. D.; Gysbers, V.; McCaughan, G. W.</div><div class="citationInfo"><span class="NLM_cas:title">Scandinavian Journal of Immunology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">249-264</span>CODEN:
                <span class="NLM_cas:coden">SJIMAX</span>;
        ISSN:<span class="NLM_cas:issn">0300-9475</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">A review.  CD26 has proved interesting in the fields of immunol., endocrinol., cancer biol. and nutrition owing to its ubiquitous and unusual enzyme activity.  This dipeptidyl aminopeptidase (DPP IV) activity generally inactivates but sometimes alters or enhances the biol. activities of its peptide substrates, which include several chemokines.  CD26 costimulates both the CD3 and the CD2 dependent T-cell activation and tyrosine phosphorylation of TCR/CD3 signal transduction pathway proteins.  CD26 in vivo has integral membrane protein and sol. forms.  Sol. CD26 is at significant levels in serum, these levels alter in many diseases and sol. CD26 can modulate in vitro T-cell proliferation.  CD26, being an adenosine deaminase binding protein (ADAbp), functions as a receptor for ADA on lymphocytes.  The focus of this review is the structure and function of CD26 and the influence of its ligand binding activity on T-cell proliferation and the T cell costimulatory activity of CD26.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBV_U3MaLyFbVg90H21EOLACvtfcHk0lhdwa08L7Wrvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXnt1Sru7c%253D&md5=caa68f661699756a7cbce01dfe5c76e3</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1046%2Fj.1365-3083.2001.00984.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1365-3083.2001.00984.x%26sid%3Dliteratum%253Aachs%26aulast%3DGorrell%26aufirst%3DM.%2BD.%26aulast%3DGysbers%26aufirst%3DV.%26aulast%3DMcCaughan%26aufirst%3DG.%2BW.%26atitle%3DCD26%253A%2520A%2520multifunctional%2520integral%2520membrane%2520and%2520secreted%2520protein%2520of%2520activated%2520lymphocytes%26jtitle%3DScand.%2520J.%2520Immunol.%26date%3D2001%26volume%3D54%26spage%3D249%26epage%3D264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Meester, I. De; Durinx, C.; Proost, P.; Scharpe, S.; Lambier, A. M</span>. In  <span class="citation_source-book">Ectopeptidases: CD13/Aminopeptidase N and CD26/Dipeptidylpeptidase IV in Medicine and Biology</span>; <span class="NLM_contrib-group">Langner, J.; Ansore, S.</span>; Eds.; <span class="NLM_publisher-name">Kluwer Academic/Pleneu Publisher</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2002</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">223</span>− <span class="NLM_lpage">257</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Fjm101236h&amp;key=10.1007%2F978-1-4615-0619-5_9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&pages=223-257&author=I.+De+Meester&author=C.+Durinx&author=P.+Proost&author=S.+Scharpe&author=A.+M+Lambierauthor=J.+Langner&author=S.+Ansore&title=Ectopeptidases%3A+CD13%2FAminopeptidase+N+and+CD26%2FDipeptidylpeptidase+IV+in+Medicine+and+Biology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1007%2F978-1-4615-0619-5_9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-1-4615-0619-5_9%26sid%3Dliteratum%253Aachs%26aulast%3DMeester%26aufirst%3DI.%2BDe%26btitle%3DEctopeptidases%253A%2520CD13%252FAminopeptidase%2520N%2520and%2520CD26%252FDipeptidylpeptidase%2520IV%2520in%2520Medicine%2520and%2520Biology%26aulast%3DLangner%26aufirst%3DJ.%26pub%3DKluwer%2520Academic%252FPleneu%2520Publisher%26date%3D2002%26spage%3D223%26epage%3D257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Mentlein, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballwitz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, W. E.</span><span> </span><span class="NLM_article-title">Dipeptidylpeptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1 (7−36) amide, peptide histidine methionine and is responsible for their degradation in human serum</span> <span class="citation_source-journal">Eur. J. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">214</span><span class="NLM_x">, </span> <span class="NLM_fpage">829</span><span class="NLM_x">–</span> <span class="NLM_lpage">835</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Fjm101236h&amp;key=10.1111%2Fj.1432-1033.1993.tb17986.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=8&amp;doi=10.1021%2Fjm101236h&amp;key=8100523" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Fjm101236h&amp;key=1%3ACAS%3A528%3ADyaK3sXks1elsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=214&publication_year=1993&pages=829-835&author=R.+Mentleinauthor=B.+Ballwitzauthor=W.+E.+Schmidt&title=Dipeptidylpeptidase+IV+hydrolyses+gastric+inhibitory+polypeptide%2C+glucagon-like+peptide-1+%287%E2%88%9236%29+amide%2C+peptide+histidine+methionine+and+is+responsible+for+their+degradation+in+human+serum"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2a</span><div class="casTitle"><span class="NLM_cas:atitle">Dipeptidyl-peptidase IV hydrolyzes gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum</span></div><div class="casAuthors">Mentlein, Rolf; Gallwitz, Baptist; Schmidt, Wolfgang E.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">214</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">829-35</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    </div><div class="casAbstract">Peptides of the glucagon/VIP family share a considerable sequence similarity at their N-terminus.  They either start with Tyr-Ala, His-Ala or His-Ser which might be in part potential targets for dipeptidyl-peptidase IV, a highly specialized aminopeptidase removing dipeptides only from peptides with N-terminal penultimate proline or alanine.  GH-releasing factor(1-29)amide and gastric inhibitory peptide/glucose-dependent insulinotropic peptide (GIP) with terminal Tyr-Ala as well as glucagon-like peptide-1(7-36)amide/insulinotropin [GLP-1(7-36)amide] and peptide histidine methionine (PHM) with terminal His-Ala were hydrolyzed to their des-Xaa-Ala derivs. by dipeptidyl-peptidase IV purified from human placenta.  VIP with terminal His-Ser was not degraded by the peptidase.  The kinetics of the hydrolysis of GIP, GLP-1(7-36)amide and PHM were analyzed in detail.  For these peptides Km values of 4-34 μM and Vmax values of 0.6-3.8 μmol/min/mg protein were detd. for the purified peptidase which should allow their enzymic degrdn. also at physiol., nanomolar concns.  When human serum was incubated with GIP or GLP-1(7-36)amide the same fragments as with the purified dipeptidyl-peptidase IV, namely the des-Xaa-Ala peptides and Tyr-Ala in the case of GIP or His-Ala in the case of GLP-1(7-36)amide, were identified as the main degrdn. products of these peptide hormones.  Incorporation of inhibitors specific for dipeptidyl-peptidase IV, 1 mM Lys-pyrrolidide or 0.1 mM diprotin A (Ile-Pro-Ile), completely abolished the prodn. of these fragments by serum.  It is concluded that dipeptidyl-peptidase IV initiates the metab. of GIP and GLP-1(7-36)amide in human serum.  Since an intact N-terminus is obligate for the biol. activity of the members of the glucagon/VIP peptide family [e.g., GIP(3-42) is known to be inactive to release insulin in the presence of glucose as is intact GIP], dipeptidyl-peptidase-IV action inactivates these peptide hormones.  The relevance of this finding for their inactivation and their detn. by immunoassays is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaIzMbUUoh9LVg90H21EOLACvtfcHk0lhdwa08L7Wrvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXks1elsLs%253D&md5=dd06411585d4e8bb42d5b093e895b900</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1111%2Fj.1432-1033.1993.tb17986.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1432-1033.1993.tb17986.x%26sid%3Dliteratum%253Aachs%26aulast%3DMentlein%26aufirst%3DR.%26aulast%3DBallwitz%26aufirst%3DB.%26aulast%3DSchmidt%26aufirst%3DW.%2BE.%26atitle%3DDipeptidylpeptidase%2520IV%2520hydrolyses%2520gastric%2520inhibitory%2520polypeptide%252C%2520glucagon-like%2520peptide-1%2520%25287%25E2%2588%259236%2529%2520amide%252C%2520peptide%2520histidine%2520methionine%2520and%2520is%2520responsible%2520for%2520their%2520degradation%2520in%2520human%2520serum%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D1993%26volume%3D214%26spage%3D829%26epage%3D835" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kieffer, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntosh, C. H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pederson, T. A.</span><span> </span><span class="NLM_article-title">Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">136</span><span class="NLM_x">, </span> <span class="NLM_fpage">3585</span><span class="NLM_x">–</span> <span class="NLM_lpage">3596</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=1995&pages=3585-3596&author=T.+J.+Kiefferauthor=C.+H.+S.+McIntoshauthor=T.+A.+Pederson&title=Degradation+of+glucose-dependent+insulinotropic+polypeptide+and+truncated+glucagon-like+peptide+1+in+vitro+and+in+vivo+by+dipeptidyl+peptidase+IV"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKieffer%26aufirst%3DT.%2BJ.%26aulast%3DMcIntosh%26aufirst%3DC.%2BH.%2BS.%26aulast%3DPederson%26aufirst%3DT.%2BA.%26atitle%3DDegradation%2520of%2520glucose-dependent%2520insulinotropic%2520polypeptide%2520and%2520truncated%2520glucagon-like%2520peptide%25201%2520in%2520vitro%2520and%2520in%2520vivo%2520by%2520dipeptidyl%2520peptidase%2520IV%26jtitle%3DEndocrinology%26date%3D1995%26volume%3D136%26spage%3D3585%26epage%3D3596" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Vilsbøll, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knop, F. K.</span><span> </span><span class="NLM_article-title">DPP IV inhibitors-current evidence and future directions</span> <span class="citation_source-journal">Br. J. Diabetes Vasc. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">69</span><span class="NLM_x">–</span> <span class="NLM_lpage">74</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Fjm101236h&amp;key=10.1177%2F14746514070070020401" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=69-74&author=T.+Vilsb%C3%B8llauthor=F.+K.+Knop&title=DPP+IV+inhibitors-current+evidence+and+future+directions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1177%2F14746514070070020401&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F14746514070070020401%26sid%3Dliteratum%253Aachs%26aulast%3DVilsb%25C3%25B8ll%26aufirst%3DT.%26aulast%3DKnop%26aufirst%3DF.%2BK.%26atitle%3DDPP%2520IV%2520inhibitors-current%2520evidence%2520and%2520future%2520directions%26jtitle%3DBr.%2520J.%2520Diabetes%2520Vasc.%2520Dis.%26date%3D2007%26volume%3D7%26spage%3D69%26epage%3D74" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Wiedeman, P. E.</span><span> </span><span class="NLM_article-title">DPPIV inhibition: Promising therapy for the treatment of type 2 diabetes</span> <span class="citation_source-journal">Prog. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">63</span><span class="NLM_x">–</span> <span class="NLM_lpage">109</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Fjm101236h&amp;key=10.1016%2FS0079-6468%2806%2945502-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=8&amp;doi=10.1021%2Fjm101236h&amp;key=17280902" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Fjm101236h&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1Wltbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2007&pages=63-109&author=P.+E.+Wiedeman&title=DPPIV+inhibition%3A+Promising+therapy+for+the+treatment+of+type+2+diabetes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3b</span><div class="casTitle"><span class="NLM_cas:atitle">DPPIV inhibition: promising therapy for the treatment of type 2 diabetes</span></div><div class="casAuthors">Wiedeman, Paul E.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">63-109</span>CODEN:
                <span class="NLM_cas:coden">PMDCAY</span>;
        ISSN:<span class="NLM_cas:issn">0079-6468</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review on dipeptidyl peptidase IV (DPPIV) inhibition as a promising therapy for the treatment of type 2 diabetes.  The prevalence of type 2 diabetes is discussed, along with inhibition of DPPIV as a strategy to enhance the incretin effect, potential for disease modification with DPPIV inhibitors, importance of DPPIV selectivity, and structural biol. of DPPIV.  The medicinal chem. and preclin. studies on DPPIV inhibitors are also considered, together with clin. data for oral DPPIV inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrof7HCUTdzTLVg90H21EOLACvtfcHk0ljqOpcFsXduJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1Wltbo%253D&md5=42622df89ac83d586bb6bcfc0e184da9</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.1016%2FS0079-6468%2806%2945502-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0079-6468%252806%252945502-8%26sid%3Dliteratum%253Aachs%26aulast%3DWiedeman%26aufirst%3DP.%2BE.%26atitle%3DDPPIV%2520inhibition%253A%2520Promising%2520therapy%2520for%2520the%2520treatment%2520of%2520type%25202%2520diabetes%26jtitle%3DProg.%2520Med.%2520Chem.%26date%3D2007%26volume%3D45%26spage%3D63%26epage%3D109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Ahrén, B.</span><span> </span><span class="NLM_article-title">Emerging dipeptidyl peptidase-4 inhibitors for the treatment of diabetes</span> <span class="citation_source-journal">Expert Opin. Emerging Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">593</span><span class="NLM_x">–</span> <span class="NLM_lpage">607</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=16&amp;doi=10.1021%2Fjm101236h&amp;key=10.1517%2F14728210802584126" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=8&amp;doi=10.1021%2Fjm101236h&amp;key=19046129" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=32&amp;doi=10.1021%2Fjm101236h&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVCnurjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2008&pages=593-607&issue=4&author=B.+Ahr%C3%A9n&title=Emerging+dipeptidyl+peptidase-4+inhibitors+for+the+treatment+of+diabetes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3cR"><div class="casContent"><span class="casTitleNuber">3c</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging dipeptidyl peptidase-4 inhibitors for the treatment of diabetes</span></div><div class="casAuthors">Ahren, Bo</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Emerging Drugs</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">593-607</span>CODEN:
                <span class="NLM_cas:coden">EOEDA3</span>;
        ISSN:<span class="NLM_cas:issn">1472-8214</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Inhibition of dipeptidyl peptidase-4 (DPP-4) prevents the inactivation of glucagon-like peptide-1 (GLP-1).  This increases circulating levels of active GLP-1, stimulates insulin secretion and inhibits glucagon secretion, resulting in lowering of glucose levels and improvement of glycemic control in patients with type 2 diabetes.  Several DPP-4 inhibitors are emerging for therapeutic use.  Most experience exists for sitagliptin, vildagliptin, saxagliptin and alogliptin.  They all improve metabolic control in type 2 diabetes in monotherapy and in combination therapy with metformin, sulfonylurea and thiazolidinediones.  Vildagliptin and alogliptin have also been shown to improve glycemic control when added to insulin therapy, and sitagliptin improves glycemic control in triple therapy with metformin plus thiazolidinedione.  DPP-4 inhibition also shows a favorable safety profile, high tolerability, only a minimal risk of hypoglycemia, and body-wt. neutrality.  The main clin. indication for DPP-4 inhibitors will be in the early stage of type 2 diabetes, in combination with metformin or other treatments in subjects with inadequate glycemic control on these treatments alone.  The durability and long-term safety of DPP-4 inhibition, as well as clin. positioning in relation to GLP-1 mimetics, remain now to be established.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoc18qdMIDGU7Vg90H21EOLACvtfcHk0ljqOpcFsXduJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVCnurjE&md5=47f973c7343e215dd6d06e770936f5ba</span></div><a href="/servlet/linkout?suffix=cit3c&amp;dbid=16384&amp;doi=10.1517%2F14728210802584126&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728210802584126%26sid%3Dliteratum%253Aachs%26aulast%3DAhr%25C3%25A9n%26aufirst%3DB.%26atitle%3DEmerging%2520dipeptidyl%2520peptidase-4%2520inhibitors%2520for%2520the%2520treatment%2520of%2520diabetes%26jtitle%3DExpert%2520Opin.%2520Emerging%2520Drugs%26date%3D2008%26volume%3D13%26issue%3D4%26spage%3D593%26epage%3D607" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Drucker, D. J.</span><span> </span><span class="NLM_article-title">Dipeptidyl peptidase-4 inhibition and the treatment of type 2 diabetes. Preclinical biology and mechanisms of action</span> <span class="citation_source-journal">Diabetes Care</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">1335</span><span class="NLM_x">–</span> <span class="NLM_lpage">1343</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2007&pages=1335-1343&issue=6&author=D.+J.+Drucker&title=Dipeptidyl+peptidase-4+inhibition+and+the+treatment+of+type+2+diabetes.+Preclinical+biology+and+mechanisms+of+action"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDrucker%26aufirst%3DD.%2BJ.%26atitle%3DDipeptidyl%2520peptidase-4%2520inhibition%2520and%2520the%2520treatment%2520of%2520type%25202%2520diabetes.%2520Preclinical%2520biology%2520and%2520mechanisms%2520of%2520action%26jtitle%3DDiabetes%2520Care%26date%3D2007%26volume%3D30%26issue%3D6%26spage%3D1335%26epage%3D1343" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Ahrén, B.</span><span> </span><span class="NLM_article-title">Dipeptidyl Peptidase-4 Inhibitors. Clinical data and clinical implications</span> <span class="citation_source-journal">Diabetes Care</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">1344</span><span class="NLM_x">–</span> <span class="NLM_lpage">1350</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2007&pages=1344-1350&issue=6&author=B.+Ahr%C3%A9n&title=Dipeptidyl+Peptidase-4+Inhibitors.+Clinical+data+and+clinical+implications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAhr%25C3%25A9n%26aufirst%3DB.%26atitle%3DDipeptidyl%2520Peptidase-4%2520Inhibitors.%2520Clinical%2520data%2520and%2520clinical%2520implications%26jtitle%3DDiabetes%2520Care%26date%3D2007%26volume%3D30%26issue%3D6%26spage%3D1344%26epage%3D1350" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Kim, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beconi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eiermann, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickey, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kowalchick, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leiting, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyons, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marisilio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCann, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scapin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roy, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyvratt, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thornberry, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, A. E.</span><span> </span><span class="NLM_article-title">(2<i>R</i>)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-<i>a</i>]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine: A potent, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">141</span><span class="NLM_x">–</span> <span class="NLM_lpage">151</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0493156" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=141-151&author=D.+Kimauthor=L.+Wangauthor=M.+Beconiauthor=G.+J.+Eiermannauthor=M.+H.+Fisherauthor=H.+Heauthor=G.+J.+Hickeyauthor=J.+E.+Kowalchickauthor=B.+Leitingauthor=K.+Lyonsauthor=F.+Marisilioauthor=M.+E.+McCannauthor=R.+A.+Patelauthor=A.+Petrovauthor=G.+Scapinauthor=S.+B.+Patelauthor=R.+S.+Royauthor=J.+K.+Wuauthor=M.+J.+Wyvrattauthor=B.+B.+Zhangauthor=L.+Zhuauthor=N.+A.+Thornberryauthor=A.+E.+Weber&title=%282R%29-4-Oxo-4-%5B3-%28trifluoromethyl%29-5%2C6-dihydro%5B1%2C2%2C4%5Dtriazolo%5B4%2C3-a%5Dpyrazin-7%288H%29-yl%5D-1-%282%2C4%2C5-trifluorophenyl%29butan-2-amine%3A+A+potent%2C+orally+active+dipeptidyl+peptidase+IV+inhibitor+for+the+treatment+of+type+2+diabetes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1021%2Fjm0493156&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0493156%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DBeconi%26aufirst%3DM.%26aulast%3DEiermann%26aufirst%3DG.%2BJ.%26aulast%3DFisher%26aufirst%3DM.%2BH.%26aulast%3DHe%26aufirst%3DH.%26aulast%3DHickey%26aufirst%3DG.%2BJ.%26aulast%3DKowalchick%26aufirst%3DJ.%2BE.%26aulast%3DLeiting%26aufirst%3DB.%26aulast%3DLyons%26aufirst%3DK.%26aulast%3DMarisilio%26aufirst%3DF.%26aulast%3DMcCann%26aufirst%3DM.%2BE.%26aulast%3DPatel%26aufirst%3DR.%2BA.%26aulast%3DPetrov%26aufirst%3DA.%26aulast%3DScapin%26aufirst%3DG.%26aulast%3DPatel%26aufirst%3DS.%2BB.%26aulast%3DRoy%26aufirst%3DR.%2BS.%26aulast%3DWu%26aufirst%3DJ.%2BK.%26aulast%3DWyvratt%26aufirst%3DM.%2BJ.%26aulast%3DZhang%26aufirst%3DB.%2BB.%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DThornberry%26aufirst%3DN.%2BA.%26aulast%3DWeber%26aufirst%3DA.%2BE.%26atitle%3D%25282R%2529-4-Oxo-4-%255B3-%2528trifluoromethyl%2529-5%252C6-dihydro%255B1%252C2%252C4%255Dtriazolo%255B4%252C3-a%255Dpyrazin-7%25288H%2529-yl%255D-1-%25282%252C4%252C5-trifluorophenyl%2529butan-2-amine%253A%2520A%2520potent%252C%2520orally%2520active%2520dipeptidyl%2520peptidase%2520IV%2520inhibitor%2520for%2520the%2520treatment%2520of%2520type%25202%2520diabetes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D141%26epage%3D151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Gallwitz, B.</span><span> </span><span class="NLM_article-title">Review of sitagliptin phosphate: a novel treatment for type 2 diabetes</span> <span class="citation_source-journal">Vasc. Health. Risk Manage.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">203</span><span class="NLM_x">–</span> <span class="NLM_lpage">210</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm101236h&amp;key=10.2147%2Fvhrm.2007.3.2.203" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm101236h&amp;key=17580730" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm101236h&amp;key=1%3ACAS%3A528%3ADC%252BD2sXntFOmt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2007&pages=203-210&author=B.+Gallwitz&title=Review+of+sitagliptin+phosphate%3A+a+novel+treatment+for+type+2+diabetes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Review of sitagliptin phosphate: a novel treatment for type 2 diabetes</span></div><div class="casAuthors">Gallwitz, Baptist</div><div class="citationInfo"><span class="NLM_cas:title">Vascular Health and Risk Management</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">203-210</span>CODEN:
                <span class="NLM_cas:coden">VHRMAT</span>;
        ISSN:<span class="NLM_cas:issn">1176-6344</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press (NZ) Ltd.</span>)
        </div><div class="casAbstract">A review.  Sitagliptin (Januvia, Merck Pharmaceuticals) is a dipeptidyl-peptidase inhibitor (DPP-4 inhibitor) that has recently been approved for the therapy of type 2 diabetes.  Like other DPP-4 inhibitors its action is mediated by increasing levels of the incretin hormones glucagon-like peptide-1 (GLP-1) and gastric inhibitory polypeptide (GIP).  Sitagliptin is effective in lowering HbA1c, and fasting as well as postprandial glucose in monotherapy and in combination with other oral antidiabetic agents.  It stimulates insulin secretion when hyperglycemia is present and inhibits glucagon secretion.  In clin. studies it is wt. neutral.  This article gives an overview of the mechanism of action, the pharmacol., and the clin. efficacy and safety of Sitagliptin in type 2 diabetes therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpX7u730i9-AbVg90H21EOLACvtfcHk0lg3cZWfdJEQoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXntFOmt74%253D&md5=7cc00fceff9c5fac317be5c83b74d8b2</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.2147%2Fvhrm.2007.3.2.203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252Fvhrm.2007.3.2.203%26sid%3Dliteratum%253Aachs%26aulast%3DGallwitz%26aufirst%3DB.%26atitle%3DReview%2520of%2520sitagliptin%2520phosphate%253A%2520a%2520novel%2520treatment%2520for%2520type%25202%2520diabetes%26jtitle%3DVasc.%2520Health.%2520Risk%2520Manage.%26date%3D2007%26volume%3D3%26spage%3D203%26epage%3D210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ahren, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simonsson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsson, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landin-Olsson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torgeirsson, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jansson, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandqvist, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bavenholm, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Efedic, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eriksson, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickinson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmes, D.</span><span> </span><span class="NLM_article-title">Inhibition of dipeptidyl peptidase IV improves metabolic control over a 4-week study period in type 2 diabetes</span> <span class="citation_source-journal">Diabetes Care</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">869</span><span class="NLM_x">–</span> <span class="NLM_lpage">875</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2002&pages=869-875&author=B.+Ahrenauthor=E.+Simonssonauthor=H.+Larssonauthor=M.+Landin-Olssonauthor=H.+Torgeirssonauthor=P.+A.+Janssonauthor=M.+Sandqvistauthor=P.+Bavenholmauthor=S.+Efedicauthor=J.+W.+Erikssonauthor=S.+Dickinsonauthor=D.+Holmes&title=Inhibition+of+dipeptidyl+peptidase+IV+improves+metabolic+control+over+a+4-week+study+period+in+type+2+diabetes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAhren%26aufirst%3DB.%26aulast%3DSimonsson%26aufirst%3DE.%26aulast%3DLarsson%26aufirst%3DH.%26aulast%3DLandin-Olsson%26aufirst%3DM.%26aulast%3DTorgeirsson%26aufirst%3DH.%26aulast%3DJansson%26aufirst%3DP.%2BA.%26aulast%3DSandqvist%26aufirst%3DM.%26aulast%3DBavenholm%26aufirst%3DP.%26aulast%3DEfedic%26aufirst%3DS.%26aulast%3DEriksson%26aufirst%3DJ.%2BW.%26aulast%3DDickinson%26aufirst%3DS.%26aulast%3DHolmes%26aufirst%3DD.%26atitle%3DInhibition%2520of%2520dipeptidyl%2520peptidase%2520IV%2520improves%2520metabolic%2520control%2520over%2520a%25204-week%2520study%2520period%2520in%2520type%25202%2520diabetes%26jtitle%3DDiabetes%2520Care%26date%3D2002%26volume%3D25%26spage%3D869%26epage%3D875" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ahren, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomis, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Standl, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schweizer, A.</span><span> </span><span class="NLM_article-title">Twelve and 52-week efficacy of the dipeptidyl peptidase IV inhibitor LAF237 in metformin-treated patients with type 2 diabetes</span> <span class="citation_source-journal">Diabetes Care</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">2874</span><span class="NLM_x">–</span> <span class="NLM_lpage">2880</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2004&pages=2874-2880&author=B.+Ahrenauthor=R.+Gomisauthor=E.+Standlauthor=D.+Millsauthor=A.+Schweizer&title=Twelve+and+52-week+efficacy+of+the+dipeptidyl+peptidase+IV+inhibitor+LAF237+in+metformin-treated+patients+with+type+2+diabetes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAhren%26aufirst%3DB.%26aulast%3DGomis%26aufirst%3DR.%26aulast%3DStandl%26aufirst%3DE.%26aulast%3DMills%26aufirst%3DD.%26aulast%3DSchweizer%26aufirst%3DA.%26atitle%3DTwelve%2520and%252052-week%2520efficacy%2520of%2520the%2520dipeptidyl%2520peptidase%2520IV%2520inhibitor%2520LAF237%2520in%2520metformin-treated%2520patients%2520with%2520type%25202%2520diabetes%26jtitle%3DDiabetes%2520Care%26date%3D2004%26volume%3D27%26spage%3D2874%26epage%3D2880" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Ahren, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landing-Olsson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jansson, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svensson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmes, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schweizer, A.</span><span> </span><span class="NLM_article-title">Inhibition of dipeptidyl peptidase-4 reduces glycemia, sustains insulin levels, and reduces glucagons levels in type 2 diabetes</span> <span class="citation_source-journal">J. Clin. Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">89</span><span class="NLM_x">, </span> <span class="NLM_fpage">2078</span><span class="NLM_x">–</span> <span class="NLM_lpage">2084</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=16&amp;doi=10.1021%2Fjm101236h&amp;key=10.1210%2Fjc.2003-031907" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=8&amp;doi=10.1021%2Fjm101236h&amp;key=15126524" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=32&amp;doi=10.1021%2Fjm101236h&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjvFyrsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2004&pages=2078-2084&author=B.+Ahrenauthor=L.+Landing-Olssonauthor=P.+A.+Janssonauthor=M.+Svenssonauthor=D.+Holmesauthor=A.+Schweizer&title=Inhibition+of+dipeptidyl+peptidase-4+reduces+glycemia%2C+sustains+insulin+levels%2C+and+reduces+glucagons+levels+in+type+2+diabetes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6cR"><div class="casContent"><span class="casTitleNuber">6c</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of dipeptidyl peptidase-4 reduces glycemia, sustains insulin levels, and reduces glucagon levels in type 2 diabetes</span></div><div class="casAuthors">Ahren, Bo; Landin-Olsson, Mona; Jansson, Per-Anders; Svensson, Maria; Holmes, David; Schweizer, Anja</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2078-2084</span>CODEN:
                <span class="NLM_cas:coden">JCEMAZ</span>;
        ISSN:<span class="NLM_cas:issn">0021-972X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">The stimulation of insulin vs. inhibition of glucagon secretion in relation to the antidiabetic action of glucagon-like peptide-1 (GLP-1) is not established.  Here, the influence of a 4-wk increase in circulating GLP-1 by inhibition of dipeptidyl peptidase-4 (DPP-4) on 24-h glucose and insulin and glucagon responses to breakfast was studied in subjects with dietary controlled diabetes [age: 65±8 yr (SD), body mass index: 27.3±3.3 kg/m2, fasting plasma glucose: 9.0±1.3 mmol/L].  Compared with placebo (n = 19), a specific DPP-4 inhibitor [(1-[[(3-hydroxy-1-adamantyl) amino] acetyl]-2-cyano-(S)-pyrrolidine) (LAF237); 100 mg daily, n = 18] reduced fasting glucose by 0.70 mmol/L (P = 0.037), 4-h prandial glucose excursion by 1.45 mmol/L (P < 0.001), and mean 24-h glucose by 0.93 mmol/L (P < 0.001).  Baseline and postprandial active GLP-1 were increased by LAF237.  The glucagon response to breakfast was reduced by LAF237 (glucagon levels at 60 min were 88±8 pg/mL before treatment vs. 77±5 pg/mL after; P = 0.001).  In contrast, the overall insulin levels were not altered.  The 4-wk redn. in glucagon correlated with the redn. in 2-h glucose (r = 0.61; P = 0.008).  No such assocn. was obsd. for insulin.  Thus, improved metabolic control by DPP-4 inhibition in type 2 diabetes is seen in assocn. with reduced glucagon levels and, despite the lower glycemia, unaltered insulin levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrn9NQIGNxS0bVg90H21EOLACvtfcHk0lg3cZWfdJEQoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjvFyrsbs%253D&md5=170b2afd60510a01348c88aebc9e4aff</span></div><a href="/servlet/linkout?suffix=cit6c&amp;dbid=16384&amp;doi=10.1210%2Fjc.2003-031907&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fjc.2003-031907%26sid%3Dliteratum%253Aachs%26aulast%3DAhren%26aufirst%3DB.%26aulast%3DLanding-Olsson%26aufirst%3DL.%26aulast%3DJansson%26aufirst%3DP.%2BA.%26aulast%3DSvensson%26aufirst%3DM.%26aulast%3DHolmes%26aufirst%3DD.%26aulast%3DSchweizer%26aufirst%3DA.%26atitle%3DInhibition%2520of%2520dipeptidyl%2520peptidase-4%2520reduces%2520glycemia%252C%2520sustains%2520insulin%2520levels%252C%2520and%2520reduces%2520glucagons%2520levels%2520in%2520type%25202%2520diabetes%26jtitle%3DJ.%2520Clin.%2520Endocrinol.%2520Metab.%26date%3D2004%26volume%3D89%26spage%3D2078%26epage%3D2084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Ahren, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pacini, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forey, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schweizer, A.</span><span> </span><span class="NLM_article-title">Improved meal-related beta-cell function and insulin sensitivity by the dipeptidyl peptidase-IV inhibitor vildagliptin in metformin-treated patients with type 2 diabetes over 1 year</span> <span class="citation_source-journal">Diabetes Care</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">1936</span><span class="NLM_x">–</span> <span class="NLM_lpage">1940</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2005&pages=1936-1940&author=B.+Ahrenauthor=G.+Paciniauthor=J.+E.+Foreyauthor=A.+Schweizer&title=Improved+meal-related+beta-cell+function+and+insulin+sensitivity+by+the+dipeptidyl+peptidase-IV+inhibitor+vildagliptin+in+metformin-treated+patients+with+type+2+diabetes+over+1+year"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAhren%26aufirst%3DB.%26aulast%3DPacini%26aufirst%3DG.%26aulast%3DForey%26aufirst%3DJ.%2BE.%26aulast%3DSchweizer%26aufirst%3DA.%26atitle%3DImproved%2520meal-related%2520beta-cell%2520function%2520and%2520insulin%2520sensitivity%2520by%2520the%2520dipeptidyl%2520peptidase-IV%2520inhibitor%2520vildagliptin%2520in%2520metformin-treated%2520patients%2520with%2520type%25202%2520diabetes%2520over%25201%2520year%26jtitle%3DDiabetes%2520Care%26date%3D2005%26volume%3D28%26spage%3D1936%26epage%3D1940" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Croxtall, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keam, S. J.</span><span> </span><span class="NLM_article-title">Vildagliptin: a review of its use in the management of type 2 diabetes mellitus</span> <span class="citation_source-journal">Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">2387</span><span class="NLM_x">–</span> <span class="NLM_lpage">2409</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2008&pages=2387-2409&author=J.+D.+Croxtallauthor=S.+J.+Keam&title=Vildagliptin%3A+a+review+of+its+use+in+the+management+of+type+2+diabetes+mellitus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCroxtall%26aufirst%3DJ.%2BD.%26aulast%3DKeam%26aufirst%3DS.%2BJ.%26atitle%3DVildagliptin%253A%2520a%2520review%2520of%2520its%2520use%2520in%2520the%2520management%2520of%2520type%25202%2520diabetes%2520mellitus%26jtitle%3DDrugs%26date%3D2008%26volume%3D68%26spage%3D2387%26epage%3D2409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Augeri, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robl, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Betebenner, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnin, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khanna, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simpkins, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taunk, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abboa-Offei, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cap, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tozzo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welzel, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egan, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcinkeviciene, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biller, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirby, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamann, L. G.</span><span> </span><span class="NLM_article-title">Discovery and preclinical profile of saxagliptin (BMS-477118): A highly potent, long-acting, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">5025</span><span class="NLM_x">–</span> <span class="NLM_lpage">5037</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050261p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=32&amp;doi=10.1021%2Fjm101236h&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlsVeltb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=5025-5037&author=D.+J.+Augeriauthor=J.+A.+Roblauthor=D.+A.+Betebennerauthor=D.+R.+Magninauthor=A.+Khannaauthor=J.+G.+Robertsonauthor=A.+Wangauthor=L.+M.+Simpkinsauthor=P.+Taunkauthor=Q.+Huangauthor=S.+P.+Hanauthor=B.+Abboa-Offeiauthor=M.+Capauthor=L.+Xinauthor=L.+Taoauthor=E.+Tozzoauthor=G.+E.+Welzelauthor=D.+M.+Eganauthor=J.+Marcinkevicieneauthor=S.+Y.+Changauthor=S.+A.+Billerauthor=M.+S.+Kirbyauthor=R.+A.+Parkerauthor=L.+G.+Hamann&title=Discovery+and+preclinical+profile+of+saxagliptin+%28BMS-477118%29%3A+A+highly+potent%2C+long-acting%2C+orally+active+dipeptidyl+peptidase+IV+inhibitor+for+the+treatment+of+type+2+diabetes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7aR"><div class="casContent"><span class="casTitleNuber">7a</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Preclinical Profile of Saxagliptin (BMS-477118): A Highly Potent, Long-Acting, Orally Active Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes</span></div><div class="casAuthors">Augeri, David J.; Robl, Jeffrey A.; Betebenner, David A.; Magnin, David R.; Khanna, Ashish; Robertson, James G.; Wang, Aiying; Simpkins, Ligaya M.; Taunk, Prakash; Huang, Qi; Han, Song-Ping; Abboa-Offei, Benoni; Cap, Michael; Xin, Li; Tao, Li; Tozzo, Effie; Welzel, Gustav E.; Egan, Donald M.; Marcinkeviciene, Jovita; Chang, Shu Y.; Biller, Scott A.; Kirby, Mark S.; Parker, Rex A.; Hamann, Lawrence G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">5025-5037</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Efforts to further elucidate structure-activity relationships (SAR) within the authors previously disclosed series of β-quaternary amino acid linked L-cis-4,5-methanoprolinenitrile dipeptidyl peptidase IV (DPP-IV) inhibitors led to the investigation of vinyl substitution at the β-position of α-cycloalkyl-substituted glycines.  Despite poor systemic exposure, vinyl-substituted compds. showed extended duration of action in acute rat ex vivo plasma DPP-IV inhibition models.  Oxygenated putative metabolites were prepd. and were shown to exhibit the potency and extended duration of action of their precursors in efficacy models measuring glucose clearance in Zuckerfa/fa rats.  Extension of this approach to adamantylglycine-derived inhibitors led to the discovery of highly potent inhibitors, including hydroxyadamantyl compd. BMS-477118 (saxagliptin), a highly efficacious, stable, and long-acting DPP-IV inhibitor, which is currently undergoing clin. trials for treatment of type 2 diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGrIJX7K8p67Vg90H21EOLACvtfcHk0lgho6N3V7dpcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlsVeltb0%253D&md5=878355880133bb0ddd6bd14ecbf1d070</span></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.1021%2Fjm050261p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050261p%26sid%3Dliteratum%253Aachs%26aulast%3DAugeri%26aufirst%3DD.%2BJ.%26aulast%3DRobl%26aufirst%3DJ.%2BA.%26aulast%3DBetebenner%26aufirst%3DD.%2BA.%26aulast%3DMagnin%26aufirst%3DD.%2BR.%26aulast%3DKhanna%26aufirst%3DA.%26aulast%3DRobertson%26aufirst%3DJ.%2BG.%26aulast%3DWang%26aufirst%3DA.%26aulast%3DSimpkins%26aufirst%3DL.%2BM.%26aulast%3DTaunk%26aufirst%3DP.%26aulast%3DHuang%26aufirst%3DQ.%26aulast%3DHan%26aufirst%3DS.%2BP.%26aulast%3DAbboa-Offei%26aufirst%3DB.%26aulast%3DCap%26aufirst%3DM.%26aulast%3DXin%26aufirst%3DL.%26aulast%3DTao%26aufirst%3DL.%26aulast%3DTozzo%26aufirst%3DE.%26aulast%3DWelzel%26aufirst%3DG.%2BE.%26aulast%3DEgan%26aufirst%3DD.%2BM.%26aulast%3DMarcinkeviciene%26aufirst%3DJ.%26aulast%3DChang%26aufirst%3DS.%2BY.%26aulast%3DBiller%26aufirst%3DS.%2BA.%26aulast%3DKirby%26aufirst%3DM.%2BS.%26aulast%3DParker%26aufirst%3DR.%2BA.%26aulast%3DHamann%26aufirst%3DL.%2BG.%26atitle%3DDiscovery%2520and%2520preclinical%2520profile%2520of%2520saxagliptin%2520%2528BMS-477118%2529%253A%2520A%2520highly%2520potent%252C%2520long-acting%252C%2520orally%2520active%2520dipeptidyl%2520peptidase%2520IV%2520inhibitor%2520for%2520the%2520treatment%2520of%2520type%25202%2520diabetes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D5025%26epage%3D5037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Dhillon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, J.</span><span> </span><span class="NLM_article-title">Saxagliptin</span> <span class="citation_source-journal">Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">2103</span><span class="NLM_x">–</span> <span class="NLM_lpage">2114</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2009&pages=2103-2114&author=S.+Dhillonauthor=J.+Weber&title=Saxagliptin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDhillon%26aufirst%3DS.%26aulast%3DWeber%26aufirst%3DJ.%26atitle%3DSaxagliptin%26jtitle%3DDrugs%26date%3D2009%26volume%3D69%26spage%3D2103%26epage%3D2114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Feng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallace, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stafford, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaldor, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kassel, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navre, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skene, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asakawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeuchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gwaltney, S. L.</span><span> </span><span class="NLM_article-title">Discovery of alogliptin: a potent, selective, bioavailable, and efficacious inhibitor of dipeptidyl peptidase IV</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">2297</span><span class="NLM_x">–</span> <span class="NLM_lpage">2300</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070104l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=2297-2300&author=J.+Fengauthor=Z.+Zhangauthor=M.+B.+Wallaceauthor=J.+A.+Staffordauthor=S.+W.+Kaldorauthor=D.+B.+Kasselauthor=M.+Navreauthor=L.+Shiauthor=R.+J.+Skeneauthor=T.+Asakawaauthor=K.+Takeuchiauthor=R.+Xuauthor=D.+R.+Webbauthor=S.+L.+Gwaltney&title=Discovery+of+alogliptin%3A+a+potent%2C+selective%2C+bioavailable%2C+and+efficacious+inhibitor+of+dipeptidyl+peptidase+IV"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=10.1021%2Fjm070104l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070104l%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DWallace%26aufirst%3DM.%2BB.%26aulast%3DStafford%26aufirst%3DJ.%2BA.%26aulast%3DKaldor%26aufirst%3DS.%2BW.%26aulast%3DKassel%26aufirst%3DD.%2BB.%26aulast%3DNavre%26aufirst%3DM.%26aulast%3DShi%26aufirst%3DL.%26aulast%3DSkene%26aufirst%3DR.%2BJ.%26aulast%3DAsakawa%26aufirst%3DT.%26aulast%3DTakeuchi%26aufirst%3DK.%26aulast%3DXu%26aufirst%3DR.%26aulast%3DWebb%26aufirst%3DD.%2BR.%26aulast%3DGwaltney%26aufirst%3DS.%2BL.%26atitle%3DDiscovery%2520of%2520alogliptin%253A%2520a%2520potent%252C%2520selective%252C%2520bioavailable%252C%2520and%2520efficacious%2520inhibitor%2520of%2520dipeptidyl%2520peptidase%2520IV%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D2297%26epage%3D2300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Pratley, R. E.</span><span> </span><span class="NLM_article-title">Alogliptin: a new, highly selective dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes</span> <span class="citation_source-journal">Expert Opin. Pharmachother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">503</span><span class="NLM_x">–</span> <span class="NLM_lpage">512</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=16&amp;doi=10.1021%2Fjm101236h&amp;key=10.1517%2F14656560802694713" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=8&amp;doi=10.1021%2Fjm101236h&amp;key=19191685" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=32&amp;doi=10.1021%2Fjm101236h&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVaiurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=503-512&author=R.+E.+Pratley&title=Alogliptin%3A+a+new%2C+highly+selective+dipeptidyl+peptidase-4+inhibitor+for+the+treatment+of+type+2+diabetes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8bR"><div class="casContent"><span class="casTitleNuber">8b</span><div class="casTitle"><span class="NLM_cas:atitle">Alogliptin: a new, highly selective dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes</span></div><div class="casAuthors">Pratley, Richard E.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Pharmacotherapy</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">503-512</span>CODEN:
                <span class="NLM_cas:coden">EOPHF7</span>;
        ISSN:<span class="NLM_cas:issn">1465-6566</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Background: Alogliptin is a potent, highly selective dipeptidyl peptidase-4 inhibitor now undergoing clin. testing to support a new drug application for the treatment of type 2 diabetes.  Objective: To provide an overview of the mechanism by which alogliptin reduces hyperglycemia and to summarize the pharmacol., efficacy and safety of the drug.  Methods: A Medline search was conducted and abstrs. and presentations from recent American Diabetes Assocn. and European Assocn. for the Study of Diabetes (EASD) meetings were reviewed.  The results of phase II and phase III human studies were evaluated for clin. efficacy, safety and tolerability in patients with type 2 diabetes.  Results/conclusions: Alogliptin is effective as a treatment for type 2 diabetes, either as monotherapy or in combination with metformin, thiazolidinediones, sulfonylureas and insulin.  It is well tolerated and has an excellent safety profile.  Addnl. studies are needed to evaluate the long-term safety and efficacy of alogliptin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVASaAmsEezrVg90H21EOLACvtfcHk0liq678nRVJgEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVaiurY%253D&md5=26b93655020e344a7a063a25aaed728d</span></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.1517%2F14656560802694713&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14656560802694713%26sid%3Dliteratum%253Aachs%26aulast%3DPratley%26aufirst%3DR.%2BE.%26atitle%3DAlogliptin%253A%2520a%2520new%252C%2520highly%2520selective%2520dipeptidyl%2520peptidase-4%2520inhibitor%2520for%2520the%2520treatment%2520of%2520type%25202%2520diabetes%26jtitle%3DExpert%2520Opin.%2520Pharmachother.%26date%3D2009%26volume%3D10%26spage%3D503%26epage%3D512" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Satoru, O.; Mitsuru, S.; Tohru, Y.; Yasufumi, M.; Yoshihiro, B.; Hironobu, M.; Koji, I.; Takuo, K.; Shigetoshi, T.; Koji, T.; Tomoko, A.; Osamu, K.; Nobuhiro, S.; Yoshio, Y.; Robert, S.; Jason, Y.; Kathleen, A.</span><span> </span><span class="NLM_article-title">Design and synthesis of isoquinolone and quinoline derivatives as a new class of dipeptidyl peptidase-4 inhibitors</span>. Poster presentation at the 27th Medicinal Chemistry Symposium of the pharmaceutical society of Japan, Osaka, Japan, November 26−28,<span class="NLM_x"> </span><span class="NLM_year">2008</span><span class="NLM_x">; </span>Abstract 2P05.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=O.+Satoru&author=S.+Mitsuru&author=Y.+Tohru&author=M.+Yasufumi&author=B.+Yoshihiro&author=M.+Hironobu&author=I.+Koji&author=K.+Takuo&author=T.+Shigetoshi&author=T.+Koji&author=A.+Tomoko&author=K.+Osamu&author=S.+Nobuhiro&author=Y.+Yoshio&author=S.+Robert&author=Y.+Jason&author=A.+Kathleen&title=Design+and+synthesis+of+isoquinolone+and+quinoline+derivatives+as+a+new+class+of+dipeptidyl+peptidase-4+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DSatoru%26aufirst%3DO.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520isoquinolone%2520and%2520quinoline%2520derivatives%2520as%2520a%2520new%2520class%2520of%2520dipeptidyl%2520peptidase-4%2520inhibitors%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Edmondson, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mastracchio, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beconi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colwell, L. F.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habulihaz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leiting, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyons, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsilio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reshma, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, L. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thornberry, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parmee, E. R.</span><span> </span><span class="NLM_article-title">Potent and selective proline derived dipeptidyl peptidase IV inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">5151</span><span class="NLM_x">–</span> <span class="NLM_lpage">5155</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=5151-5155&author=S.+D.+Edmondsonauthor=A.+Mastracchioauthor=M.+Beconiauthor=L.+F.+Colwellauthor=B.+Habulihazauthor=H.+Heauthor=S.+Kumarauthor=B.+Leitingauthor=K.+A.+Lyonsauthor=A.+Maoauthor=F.+Marsilioauthor=A.+Reshmaauthor=J.+K.+Patelauthor=L.+Z.+Wuauthor=N.+A.+Thornberryauthor=A.+E.+Weberauthor=E.+R.+Parmee&title=Potent+and+selective+proline+derived+dipeptidyl+peptidase+IV+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEdmondson%26aufirst%3DS.%2BD.%26aulast%3DMastracchio%26aufirst%3DA.%26aulast%3DBeconi%26aufirst%3DM.%26aulast%3DColwell%26aufirst%3DL.%2BF.%26aulast%3DHabulihaz%26aufirst%3DB.%26aulast%3DHe%26aufirst%3DH.%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DLeiting%26aufirst%3DB.%26aulast%3DLyons%26aufirst%3DK.%2BA.%26aulast%3DMao%26aufirst%3DA.%26aulast%3DMarsilio%26aufirst%3DF.%26aulast%3DReshma%26aufirst%3DA.%26aulast%3DPatel%26aufirst%3DJ.%2BK.%26aulast%3DWu%26aufirst%3DL.%2BZ.%26aulast%3DThornberry%26aufirst%3DN.%2BA.%26aulast%3DWeber%26aufirst%3DA.%2BE.%26aulast%3DParmee%26aufirst%3DE.%2BR.%26atitle%3DPotent%2520and%2520selective%2520proline%2520derived%2520dipeptidyl%2520peptidase%2520IV%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D5151%26epage%3D5155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Koo, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hur, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yim, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, H. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwon, O. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwon, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koh, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C. S.</span><span> </span><span class="NLM_article-title">Synthesis, SAR, and X-ray structure of novel potent DPPIV inhibitors: Oxadiazolyl ketones</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">4167</span><span class="NLM_x">–</span> <span class="NLM_lpage">4172</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=4167-4172&author=K.+D.+Kooauthor=M.+J.+Kimauthor=S.+Kimauthor=K.+S.+Kimauthor=S.+Y.+Hongauthor=G.+C.+Hurauthor=H.+J.+Yimauthor=G.+T.+Kimauthor=H.+O.+Hanauthor=O.+H.+Kwonauthor=T.+S.+Kwonauthor=J.+S.+Kohauthor=C.+S.+Lee&title=Synthesis%2C+SAR%2C+and+X-ray+structure+of+novel+potent+DPPIV+inhibitors%3A+Oxadiazolyl+ketones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKoo%26aufirst%3DK.%2BD.%26aulast%3DKim%26aufirst%3DM.%2BJ.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DK.%2BS.%26aulast%3DHong%26aufirst%3DS.%2BY.%26aulast%3DHur%26aufirst%3DG.%2BC.%26aulast%3DYim%26aufirst%3DH.%2BJ.%26aulast%3DKim%26aufirst%3DG.%2BT.%26aulast%3DHan%26aufirst%3DH.%2BO.%26aulast%3DKwon%26aufirst%3DO.%2BH.%26aulast%3DKwon%26aufirst%3DT.%2BS.%26aulast%3DKoh%26aufirst%3DJ.%2BS.%26aulast%3DLee%26aufirst%3DC.%2BS.%26atitle%3DSynthesis%252C%2520SAR%252C%2520and%2520X-ray%2520structure%2520of%2520novel%2520potent%2520DPPIV%2520inhibitors%253A%2520Oxadiazolyl%2520ketones%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D4167%26epage%3D4172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Yamada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okagaki, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higashijima, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohnuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugita, T.</span><span> </span><span class="NLM_article-title">A potent dipeptide inhibitor of dipeptidyl peptidase IV</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1537</span><span class="NLM_x">–</span> <span class="NLM_lpage">1540</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10c&amp;dbid=16&amp;doi=10.1021%2Fjm101236h&amp;key=10.1016%2FS0960-894X%2898%2900259-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10c&amp;dbid=8&amp;doi=10.1021%2Fjm101236h&amp;key=9873385" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10c&amp;dbid=32&amp;doi=10.1021%2Fjm101236h&amp;key=1%3ACAS%3A528%3ADyaK1cXkt1OgtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1998&pages=1537-1540&author=M.+Yamadaauthor=C.+Okagakiauthor=T.+Higashijimaauthor=S.+Tanakaauthor=T.+Ohnukiauthor=T.+Sugita&title=A+potent+dipeptide+inhibitor+of+dipeptidyl+peptidase+IV"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10cR"><div class="casContent"><span class="casTitleNuber">10c</span><div class="casTitle"><span class="NLM_cas:atitle">A potent dipeptide inhibitor of dipeptidyl peptidase IV</span></div><div class="casAuthors">Yamada, Masaki; Okagaki, Chieko; Higashijima, Takanori; Tanaka, Sumiko; Ohnuki, Tetsuo; Sugita, Takahisa</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1537-1540</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A series of novel potent inhibitors of dipeptidyl peptidase IV (DPP-IV) has been developed.  A brief structure-activity relation of the inhibitors was investigated.  The dipeptide TSL-225, tryptophyl-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid, was identified with the crit. structure for the inhibitory activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4Z9ZJ7DKaprVg90H21EOLACvtfcHk0liq678nRVJgEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXkt1OgtL8%253D&md5=592d3a566a8d3d2a9df518d311fecd56</span></div><a href="/servlet/linkout?suffix=cit10c&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2898%2900259-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252898%252900259-5%26sid%3Dliteratum%253Aachs%26aulast%3DYamada%26aufirst%3DM.%26aulast%3DOkagaki%26aufirst%3DC.%26aulast%3DHigashijima%26aufirst%3DT.%26aulast%3DTanaka%26aufirst%3DS.%26aulast%3DOhnuki%26aufirst%3DT.%26aulast%3DSugita%26aufirst%3DT.%26atitle%3DA%2520potent%2520dipeptide%2520inhibitor%2520of%2520dipeptidyl%2520peptidase%2520IV%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1998%26volume%3D8%26spage%3D1537%26epage%3D1540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><i>EP135252A2</i>. <span class="NLM_contrib-group">Hackler, R. E.; Wickiser, D. I.</span> Eli Lilly and Company; Process for preparing 3-substituted-3-aminonitrile.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=EP135252A2.+Hackler%2C+R.+E.%3B+Wickiser%2C+D.+I.+Eli+Lilly+and+Company%3B+Process+for+preparing+3-substituted-3-aminonitrile."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DHackler%26aufirst%3DR.%2BE." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Suzuki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanikawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakoda, R.</span><span> </span><span class="NLM_article-title">Practical synthesis of quinoline nucleus of NK-104</span> <span class="citation_source-journal">Heterocycles</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">479</span><span class="NLM_x">–</span> <span class="NLM_lpage">483</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1999&pages=479-483&issue=1&author=M.+Suzukiauthor=K.+Tanikawaauthor=R.+Sakoda&title=Practical+synthesis+of+quinoline+nucleus+of+NK-104"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DM.%26aulast%3DTanikawa%26aufirst%3DK.%26aulast%3DSakoda%26aufirst%3DR.%26atitle%3DPractical%2520synthesis%2520of%2520quinoline%2520nucleus%2520of%2520NK-104%26jtitle%3DHeterocycles%26date%3D1999%26volume%3D50%26issue%3D1%26spage%3D479%26epage%3D483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13a"><span><span class="NLM_contrib-group">Singer, A.; McElvain, S. M.</span><span> </span><span class="NLM_article-title">2.6-Dimethylpyridine</span>.  <span class="citation_source-book">Org. Synth., Coll. Vol. 2</span>, p  <span class="NLM_fpage">214</span><span class="NLM_x"> (</span><span class="NLM_year">1943</span><span class="NLM_x">) </span>;</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1943&pages=214&author=A.+Singer&author=S.+M.+McElvain&title=Org.+Synth.%2C+Coll.+Vol.+2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DSinger%26aufirst%3DA.%26atitle%3D2.6-Dimethylpyridine%26btitle%3DOrg.%2520Synth.%252C%2520Coll.%2520Vol.%25202%26spage%3D214%26date%3D1943" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit13b"><span>Vol.  <span class="NLM_volume">14</span>, p  <span class="NLM_fpage">30</span><span class="NLM_x"> (</span><span class="NLM_year">1934</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Vol.+14%2C+p+30+%281934%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26volume%3D14%26spage%3D30%26date%3D1934" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="note"><p class="first last">Refer to the <a class="ref internalNav" href="#notes-2" aria-label="Supporting Information">Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Leiting, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pryor, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsilio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craik, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellman, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummings, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thornberry, N. A.</span><span> </span><span class="NLM_article-title">Catalytic properties and inhibition of proline-specific dipeptidyl peptidases II, IV and VII</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">371</span><span class="NLM_x">, </span> <span class="NLM_fpage">525</span><span class="NLM_x">–</span> <span class="NLM_lpage">532</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=371&publication_year=2003&pages=525-532&author=B.+Leitingauthor=K.+D.+Pryorauthor=J.+K.+Wuauthor=F.+Marsilioauthor=R.+A.+Patelauthor=C.+S.+Craikauthor=J.+A.+Ellmanauthor=R.+T.+Cummingsauthor=N.+A.+Thornberry&title=Catalytic+properties+and+inhibition+of+proline-specific+dipeptidyl+peptidases+II%2C+IV+and+VII"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeiting%26aufirst%3DB.%26aulast%3DPryor%26aufirst%3DK.%2BD.%26aulast%3DWu%26aufirst%3DJ.%2BK.%26aulast%3DMarsilio%26aufirst%3DF.%26aulast%3DPatel%26aufirst%3DR.%2BA.%26aulast%3DCraik%26aufirst%3DC.%2BS.%26aulast%3DEllman%26aufirst%3DJ.%2BA.%26aulast%3DCummings%26aufirst%3DR.%2BT.%26aulast%3DThornberry%26aufirst%3DN.%2BA.%26atitle%3DCatalytic%2520properties%2520and%2520inhibition%2520of%2520proline-specific%2520dipeptidyl%2520peptidases%2520II%252C%2520IV%2520and%2520VII%26jtitle%3DBiochem.%2520J.%26date%3D2003%26volume%3D371%26spage%3D525%26epage%3D532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Chiravuri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmitz, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yardley, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Underwood, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dayal, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, B. T.</span><span> </span><span class="NLM_article-title">A novel apoptotic pathway in quiescent lymphocytes identified by inhibition of post-proline cleaving aminopeptidase: A candidate target protease, quiescent cell proline dipeptidase</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">163</span><span class="NLM_x">, </span> <span class="NLM_fpage">3092</span><span class="NLM_x">–</span> <span class="NLM_lpage">3099</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=163&publication_year=1999&pages=3092-3099&author=M.+Chiravuriauthor=T.+Schmitzauthor=K.+Yardleyauthor=R.+Underwoodauthor=Y.+Dayalauthor=B.+T.+Huber&title=A+novel+apoptotic+pathway+in+quiescent+lymphocytes+identified+by+inhibition+of+post-proline+cleaving+aminopeptidase%3A+A+candidate+target+protease%2C+quiescent+cell+proline+dipeptidase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChiravuri%26aufirst%3DM.%26aulast%3DSchmitz%26aufirst%3DT.%26aulast%3DYardley%26aufirst%3DK.%26aulast%3DUnderwood%26aufirst%3DR.%26aulast%3DDayal%26aufirst%3DY.%26aulast%3DHuber%26aufirst%3DB.%2BT.%26atitle%3DA%2520novel%2520apoptotic%2520pathway%2520in%2520quiescent%2520lymphocytes%2520identified%2520by%2520inhibition%2520of%2520post-proline%2520cleaving%2520aminopeptidase%253A%2520A%2520candidate%2520target%2520protease%252C%2520quiescent%2520cell%2520proline%2520dipeptidase%26jtitle%3DJ.%2520Immunol.%26date%3D1999%26volume%3D163%26spage%3D3092%26epage%3D3099" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Lankas, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leiting, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinha, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eiermann, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beconi, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biftu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edmonson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freeney, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ippolito, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyons, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ok, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrov, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pryor, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reigle, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woods, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaller, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thornberry, N. A.</span><span> </span><span class="NLM_article-title">Dipeptidyl peptidase IV inhibition for the treatment of type 2 diabetes: Potential importance of selectivity over dipeptidyl peptidase 8 and 9</span> <span class="citation_source-journal">Diabetes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">2988</span><span class="NLM_x">–</span> <span class="NLM_lpage">2994</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2005&pages=2988-2994&author=G.+Lankasauthor=B.+Leitingauthor=R.+R.+Sinhaauthor=G.+Eiermannauthor=M.+G.+Beconiauthor=T.+Biftuauthor=C.+C.+Chanauthor=S.+Edmonsonauthor=W.+P.+Freeneyauthor=H.+Heauthor=D.+E.+Ippolitoauthor=D.+Kimauthor=K.+A.+Lyonsauthor=H.+Okauthor=R.+A.+Patelauthor=A.+N.+Petrovauthor=K.+A.+Pryorauthor=X.+Qianauthor=L.+Reigleauthor=A.+Woodsauthor=J.+K.+Wuauthor=D.+Zallerauthor=X.+Zhangauthor=L.+Zhuauthor=A.+E.+Weberauthor=N.+A.+Thornberry&title=Dipeptidyl+peptidase+IV+inhibition+for+the+treatment+of+type+2+diabetes%3A+Potential+importance+of+selectivity+over+dipeptidyl+peptidase+8+and+9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLankas%26aufirst%3DG.%26aulast%3DLeiting%26aufirst%3DB.%26aulast%3DSinha%26aufirst%3DR.%2BR.%26aulast%3DEiermann%26aufirst%3DG.%26aulast%3DBeconi%26aufirst%3DM.%2BG.%26aulast%3DBiftu%26aufirst%3DT.%26aulast%3DChan%26aufirst%3DC.%2BC.%26aulast%3DEdmonson%26aufirst%3DS.%26aulast%3DFreeney%26aufirst%3DW.%2BP.%26aulast%3DHe%26aufirst%3DH.%26aulast%3DIppolito%26aufirst%3DD.%2BE.%26aulast%3DKim%26aufirst%3DD.%26aulast%3DLyons%26aufirst%3DK.%2BA.%26aulast%3DOk%26aufirst%3DH.%26aulast%3DPatel%26aufirst%3DR.%2BA.%26aulast%3DPetrov%26aufirst%3DA.%2BN.%26aulast%3DPryor%26aufirst%3DK.%2BA.%26aulast%3DQian%26aufirst%3DX.%26aulast%3DReigle%26aufirst%3DL.%26aulast%3DWoods%26aufirst%3DA.%26aulast%3DWu%26aufirst%3DJ.%2BK.%26aulast%3DZaller%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DWeber%26aufirst%3DA.%2BE.%26aulast%3DThornberry%26aufirst%3DN.%2BA.%26atitle%3DDipeptidyl%2520peptidase%2520IV%2520inhibition%2520for%2520the%2520treatment%2520of%2520type%25202%2520diabetes%253A%2520Potential%2520importance%2520of%2520selectivity%2520over%2520dipeptidyl%2520peptidase%25208%2520and%25209%26jtitle%3DDiabetes%26date%3D2005%26volume%3D54%26spage%3D2988%26epage%3D2994" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Aertgeerts, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tennant, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraus, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sang, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skene, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prasad, G. S.</span><span> </span><span class="NLM_article-title">Crystal structure of human dipeptidyl peptidase IV in complex with a decapeptide reveals details on substrate specificity and tetrahedral intermediate formation</span> <span class="citation_source-journal">Protein Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">412</span><span class="NLM_x">–</span> <span class="NLM_lpage">421</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm101236h&amp;key=10.1110%2Fps.03460604" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm101236h&amp;key=14718659" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm101236h&amp;key=1%3ACAS%3A528%3ADC%252BD2cXotFOlsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2004&pages=412-421&author=K.+Aertgeertsauthor=S.+Yeauthor=M.+G.+Tennantauthor=M.+L.+Krausauthor=J.+Rogersauthor=B.+C.+Sangauthor=R.+J.+Skeneauthor=D.+R.+Webbauthor=G.+S.+Prasad&title=Crystal+structure+of+human+dipeptidyl+peptidase+IV+in+complex+with+a+decapeptide+reveals+details+on+substrate+specificity+and+tetrahedral+intermediate+formation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of human dipeptidyl peptidase IV in complex with a decapeptide reveals details on substrate specificity and tetrahedral intermediate formation</span></div><div class="casAuthors">Aertgeerts, Kathleen; Ye, Sheng; Tennant, Mike G.; Kraus, Michelle L.; Rogers, Joe; Sang, Bi-Ching; Skene, Robert J.; Webb, David R.; Prasad, G. Sridhar</div><div class="citationInfo"><span class="NLM_cas:title">Protein Science</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">412-421</span>CODEN:
                <span class="NLM_cas:coden">PRCIEI</span>;
        ISSN:<span class="NLM_cas:issn">0961-8368</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">Dipeptidyl peptidase IV (DPPIV) is a member of the prolyl oligopeptidase family of serine proteases.  DPPIV removes dipeptides from the N terminus of substrates, including many chemokines, neuropeptides, and peptide hormones.  Specific inhibition of DPPIV is being investigated in human trials for the treatment of type II diabetes.  To understand better the mol. determinants that underlie enzyme catalysis and substrate specificity, we report the crystal structures of DPPIV in the free form and in complex with the first 10 residues of the physiol. substrate, Neuropeptide Y (residues 1-10; tNPY).  The crystal structure of the free form of the enzyme reveals two potential channels through which substrates could access the active site-a so-called propeller opening, and side opening.  The crystal structure of the DPPIV/tNPY complex suggests that bioactive peptides utilize the side opening unique to DPPIV to access the active site.  Other structural features in the active site such as the presence of a Glu motif, a well-defined hydrophobic S1 subsite, and minimal long-range interactions explain the substrate recognition and binding properties of DPPIV.  Moreover, in the DPPIV/tNPY complex structure, the peptide is not cleaved but trapped in a tetrahedral intermediate that occurs during catalysis.  Conformational changes of S630 and H740 between DPPIV in its free form and in complex with tNPY were obsd. and contribute to the stabilization of the tetrahedral intermediate.  Our results facilitate the design of potent, selective small mol. inhibitors of DPPIV that may yield compds. for the development of novel drugs to treat type II diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBugA5cQcmbrVg90H21EOLACvtfcHk0ljqjraYvnZ_GQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXotFOlsg%253D%253D&md5=bba77030cb978a9cc84fef52e6d5e1d1</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1110%2Fps.03460604&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1110%252Fps.03460604%26sid%3Dliteratum%253Aachs%26aulast%3DAertgeerts%26aufirst%3DK.%26aulast%3DYe%26aufirst%3DS.%26aulast%3DTennant%26aufirst%3DM.%2BG.%26aulast%3DKraus%26aufirst%3DM.%2BL.%26aulast%3DRogers%26aufirst%3DJ.%26aulast%3DSang%26aufirst%3DB.%2BC.%26aulast%3DSkene%26aufirst%3DR.%2BJ.%26aulast%3DWebb%26aufirst%3DD.%2BR.%26aulast%3DPrasad%26aufirst%3DG.%2BS.%26atitle%3DCrystal%2520structure%2520of%2520human%2520dipeptidyl%2520peptidase%2520IV%2520in%2520complex%2520with%2520a%2520decapeptide%2520reveals%2520details%2520on%2520substrate%2520specificity%2520and%2520tetrahedral%2520intermediate%2520formation%26jtitle%3DProtein%2520Sci.%26date%3D2004%26volume%3D13%26spage%3D412%26epage%3D421" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Otwinowski, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minor, W.</span><span> </span><span class="NLM_article-title">Processing of X-ray diffraction data collected in oscillation mode</span> <span class="citation_source-journal">Methods Enzymol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">307</span><span class="NLM_x">–</span> <span class="NLM_lpage">326</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm101236h&amp;key=10.1016%2FS0076-6879%2897%2976066-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm101236h&amp;key=27754618" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm101236h&amp;key=1%3ACAS%3A528%3ADyaK2sXivFehsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=1997&pages=307-326&author=Z.+Otwinowskiauthor=W.+Minor&title=Processing+of+X-ray+diffraction+data+collected+in+oscillation+mode"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Processing of x-ray diffraction data collected in oscillation mode</span></div><div class="casAuthors">Otwinowski, Zbyszek; Minor, Wladek</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Enzymology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">Macromolecular Crystallography, Part A</span>),
    <span class="NLM_cas:pages">307-326</span>CODEN:
                <span class="NLM_cas:coden">MENZAU</span>;
        ISSN:<span class="NLM_cas:issn">0076-6879</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">Macromol. crystallog. is an iterative process.  Rarely do the first crystals provide all the necessary data to solve the biol. problem being studied.  Each step benefits from experience learned in previous steps.  To monitor the progress, the HKL package provides 2 tools: (1) statistics, both weighted (χ2) and unweighted (R-merge), are provided, and the Bayesian reasoning and multicomponent error model facilitates obtaining the proper error ests. and (2) visualization of the process plays a double role by helping the operator to confirm that the process of data redn., including the resulting statistics, is correct, and allowing one to evaluate problems for which there are no good statistical criteria.  Visualization also provides confidence that the point of diminishing returns in data collection and redn. has been reached.  At that point, the effort should be directed to solving the structure.  The methods presented here have been applied to solve a large variety of problems, from inorg. mols. with 5 Å unit cell to rotavirus of 700 Å diam. crystd. in 700 × 1000 × 1400 Å cell.  Overall quality of the method was tested by many researchers by successful application of the programs to MAD structure detns.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrA3fvBOHqhhrVg90H21EOLACvtfcHk0ljqjraYvnZ_GQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXivFehsbw%253D&md5=c9536971d4e32cc35352c40fb9368131</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2FS0076-6879%2897%2976066-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0076-6879%252897%252976066-X%26sid%3Dliteratum%253Aachs%26aulast%3DOtwinowski%26aufirst%3DZ.%26aulast%3DMinor%26aufirst%3DW.%26atitle%3DProcessing%2520of%2520X-ray%2520diffraction%2520data%2520collected%2520in%2520oscillation%2520mode%26jtitle%3DMethods%2520Enzymol.%26date%3D1997%26volume%3D276%26spage%3D307%26epage%3D326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span>Collaborative Computational Project, Number 4. <span> </span><span class="NLM_article-title">The CCP4 suite: programs for protein crystallography</span>.  <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">760</span>− <span class="NLM_lpage">763</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm101236h&amp;key=10.1107%2FS0907444994003112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm101236h&amp;key=15299374" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm101236h&amp;key=1%3ACAS%3A280%3ADC%252BD2czpsV2gug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Collaborative+Computational+Project%2C+Number+4.+The+CCP4+suite%3A+programs+for+protein+crystallography.+Acta+Crystallogr.%2C+Sect.+D%3A+Biol.+Crystallogr.+1994%2C+50%2C+760%E2%88%92763."target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">The CCP4 suite: programs for protein crystallography</span></div><div class="casAuthors">Anonymous</div><div class="citationInfo"><span class="NLM_cas:title">Acta crystallographica. Section D, Biological crystallography</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">Pt 5</span>),
    <span class="NLM_cas:pages">760-3</span>
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    </div><div class="casAbstract">The CCP4 (Collaborative Computational Project, number 4) program suite is a collection of programs and associated data and subroutine libraries which can be used for macromolecular structure determination by X-ray crystallography.  The suite is designed to be flexible, allowing users a number of methods of achieving their aims and so there may be more than one program to cover each function.  The programs are written mainly in standard Fortran77.  They are from a wide variety of sources but are connected by standard data file formats.  The package has been ported to all the major platforms under both Unix and VMS.  The suite is distributed by anonymous ftp from Daresbury Laboratory and is widely used throughout the world.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ1Q-skJYIZ2IYPsCkJIw00fW6udTcc2eaRWTqIs3zy-rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2czpsV2gug%253D%253D&md5=92b759927d6071ea3f20c08b78ad1eb2</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1107%2FS0907444994003112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444994003112%26sid%3Dliteratum%253Aachs%26atitle%3DThe%2520CCP4%2520suite%253A%2520programs%2520for%2520protein%2520crystallography%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D1994%26volume%3D50%26spage%3D760%26epage%3D763" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">McRee, D. E.</span><span> </span><span class="NLM_article-title">XtalView/Xfit—A versatile program for manipulating atomic coordinates and electron density</span> <span class="citation_source-journal">J. Struct. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">125</span><span class="NLM_x">, </span> <span class="NLM_fpage">156</span><span class="NLM_x">–</span> <span class="NLM_lpage">165</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=1999&pages=156-165&author=D.+E.+McRee&title=XtalView%2FXfit%E2%80%94A+versatile+program+for+manipulating+atomic+coordinates+and+electron+density"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcRee%26aufirst%3DD.%2BE.%26atitle%3DXtalView%252FXfit%25E2%2580%2594A%2520versatile%2520program%2520for%2520manipulating%2520atomic%2520coordinates%2520and%2520electron%2520density%26jtitle%3DJ.%2520Struct.%2520Biol.%26date%3D1999%26volume%3D125%26spage%3D156%26epage%3D165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><i>GOLD (version 3.0)</i>; <span class="NLM_publisher-name">The Cambridge Crystallographic Data Centre (CCDC)</span>: <span class="NLM_publisher-loc">12 Union Road, Cambridge, CB2 1EZ2, U.K.</span>,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=GOLD+%28version+3.0%29%3B+The+Cambridge+Crystallographic+Data+Centre+%28CCDC%29%3A+12+Union+Road%2C+Cambridge%2C+CB2+1EZ2%2C+U.K.%2C+2005."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26pub%3DThe%2520Cambridge%2520Crystallographic%2520Data%2520Centre%2520%2528CCDC%2529%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><i>MOE (version 2005.06)</i>; <span class="NLM_publisher-name">Chemical Computing Group Inc. (CCG)</span>: <span class="NLM_publisher-loc">1010 Sherbrooke St. W, Suite 910 Montreal, Quebec, Canada</span>,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=MOE+%28version+2005.06%29%3B+Chemical+Computing+Group+Inc.+%28CCG%29%3A+1010+Sherbrooke+St.+W%2C+Suite+910+Montreal%2C+Quebec%2C+Canada%2C+2005."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26pub%3DChemical%2520Computing%2520Group%2520Inc.%2520%2528CCG%2529%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Mantle, D.</span><span> </span><span class="NLM_article-title">Characterization of dipeptidyl and tripeptidyl aminopeptidases in human kidney soluble fraction</span> <span class="citation_source-journal">Clin. Chim. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">196</span><span class="NLM_x">, </span> <span class="NLM_fpage">135</span><span class="NLM_x">–</span> <span class="NLM_lpage">142</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm101236h&amp;key=10.1016%2F0009-8981%2891%2990066-L" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm101236h&amp;key=1674238" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm101236h&amp;key=1%3ACAS%3A528%3ADyaK3MXhsVSgsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=196&publication_year=1991&pages=135-142&author=D.+Mantle&title=Characterization+of+dipeptidyl+and+tripeptidyl+aminopeptidases+in+human+kidney+soluble+fraction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of dipeptidyl and tripeptidyl aminopeptidases in human kidney soluble fraction</span></div><div class="casAuthors">Mantle, David</div><div class="citationInfo"><span class="NLM_cas:title">Clinica Chimica Acta</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">196</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">135-42</span>CODEN:
                <span class="NLM_cas:coden">CCATAR</span>;
        ISSN:<span class="NLM_cas:issn">0009-8981</span>.
    </div><div class="casAbstract">To identify improved biochem. markers for the diagnosis of early kidney damage via urinary anal. of kidney derived enzymes, systematic identification, quantification, and characterization (following purifn. via anion exchange and gel filtration chromatog., and preparative electrophoresis) was undertaken of the dipeptidyl and tripeptidyl aminopeptidases in normal human kidney sol. ext. (with which the majority of the cellular activity of these enzymes is assocd.).  Four chromatog. separable enzyme types were identified as follows (% relative activity in parentheses): dipeptidyl aminopeptidase I (EC 3.4.14.1; 24%); dipeptidyl aminopeptidase II (EC 3.4.14.2; 8%); dipeptidyl aminopeptidase IV (EC 3.4.14.5; 61%); tripeptidyl aminopeptidase (unclassified; 7%).  Comparison of the levels of activity for the above enzyme types in normal and pathol. urine may lead to an improvement upon existing procedures for the early detection of renal damage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1rWf7QqQ7BLVg90H21EOLACvtfcHk0lhL_292-tKIVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXhsVSgsb0%253D&md5=c13a0cb8a94f066ebb7725ea38742db4</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2F0009-8981%2891%2990066-L&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0009-8981%252891%252990066-L%26sid%3Dliteratum%253Aachs%26aulast%3DMantle%26aufirst%3DD.%26atitle%3DCharacterization%2520of%2520dipeptidyl%2520and%2520tripeptidyl%2520aminopeptidases%2520in%2520human%2520kidney%2520soluble%2520fraction%26jtitle%3DClin.%2520Chim.%2520Acta%26date%3D1991%26volume%3D196%26spage%3D135%26epage%3D142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3O9V" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3O9V','PDB','3O9V'); return false;">PDB: 3O9V</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3O95" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3O95','PDB','3O95'); return false;">PDB: 3O95</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1R9M" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1R9M','PDB','1R9M'); return false;">PDB: 1R9M</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i105"><a href="/doi/suppl/10.1021/jm101236h">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_45643"></div></div></div></div></div><hr /></hr><p class="last">Experimental procedure for compound <b>25j</b>. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm101236h/suppl_file/jm101236h_si_001.pdf">jm101236h_si_001.pdf (58.84 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm101236h&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2011.54.issue-3%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Fjm101236h" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm101236h" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679aae279c3223b0","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
